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1. SUMMARY 
 
The human gastric pathogen Helicobacter pylori establishes a long-term infection leading to chronic 
inflammation of the stomach. Most of the infected individuals do not suffer symptoms or the 
manifestation occurs after many years. In some cases, the infection leads to gastric ulcers, gastric 
cancer or MALT lymphoma.  Higher probabilities to develop clinical evidence of H. pylori infection 
have been associated with virulence factors like the cag pathogenicity island (cagPAI) and the more 
toxic alleles of the cytotoxin VacA. 
H. pylori displays a high mutation rate and frequent recombination during mixed infections, which 
contribute to its great allelic diversity and genome plasticity. The high level of genetic variation of H. 
pylori has been proposed to contribute to its adaptation to different human hosts.  
Interestingly, despite the small genome size of H. pylori, the genome contains an exceptional number 
of strain-specific genes encoding Restriction-Modification (R-M) systems. They have been proposed 
to act as “primitive immune systems” in bacteria. However, other roles have been assigned to the 
methylation catalyzed by the MTases, including control of gene expression. 
So far, it is not well understood how H. pylori takes advantage of its genome variability to adapt to 
novel stomach niches and the role of the extraordinary number of R-M systems. Moreover, there is 
not much known about how methylation influences the H. pylori transcriptome and how it modifies 
the phenotype. 
In previous studies, H. pylori isolates were obtained at different intervals of time in chronically 
infected patients.  Genome analysis of sequential isolates allowed studying the distribution of genetic 
changes, the calculation of mutation rates and recombination frequencies. Imports clustered in a 
non-arbitrary distribution. Thus, it was shown that there was a selection for the diversification of 
genes encoding outer membrane proteins (OMP), which have an impact on the interaction of the 
bacteria with the gastric epithelium.  
At the onset of this thesis, only few studies had attempted to understand H. pylori genome evolution 
during acute infection. The diversification of genes during early colonization cannot be investigated 
using isolates from chronically infected patients since initial genetic changes would be hard to 
distinguish from long-term adaptation or might have disappeared following a population bottleneck. 
We have compared the genomes of isolates from human volunteers who were experimentally 
infected with a fully virulent H. pylori strain. The volunteers were given either placebo or a 
prophylactic vaccine candidate and subsequently challenged with H. pylori. Isolates were recovered 
12 weeks (62 weeks in one case) post infection, and their genomes were sequenced. The data 
Summary 
2 
 
showed that OMP-related genes were the ones most prone to vary between isolates and the 
mutation rates were in agreement with the ones calculated during chronic H pylori infections. 
Additionally, the activities of multiple virulence factors were affected during short-term infection. 
Interestingly, the gene encoding for the vacuolating cytotoxin VacA was inactivated in three isolates, 
suggesting that a vaccine-induced selection pressure modulated the activity of this virulence factor. 
Therefore, H. pylori exhibits a rapid genome evolution already within a few weeks of infection that 
may be crucial for the adaptation to novel stomach niches. 
The R-M system portfolio varies between strains leading to variable methylomes. R-M systems are 
typically composed of a restriction enzyme (REase) and a methyltransferase (MTase). The REase 
cleaves foreign unmethylated DNA at a specific target site, while the MTase adds methyl groups at 
the same motif. Thus, R-M systems act as a barrier against invading DNA. Nevertheless, other 
functions have been attributed to methylation apart from self-DNA recognition, such as modulation 
of gene expression, control of the cell cycle and DNA replication. We compared the methylomes of 
isolates from human volunteers infected with H. pylori and found that variation in the methylomes 
was caused by a switch in the expression of phase-variable MTase genes, which might play a role in 
colonization by regulating gene expression. 
So far, only few studies had shown that methylation impacts gene transcription in H. pylori. In this 
work, I focused on an extraordinarily conserved m5C-MTase gene (JHP1050) shared by every H. pylori 
strain. Analysis of 459 H. pylori genomes showed that the MTase gene was always present and 
putatively active. In contrast, the corresponding REase gene was found in 61 genomes only, and 
predicted to be functional in 15 of these. A phylogenetic analysis of the MTase and REase genes 
showed a tree structure similar to the overall population structure of the strains (as computed from 
seven gene multilocus haplotypes), suggesting that this particular R-M system was acquired early in 
the history of H. pylori. 
We used RNA sequencing to analyze the transcriptome of two H. pylori wild type strains (J99 and 
BCM-300) and their corresponding isogenic MTase mutants. Transcriptome comparison of J99 and 
J99 MTase mutant showed 225 differentially expressed genes. In contrast, the transcriptomes of 
BCM-300 and the mutated strain exhibited 29 genes with different expression. Of those, 10 genes 
were differentially expressed in both, J99 and BCM-300. Moreover, changes in gene expression 
affected several phenotypic attributes such as adherence to host cells, bacterial competence for DNA 
uptake, copper susceptibility and cell morphology.  
Using site-directed mutagenesis, we modified different GCGC motifs to GAGC sequences, which were 
not susceptible to methylation. The motifs were selected due to their location: one motif was located 
within an antitoxin gene and two motifs were placed within the 500 bp upstream region of the gene. 
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One of the upstream motifs overlapped with the -10 box of the predicted promoter. Quantification 
of the gene expression disclosed that the modification of the GCGC motif overlapping the promoter 
had a direct impact on gene expression. Similar result was observed when the whole R-M system was 
inactivated.  
The work of the current thesis provided novel insights into in vivo genome and methylome 
modifications arising in the very first stages of H. pylori infection. Additionally, we contributed to the 
understanding of how the same MTase is able to modulate the expression of several genes and the 
phenotype of H. pylori in a strain-specific manner. Furthermore, we showed that motifs within 
regulatory regions have a direct impact upon transcription.  
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2. ABBREVIATIONS 
 
m6A   N6-methyladenine 
m4C   N4-methylcytosine 
m5C   5-methylcytosine 
ANOVA   analysis of variance 
ATP   adenosine triphosphate 
BabA   blood group antigen-binding adhesin A 
cagA   cytotoxin associated gene A 
cagPAI   cag pathogenicity island 
CAT   chloramphenicol acetyl transferase 
CDS   coding sequences 
CEACAMS  carcinoembryonic antigen-related cell adhesion molecules 
CH3   methyl group 
DEGs   differentially expressed genes 
dsDNA   double-stranded DNA 
ssDNA   single-stranded DNA 
FC   fold change 
FCS   fetal calf serum 
gDNA   genomic DNA 
HGT   horizontal gene transfer 
IARC   International Agency for Research on Cancer 
IL   interleukin 
Km   kanamycin 
L/D   live or dead 
Leb   Lewis b 
LPS   lipopolysaccharides 
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MAMPs  microbe-associated molecular patterns 
MLST   multi-locus sequence typing 
MMR   mismatch repair 
MTase   methyltransferase 
MuGent  multiplex genome editing 
NAP   neutrophil-activating protein 
NGS   next generation sequencing 
O/E   observed / expected 
OMPs   outer membrane proteins 
PPIs   proton pump inhibitors 
PRRs   pattern recognition receptors 
qPCR   quantitative PCR 
REase   restriction endonuclease 
R-M   restriction-modification 
rRNA   ribosomal RNA 
RUT   rapid urease test 
S subunit  specificity subunit 
SabA   sialic acid binding adhesin A 
SAM   S-adenyl methionine 
sLex/a   sialyl-Lewis x/a antigens 
SMRT   Single Molecule, Real-Time 
SNPs   single nucleotide polymorphisms 
TA   toxin-antitoxin 
TSS   transcription start site 
T4SS   type IV secretion system 
TLR’s   toll-like receptors 
VacA   vacuolating cytotoxin A 
WHO   World Health Organization 
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3. INTRODUCTION 
3.1. Helicobacter pylori: general microbiology, clinical aspects and therapies  
3.1.1 Discovery of H. pylori and general microbiology 
The gastric pathogen Helicobacter pylori was discovered in 1982 by the Australian scientists Barry J. 
Marshall and J. Robin Warren. They observed that a spiral bacterium was present in almost all gastric 
biopsies obtained from individuals with active chronic gastritis and with duodenal ulcers, and the 
majority of those with gastric ulcers (Warren and Marshall 1983). A pioneer study using gastric 
biopsies from patients allowed these two scientists to relate the presence of this previously 
uncharacterized pathogen with gastritis and peptic ulcers (Marshall and Warren 1984). To confirm 
the results, Barry J. Marshall infected himself with an H. pylori culture and subsequently developed 
severe active gastritis (Marshall, Armstrong et al. 1985). In 2005, Marshall and Warren were awarded 
with the Nobel Prize in Physiology or Medicine for the discovery of a human pathogen causing gastric 
diseases.  
H. pylori is a spiral-shaped, Gram-negative bacterium that belongs to the phylum Proteobacteria and 
to the class Epsilonproteobacteria. The rotation of 4-6 flagella at one of the bacterial poles provides 
motility to H. pylori. The growth of H. pylori depends on microaerobic conditions (lower levels of 
oxygen, 5%), elevated concentrations of CO2 (5-10%), and a temperature of 37°C (Bury-Moné, 
Kaakoush et al. 2006). H. pylori is catalase, oxidase and urease positive; thus, tests based on the 
activity of these enzymes are classically used in the identification of the infection (Kusters, van Vliet 
et al. 2006).  
3.1.2. Clinical aspects and therapies 
About half of the world’s population is infected by H. pylori, but the infection rates differ among 
countries, with a higher prevalence in places where the access to appropriate health and sanitary 
conditions is restricted (Eusebi, Zagari et al. 2014, Peleteiro, Bastos et al. 2014). A recent systematic 
review and meta-analysis about the prevalence of H. pylori indicated that African countries have the 
highest rates of infection (70.1%) while the lowest prevalence was found in Oceania (24.4%). In 
Germany, the infection rate was estimated to be 35.5% (Hooi, Lai et al. 2017).  
H. pylori is likely to establish a life-long infection when not treated. While the majority of the patients 
do not develop clinical symptoms, chronic gastritis can progress to several diseases like gastric or 
duodenal ulcers (10%) or even gastric cancer and lymphoma of the mucosa-associated lymphoid 
tissue (MALT) (1%) (Suerbaum and Michetti 2002). Stomach cancer is, based on data provided by The 
International Agency for Research on Cancer (IARC), the fifth most common cancer in the world and 
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the third malignancy in terms of mortality (Bray, Ferlay et al. 2018). H. pylori is associated with 90% 
of all new stomach cancers; thus, it has been classified since 1994 by the World Health Organization 
(WHO) as a class I carcinogenic agent (IARC 1994).  
Eradication of H. pylori is a difficult task. The mucus layer of the stomach provides protection to the 
pathogen, making the bacteria difficult to approach by antimicrobials (Shimizu, Akamatsu et al. 
1996). Established treatment regimens consist of a combination of antibiotics and proton pump 
inhibitors (PPIs) during 7-14 days, in order to ensure the eradication of the infection (Malfertheiner, 
Megraud et al. 2017, Zagari, Rabitti et al. 2017). However, a rapid increase in antimicrobial resistance 
has led to the inclusion of H. pylori in the list of high-risk pathogens by the WHO in 2017, calling for 
the development of novel treatments against this bacterium (WHO 2017). 
Substantial efforts have been made to develop a vaccine against H. pylori. Vaccines could prevent the 
acquisition of the bacteria, avoid future infections and reduce antimicrobial resistance. However, the 
majority of the vaccine candidates under development were abandoned after preclinical or phase I 
trials (Michetti, Kreiss et al. 1999, Banerjee, Medina-Fatimi et al. 2002, Czinn and Blanchard 2011, 
Moss, Moise et al. 2011, Sutton and Boag 2018). Two types of vaccines have been mostly developed 
and applied: a prophylactic vaccine to prevent the effects of future infections via the stimulation of 
the immune responses or a therapeutic vaccine given after the infection to alter the disease 
outcome.  
Prior to clinical studies to test vaccine candidates, there was a need to develop a safe human model 
to study H. pylori infection and the immune response. This model was established by Graham and 
colleagues. Human volunteers were infected with a cag Pathogenicity Island (cagPAI) negative H. 
pylori strain (BCS 100) and treated with antibiotics to eradicate the infection after 4 or 12 weeks. 
With this study, the authors demonstrated that the infection and eradication of H. pylori were 
possible in human volunteers and that the subjects developed typical symptoms associated with H. 
pylori infection (Graham, Opekun et al. 2004). Afterwards, clinical studies used human volunteers to 
test prophylactic vaccine candidates. In one study, individuals where challenged with the cagPAI 
negative H. pylori strain BCS 100 and subsequently given a Salmonella Ty21a vaccine expressing the 
H. pylori urease A and B subunits (Aebischer, Bumann et al. 2008). Later, Malfertheiner and 
colleagues evaluated a prophylactic vaccine candidate (expressing three recombinant H. pylori 
proteins: CagA, VacA and NAP) in healthy human volunteers who were subsequently challenged with 
a fully pathogenic H. pylori strain (BCM-300) (Malfertheiner, Selgrad et al. 2018). In both cases, even 
though well tolerated and able to induce an immune response, the vaccines were ineffective in 
protecting the human volunteers against a new H. pylori infection (Aebischer, Bumann et al. 2008, 
Malfertheiner, Selgrad et al. 2018).  
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Thus, so far, there is no vaccine available against H. pylori. Some of the reasons leading to the 
difficulties in the improvement of functionally active vaccines are the high genetic variability of H. 
pylori and its ability to escape from the immune system (Aebischer, Schmitt et al. 2005). Only one 
vaccine candidate reached clinical phase III. The recombinant vaccine was provided to children, and 
after 1 and 3 years follow up, the authors observed a reduction in H. pylori infection rate (Zeng, Mao 
et al. 2015). However, there is no more information available if the vaccine study was continued.  
3.2. Colonization and virulence factors 
H. pylori is restricted to the extreme environment provided by the stomach niche. The bacterium is 
able to adhere to the gastric epithelium or swim in the mucus layer. In order to ensure a successful 
colonization, H. pylori requires a battery of resources. Once H. pylori has been acquired, the bacteria 
must face the acidic pH in the gastric fluid (pH of 1-2 between meals) by activating cytoplasmic 
urease (Kusters, van Vliet et al. 2006). Next, H. pylori is able to move along the gastric epithelium due 
to flagella-based chemotactic motility (Schreiber, Konradt et al. 2004, Lertsethtakarn, Ottemann et 
al. 2011, Behrens, Schweinitzer et al. 2013). H. pylori swims to the mucus layer and multiplies when 
an optimal pH 5-7 is reached. Part of the bacterial population attaches to the gastric epithelial cells 
using various adhesins. Finally, the bacterium secretes several virulence factors, like the cytotoxin-
associated gene product A (CagA) and the vacuolating cytotoxin A (VacA) (Dunne, Dolan et al. 2014, 
Kao, Sheu et al. 2016) (Figure 1). 
 
Figure 1. Process of H. pylori infection from the gastric fluid (acid pH) to the epithelium (neutral pH). H. 
pylori confronts the acid pH by activating cytoplasmic urease. Urea is hydrolyzed, leading to the 
buffering of the periplasm and adjusting the membrane potential. Chemotactic motility allows the 
bacterium to move through the gastric epithelium and reach neutral pH. Attachment to epithelial cells 
takes place due to a battery of adhesins. Finally, several virulence factors are secreted.  
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3.2.1. Inflammation and immune evasion 
In order to establish a life-long infection, H. pylori must evade the immune system. When the 
bacterium is transmitted to a new host, two scenarios are possible: the infection is cleared by the 
immune response or, in contrast, the gastric pathogen is able to escape from the immune system 
and establish a persistent infection leading to gastric inflammation (Baldari, Lanzavecchia et al. 
2005). To successfully establish a chronic infection, H. pylori is able to disrupt and modulate the 
immune system and ultimately escape immunity-mediated clearance.  
Every individual infected with H. pylori develops active gastritis. H. pylori uses several mechanisms 
like virulence factors and outer membrane proteins (OMPs) to recruit immune cells to the site of 
infection and induce inflammation in the gastric epithelial cells (Suerbaum and Michetti 2002, Lamb 
and Chen 2013). The activation of several host transcription factors induces the up-regulation of 
inflammatory molecules like cytokines and chemokines. Inflammatory cytokines IL-1, IL-2 IL-6, IL-8 
and TNF are overexpressed in H. pylori infected patients (Suerbaum and Michetti 2002).   
Lipopolysaccharides (LPS) and flagellin are common examples of H. pylori immune evasion. The best-
studied pattern recognition receptors (PRRs) are the toll-like receptors (TLRs). LPS act as microbe-
associated molecular patterns (MAMPs) and they can be recognized mostly by TLR4 in Gram-negative 
bacteria (Takeuchi, Hoshino et al. 1999, Mogensen 2009). Modifications within the lipid core A 
domain of H. pylori’s LPS lead to lower activation of TLR4 (Salama, Hartung et al. 2013, Varga and 
Peek Jr. 2017). TLR5 senses bacterial flagellins. However, H. pylori flagellins (FlaA and FlaB) avoid 
TLR5 detection due to modifications in the TLR5 recognition site (Lee, Stack et al. 2003, Gewirtz, Yu et 
al. 2004, Andersen-Nissen, Smith et al. 2005). 
Virulence factors can also modulate the immune system. VacA can suppress adaptive immune 
activity by targeting lymphocytes and disrupt, for example, the phagocytic killing of H. pylori. In 
addition, VacA interferes with T-cell proliferation, production of cytokines and dendritic cells, 
modulating their normal function (Djekic and Müller 2016). 
3.2.2. Urease 
In order to cope with the low pH present in the stomach lumen, H. pylori produces urease, a 
cytoplasmic enzyme, as a first line of defense. Urease is one of the most predominant enzymes in H. 
pylori, representing 10-15% of the total protein content (Bauerfeind, Garner et al. 1997). Regulation 
of urease levels depends on the availability of the cofactor nickel (van Vliet, Kuipers et al. 2001, de 
Reuse, Vinella et al. 2013). The urease gene cluster consists of two operons. The first operon contains 
the two structural subunits ureAB and the second operon, located downstream, harbours the 
accessory ureIEFGH genes (Mobley 2001). At an external pH < 6.0, urea goes through the outer and 
inner membranes thanks to the urea channel UreI and meets activated cytoplasmic urease (Krulwich, 
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Sachs et al. 2011). Hydrolysis of urea leads to the buffering of the periplasm and adjusting the 
transmembrane potential to adequate levels that allow protein synthesis and growth in acid 
environments (Scott, Weeks et al. 1998). Direct measurements showed that the periplasmic pH is 
increased to and maintained at pH 6.2 when the medium is acidic (Wen, Scott et al. 2018). Thus, 
urease is considered a key virulence factor that enables H. pylori survival in the acidic stomach 
(Eaton, Brooks et al. 1991). 
3.2.3. Motility and chemotaxis 
Motility based on flagella and chemotaxis is an essential factor for colonization and establishing the 
infection, since it allows the pathogen to migrate and move through the mucus layer (O'Toole, Lane 
et al. 2000, Josenhans and Suerbaum 2002, Lertsethtakarn, Ottemann et al. 2011). H. pylori 
possesses 4-6 unipolar flagella, which provide motility (Geis, Leying et al. 1989, Josenhans, Eaton et 
al. 2000). H. pylori harbors core chemotactic proteins (CheA, CheW and CheY) and four 
chemoreceptors (TlpA, TlpB, TlpC and TlpD) (Lertsethtakarn, Ottemann et al. 2011). TlpA, TlpB and 
TlpC are integral membrane proteins while TlpD is a cytoplasmic protein. Several compounds 
influence H. pylori chemotactic activity like urea, lactate, mucins, and others (Spohn 2001, Croxen, 
Sisson et al. 2006, Behrens, Schweinitzer et al. 2013).  
3.2.4. Outer membrane proteins and adhesins 
H. pylori attaches to the epithelial cells using a set of OMPs that can act as adhesins. Attachment to 
the gastric epithelial cells is possible due to the interaction between the bacterial adhesins and host 
oligosaccharides, glycans, and host surface-proteins (Testerman, McGee et al. 2001). It has been 
described that 4% of H. pylori’s genome encode OMPs (Dossumbekova, Prinz et al. 2006). The Hop 
family of proteins is the biggest family of OMPs, followed by the Hor, Hof and Hom families (Tomb, 
White et al. 1997, Alm, Bina et al. 2000). Many of the known H. pylori adhesins belong to the Hop 
family of OMPs. Among others, the major adhesins for which the host receptor has been identified so 
far are BabA, SabA and HopQ.  
BabA:  the blood group antigen-binding adhesin A binds to fucosylated Lewis b (Leb) antigen and 
related ABO blood group antigens present on epithelial cells and gastric mucins (Borén, Falk et al. 
1993, Aspholm-Hurtig, Dailide et al. 2004). BabA binding to Leb is reversible and acid-sensitive, with 
higher affinities when the pH increases (Bugaytsova, Bjornham et al. 2017). Gene conversion with the 
paralogous gene babB and phase variation led to the loss of babA expression during chronic infection 
of Rhesus monkeys and in some clinical isolates (Solnick, Hansen et al. 2004). The loss of babA 
expression was not dependent on Leb binding, suggesting additional functions of this important 
adhesin (Solnick, Hansen et al. 2004, Nell, Kennemann et al. 2014, Hansen, Gideonsson et al. 2017). 
Modifications in the C-terminus of BabA can affect the expression and binding abilities of the protein, 
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since the C-terminus has been reported to be relevant for the correct protein folding (Nell, 
Kennemann et al. 2014). 
SabA: the sialic acid binding adhesin recognizes the sialyl-Lewis x/a antigens (sLex and sLea) that are 
usually replacing the normal Le antigens during chronic gastric inflammation and gastric carcinoma 
(Mahdavi, Sonden et al. 2002). H. pylori binds to neutrophils via SabA, inducing an oxidative burst 
(Mahdavi, Sonden et al. 2002, Unemo, Aspholm-Hurtig et al. 2005).  
HopQ: It has been recently discovered that HopQ binds to several human and murine 
carcinoembryonic antigen-related cell adhesion molecules (CEACAMS) (Javaheri, Kruse et al. 2016, 
Königer, Holsten et al. 2016). This particular adhesin seems to be important in the pathogenesis of H. 
pylori since its interaction is essential for the translocation of the oncoprotein CagA into the host cells 
(Javaheri, Kruse et al. 2016, Königer, Holsten et al. 2016). 
Although some adhesins and their roles in infection are described in H. pylori, the great numbers of 
OMPs and still uncharacterized genes suggest there might be other undescribed adhesins 
contributing to colonization. 
3.2.5. The cagPAI and the oncoprotein CagA 
The cagPAI is one of the major virulence factors of H. pylori and it has been associated with a higher 
risk of developing gastric diseases (Blaser, Perez-Perez et al. 1995, Parsonnet, Friedman et al. 1997). 
The cagPAI consists of a 40 kb chromosomal region containing more than 30 predicted genes coding 
for a Type IV Secretion System (T4SS) (Censini, Lange et al. 1996, Olbermann, Josenhans et al. 2010). 
The T4SS of H. pylori includes genes that are considered orthologs of components of the Vir T4SS 
system of Agrobacterium tumefaciens, but also additional genes. The products of some genes were 
shown to be required for the functionality of the cagPAI (Fischer, Puls et al. 2001). 
The presence of the cagPAI in H. pylori strains varies among geographical regions, with a prevalence 
of approximately 60% in Western countries and 100% in Asia (Yamaoka, Kodama et al. 1999, 
Gressmann, Linz et al. 2005, Olbermann, Josenhans et al. 2010). The strains harboring the island, 
cagPAI+ strains, are usually associated with a higher risk of developing gastric malignancies due to a 
combination of host and strain factors (Figueiredo, Machado et al. 2002, Noto and Peek Jr. 2012, 
Cover 2016).  One important bacterial element associated with gastric cancer is the oncoprotein 
CagA. This protein contains multiple tyrosine phosphorylated (EPIYA) motifs in the carboxy-terminal 
region. The EPIYA motifs are essential for the association of CagA with the membrane (Higashi, 
Yokoyama et al. 2005). The type and number of EPIYA motifs has been associated with the risk of 
developing gastric cancer and ulcers, although several studies displayed controversial results (Jones, 
Joo et al. 2009, Li, Liu et al. 2017).  
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The oncoprotein CagA is injected into the gastric epithelial cells and subsequently phosphorylated by 
host cellular kinases, triggering multiple effects on cellular signal transduction cascades and 
morphological alterations in the host cells, like the “hummingbird phenotype”, characterized by cell 
elongation. CagA binds and deregulates the SHP-2 Tyrosine Phosphatase that is an oncoprotein 
prone to mutate in several human cancers (Hatakeyama 2004) (Figure 2).  
 
Figure 2. Representation of two major virulence factors, CagA and VacA. The oncoprotein CagA is injected in 
the epithelial cell and phosphorylated. CagA binds to several proteins triggering multiple effects on the host 
cell. VacA produces several effects on the host cell. Some examples are the formation of vacuoles, the 
localization in the mitochondria where produces cytochrome c release and possibly apoptosis, and binding to 
cell-membrane receptors activating pro-inflammatory signaling. 
3.2.6. Vacuolating cytotoxin A (VacA) 
VacA is considered a multifunctional toxin in H. pylori, causing a wide range of effects on the host 
cells (Cover and Blanke 2005). VacA molecules are secreted to the extracellular space or they can 
stay on the surface of H. pylori (Foegeding, Caston et al. 2016). Several alleles are present among 
strains and were shown to possess different abilities to cause cell damage. The s1m1 type is the most 
pathogenic allelic variant. Strains carrying the s1m1 allele have been linked to a higher risk of 
developing peptic ulcers (Atherton, Cao et al. 1995). 
VacA intoxicates several types of human cells, including immune cells, leading to distinct alterations. 
Internal vacuolization was the first direct effect caused by VacA that was discovered (de Bernard, 
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Arico et al. 1997). VacA is able to modify mitochondrial permeability via reduction of the 
mitochondrial transmembrane potential and cytochrome c release (Willhite and Blanke 2004). The 
toxin also acts on several immune cells driving to localized immunosuppression and production of 
pro-inflammatory cytokines (Gebert, Fischer et al. 2003, Montecucco and de Bernard 2003) (Figure 
2).  
3.3. Mechanisms driving genetic diversity in H. pylori 
Every infected individual is believed to carry a unique H. pylori strain, since the bacterium displays an 
extraordinarily high genetic diversity that is greater than in most other bacteria (Achtman, Azuma et 
al. 1999). Whole genome analysis of the first two sequenced H. pylori strains (J99 and 26695) 
revealed that 6% of the gene content differed between strains (Tomb, White et al. 1997, Alm, Ling et 
al. 1999). H. pylori’s genetic variability is thought to play an important role in adaptation to different 
human hosts and to the variable conditions of the gastric environment. Several mechanisms are 
responsible for the extraordinary sequence variability of the gastric pathogen.  
3.3.1. Mutation 
H. pylori mutation rates (10-5 - 10-7) are several orders of magnitude higher than the ones found for 
the majority of other bacterial species (Björkholm, Sjolund et al. 2001). This phenomenon is related 
to the lack of a classic DNA mismatch repair (MMR) system and the hypermutator role of its DNA 
polymerase I (Garcia-Ortiz, Marsin et al. 2011). Moreover, homopolymeric and dinucleotide repeats 
are prone to phase-vary by slipped-strand mispairing, switching the activity of genes when they are 
located in promoters or within gene sequences (Josenhans, Eaton et al. 2000, Salaun, Linz et al. 2004, 
Kraft and Suerbaum 2005, Baltrus, Blaser et al. 2009). Thus, spontaneous mutations within coding 
sequences or regulatory regions can alter the amino acid sequence of the translated protein, leading 
to modified functions of the protein (gain or loss) and therefore, modify the fitness of the bacteria.   
3.3.2. Recombination 
Despite the high mutation rate, recombination is the process introducing most of the allelic changes 
in the genome during mixed infections with two or more H. pylori strains (Suerbaum, Maynard Smith 
et al. 1998, Kang and Blaser 2006, Didelot, Nell et al. 2013). The natural competence of H. pylori 
allows the uptake of exogenous double-stranded DNA (dsDNA) by the ComB system (Hofreuter, 
Odenbreit et al. 2001, Stingl, Muller et al. 2010, Dorer, Sessler et al. 2011). Following uptake, dsDNA 
is transformed to single-stranded DNA (ssDNA), transferred to the cytoplasm and able to recombine 
with the recipient’s genome after interaction with RecA (Fischer and Haas 2004, Dorer, Sessler et al. 
2011). Acquisition of imports by H. pylori generates a bimodal distribution of import lengths, with 
short (less than 50 bp) and long (peak length 1,645 bp) patches of imported sequences (Bubendorfer, 
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Krebes et al. 2016). Hence, recombination is a key mechanism driving to genomic evolution and 
plasticity in H. pylori. 
3.3.3. H. pylori populations reflect human migrations 
Multi Locus Sequence Analysis (MLSA) based on the sequencing of 7 housekeeping genes in a 
collection of 370 strains from 27 geographical and ethnic human regions led to the assignment of H. 
pylori to several modern populations and permitted the reconstruction of inferred ancestral 
populations (Falush, Wirth et al. 2003) (Table 1). The high genetic diversity of H. pylori and the 
coevolution and migrations with its human host, which began at least 80,000 years ago, resulted in 
the separation into phylogeographic populations that reflect human migrations (Linz, Balloux et al. 
2007, Moodley, Linz et al. 2009, Breurec, Guillard et al. 2011, Moodley, Linz et al. 2012).  
Table 1. Phylogeographic modern populations, subpopulations and ancestral population of H. pylori. 
 
 
3.4. The H. pylori methylome: diversity of the Restriction-Modification (R-M) 
systems  
DNA methylation is the process that occurs by the addition of methyl groups (CH3) from the donor S-
adenyl methionine (SAM) to DNA sequences. In eukaryotes, methylation typically occurs at the fifth 
position of the pyrimidine ring of cytosines leading to 5-methylcytosine (m5C). In mammals, most of 
the m5C-methylations take place at cytosine residues as part of dinucleotide cytosine-guanine 
sequences, called CpG islands. In prokaryotes, there are another two types of methylation where CH3 
Modern population Modern subpopulation Ancestral population 
hpAfrica2  Ancestral Africa 2 
hpAfrica1 
hspSAfrica 
Ancestral Africa 1 hspWAfrica 
hspCAfrica 
hpNEAfrica  Ancestral Europe 2 
hpEurope  Ancestral Europe 1 and 2 
hpSahul  Ancestral Sahul 
hpEastAsia 
hspEAsia 
Ancestral East Asia hspAmerind 
hspMaori 
hpAsia2  Ancestral Europe 1 
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is added to the N6 position of adenines resulting in N6-methyladenine (m6A), or to the N4 position of 
cytosines generating N4-methylcytosine (m4C) (Figure 3).  
 
Figure 3. Chemistry of methylated nucleotides. From left to right: 5-methylcytosine (m5C), N6-methyladenine 
(m6A) and N4-methylcitosine (m4C). 
Methylation is catalyzed by methyltransferase enzymes (MTases), which add methyl groups to 
adenines or cytosines of a target motif. MTases in prokaryotes are often part of Restriction-
Modification (R-M) systems. Such systems are usually composed of one MTase that methylates host 
DNA, and the restriction enzyme (REase) that cleaves foreign unmethylated DNA at the same target 
sequence. The R-M systems can be divided into four main groups based on the mechanism 
recognizing the target motif. 
3.4.1. The discovery and functions of the R-M systems 
In the early 50s, it was observed that one bacteriophage was able to grow in a particular bacterial 
host but was restricted in growth in other strains. This singularity was called by the investigators 
“host-induced variation” (Luria and Human 1952, Bertani and Weigle 1953). The observation inspired 
many researchers to understand the mechanism responsible for this phenomenon. In 1978, W. 
Arber, D. Nathans and H. Smith shared the Nobel Prize in Physiology and Medicine for the discovery 
of DNA-specific sequences, the enzymes in charge of cleaving DNA and their application in molecular 
genetics (Arber and Dussoix 1962, Dussoix and Arber 1962, Smith and Wilcox 1970, Danna and 
Nathans 1971). Since their discovery, REases have been used in molecular biology as genetic 
engineering tools. 
R-M systems are widely distributed among bacterial species, as well as in archaea and eubacteria 
(Vasu and Nagaraja 2013). They have been classified as “primitive immune systems” (Bickle 2004), 
due to their protective role against exogenous DNA, contributing to bacterial genomic evolution and 
limiting horizontal gene transfer (HGT) (Gogarten, Doolittle et al. 2002). Although it has been shown 
that R-M systems are successful entities cutting heterologous DNA, their effectiveness diminishes 
with homeologous incoming DNA (Bubendorfer, Krebes et al. 2016). Moreover, R-M systems have 
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been suggested to act as selfish-mobile genetic elements causing adverse effects on the host cell  
(Kobayashi 2001). However, some MTases are not associated to any R-M system. They are known as 
“orphan” MTases. 
In addition to self-DNA protection, methylation plays additional roles in bacteria. In E. coli, the Dam-
MTase, methylating Gm6ATC sites, is a key element in DNA replication. SeqA binds to hemimethylated 
GATC sites in the oriC and in the promoter of dnaA, sequestering the origin of replication. The 
sequestration avoids re-initiation of the DNA replication because the oriC and the dnaA promoter 
must be fully methylated (Messer, Bellekes et al. 1985, Russell and Zinder 1987, Bogan and 
Helmstetter 1997). Another well-studied example is the regulation of the cell cycle in Caulobacter 
crescentus by the CcrM-MTase methylating Gm6ANTC motifs. Methylation within the promoter of the 
regulatory protein CtrA during a certain period adjusts the replication of the chromosome to only 
one per cycle (Berdis, Lee et al. 1998, Kozdon, Melfi et al. 2013, Gonzalez, Kozdon et al. 2014). 
Furthermore, many MTases are prone to phase-variation and can coordinate the switch of the 
expression of several genes, which is called “phasevarion” (Srikhanta, Maguire et al. 2005, Srikhanta, 
Fox et al. 2010). Phase variable MTases and associated phasevarions have been found in many 
bacterial pathogens, including Haemophilus influenzae, Neisseria meningitidis and H. pylori (Fox, 
Dowideit et al. 2007, Srikhanta, Dowideit et al. 2009, Srikhanta, Gorrell et al. 2011).  
3.4.2. Classification of R-M systems 
The R-M systems are classified in four main groups. Type I, II and III are represented in Figure 4: 
Type I R-M systems: These are the most complex type of R-M systems since they consist of multi-
subunit proteins functioning as one module (Dryden, Murray et al. 2001). Furthermore, Type I R-M 
systems can be sub-divided into four categories (A, B, C, D) (Roberts, Belfort et al. 2003). They 
comprise three genes: the REase or R subunit (hsdR), the MTase or M subunit (hsdM) and the 
specificity subunit (hsdS). The hsdS carry two target recognition domains (TRDs) defining the 
sequence that will be recognized by the R-M system. Type I R-M system genes form a R2M2S1 complex 
that requires adenosine triphosphate (ATP) hydrolysis. The entity M2S1 methylates the target motif in 
the absence of the REase (Murray 2000, Roberts, Belfort et al. 2003, Kennaway, Obarska-Kosinska et 
al. 2009). So far, most of the Type I R-M systems methylate adenines within asymmetric motifs, 
although few systems methylating cytosines have been recently identified (Morgan, Luyten et al. 
2016). The target sequences typically comprise two segments of 3-4 bp separated by a spacer of 6-8 
bp (Murray 2000).  
Type II R-M systems: Type II REases and MTases usually act as monomers independently of each 
other. Type II MTases transfer the methyl-group from the donor SAM to adenines or cytosines, 
generating m6A, m4C and m5C types of methylation (Roberts, Belfort et al. 2003). Typically, Type II R-M 
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systems recognize palindromic sequences, but multiple exceptions exist, leading to several sub-
groups. There are numerous criteria to classify the Type II R-M systems in the different sub-
categories; therefore, many Type II R-M systems can be allocated within more than one group. 
Richard J. Roberts and colleagues summarized all the Type II sub-categories in (Roberts, Belfort et al. 
2003). In H. pylori, Type II R-M systems are the most predominant ones as it has been shown in 
various methylome studies (Kong, Lin et al. 2000, Krebes, Morgan et al. 2014, Lee, Anton et al. 2015). 
Type III R-M systems: The mod gene coding for the MTase or Mod and the res gene encoding the 
REase or Res, compose the Type III R-M systems. While two Mod subunits can achieve the enzymatic 
activity without the Res, the M2R2 complex is required for ATP-dependent cleavage (Dryden, Murray 
et al. 2001, Rao, Dryden et al. 2014). Many Type III R-M systems have been described to be phase-
variable due to simple repetitive DNA sequences that are prone to length changes via slipped strand 
mispairing. The reversible ON/OFF switch of the Mod activity enables modifications in the 
methylome, driving to phasevarion (Srikhanta, Maguire et al. 2005).  
Type IV R-M systems: These type of systems differ from the other three since they cleave modified 
DNA target sequences, including methylation, hydroxymethylation or glucosyl-hydroxymethylation 
(Vasu and Nagaraja 2013). This class of R-M systems are formed by one or two genes and their 
activity is not ATP-dependent.   
 
Figure 4. Classification of R-M systems. R-M systems add methyl groups to the target motif using SAM as 
donor. When the motif is not methylated, REases act and cleave the DNA. Cleavage of DNA by Type I R-M 
systems occur at a variable location away from the motif. Type II R-M systems usually cut within the 
palindromic motif. Type III R-M systems cleave at a fixed position (25-27 bp) from the target sequence 
(Srikhanta, Fox et al. 2010). M refers to MTase, S to specificity subunit, R to REase and SAM means S-adenyl 
methionine. The blue lines are the dsDNA and the motif is colored in green. 
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3.4.3. The R-M systems in the gastric pathogen H. pylori  
Despite its small genome, H. pylori encodes an extraordinarily high number of R-M systems, where 
every strain carries a unique set of R-M system genes leading to variable methylomes (Nobusato, 
Uchiyama et al. 2000, Roberts, Vincze et al. 2015). More than half of the strain-specific genes of H. 
pylori code for R-M systems (Tomb, White et al. 1997). 
The first two H. pylori methylomes from the strains 26695 and J99-R3 were studied using Single 
Molecule Real-Time (SMRT®) sequencing technology (Krebes, Morgan et al. 2014). The DNA 
polymerase used by the SMRT® sequencing technology catalyzes the incorporation of fluorescently 
labeled nucleotides. The kinetics of the polymerase are altered when there are modifications on the 
DNA sequence, such as methylation. Thus, every DNA modification produces different kinetics, 
allowing the identification of methylated nucleotides on the DNA (Schadt, Banerjee et al. 2013, 
Ardui, Ameur et al. 2018).  
In the past years, many other H. pylori methylomes have been published, confirming methylomic 
inter-strain diversity (Krebes, Morgan et al. 2014, Lee, Anton et al. 2015, Lamichhane, Chua et al. 
2019) and, indeed, few shared methylated motifs have been found between H. pylori strains (Vale, 
Megraud et al. 2009). Furthermore, using SMRT® sequencing technology, many novel recognition 
sites and their respective associated R-M system genes have been identified.  
Although the role of some MTases in epigenetic regulation in H. pylori has been elucidated (Donahue, 
Israel et al. 2002, Srikhanta, Gorrell et al. 2017, Kumar, Karmakar et al. 2018), the reason why H. 
pylori possesses so many R-M systems and their function is still not well understood. Functionally 
active R-M systems might promote homeologous recombination between H. pylori strains generating 
allelic diversity in a given population. Nevertheless, there are many orphan MTases that are not part 
of an active R-M system since the REase gene is truncated or absent, whose functions are still 
undescribed. 
 
 
 
 
 
 
 
Aims 
19 
 
4. AIMS 
 
The comparison of the first two complete genome sequences of H. pylori strains identified great 
genetic diversity, which was higher than of most other bacteria. Analysis of sequential isolates from 
chronically infected individuals showed that H. pylori displays high mutation and recombination 
rates. It was observed that OMP genes were found to be prone to modifications. Despite the 
contribution of these studies to the knowledge of H. pylori genetic diversity, the study of genomes 
from chronic isolates does not allow the investigation of genetic modifications arising in the first 
stages of the infection. Moreover, H. pylori diversity also comes from strain-specific genes encoding 
R-M systems, leading to variable methylomes between strains. DNA modifications that produce 
changes in gene expression but do not alter the gene sequence are known as epigenetic 
modifications. Methylation protects bacterial genomes from invading DNA, but also plays key roles in 
their physiology. Up to now, the majority of the bacterial methylome studies focused on methylation 
within adenine residues, since it is the most common type of modification in bacteria. 
However, the molecular mechanisms contributing to genetic and epigenetic evolution and the 
influence of methylation in transcription are so far not well understood. During this thesis, I tried to 
address questions to improve our understanding of genetic and methylomic evolution during early 
adaptation to novel stomach niches and the influence of methylation on gene transcription and H. 
pylori physiology. 
At the time of this writing, there is no licensed vaccine capable of preventing H. pylori infections. The 
potential to escape from the immune system by the high genetic variability of this bacterium may 
make the development of a successful vaccine difficult. However, this hypothesis had not been 
formally proven yet. We obtained H. pylori isolates from human volunteers who participated in an 
experimental vaccination study, and who were challenged with a fully virulent H. pylori strain. 
Bacterial isolates were collected 12 weeks post infection (62 weeks in one particular case). We aimed 
to investigate the in vivo genome and methylome evolution of H. pylori during the initial phase of 
chronic infection. With that purpose, we planned to use a combination of NGS techniques, like 
SMRT® sequencing, and advanced bioinformatics, together with genetic and biochemical 
experimental approaches. Thus, we anticipated that the study of evolved genomes from a known H. 
pylori strain would allow us to study de novo modifications taking place during the adaptation 
process to a novel niche. Moreover, because the isolates belonged either to placebo or vaccination 
groups, we tried to understand specifically the effect caused by the vaccine in the genetic 
modifications and phenotypic changes during early infection. 
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Next, I intended investigate the role of methylation in gene transcription. Because every H. pylori 
strain carries a unique set of R-M systems leading to variable methylomes, there are very few 
methylated motifs shared between H. pylori strains. However, we observed that one motif (Gm5CGC) 
was present in all H. pylori strains whose methylomes are publically available. Some studies have 
attempted to understand how methylation within specific target motifs influences transcription in H. 
pylori. Nonetheless, the MTases studied were not universally present and active in all H. pylori 
strains, indicating that regulation by those enzymes was strain-specific.  
Therefore, during this thesis I aimed to dissect the function of a highly conserved MTase (JHP1050), 
present in all H. pylori strains analyzed so far, that methylates the sequence GCGC resulting in a 
Gm5CGC motif. The objective was to identify whether methylation of GCGC motifs had an impact on 
gene regulation. Further, I intended to understand whether the effects were comparable between H. 
pylori strains. To do so, we were planning to apply a combination of RNA sequencing and advanced 
bioinformatic tools to two different H. pylori strains and their mutants carrying an interrupted MTase 
gene. Deciphering the transcriptomes, we were aiming to observe differentially expressed genes 
between both, the wild type and mutant strain and between the two H. pylori strains analyzed. 
Differential gene expression caused by the absence of methylation can be direct and indirect. Hence, 
we wanted to address if there was a direct impact of methylated GCGC motifs on gene expression. 
For that specific aim, we created a set of mutants in which selected GCGC motifs located within or 
upstream of a specific gene. The GCGC sequences were modified to GAGC motifs not susceptible to 
methylation. Then, we planned to quantify the expression of the target gene. 
Moreover, I aimed to characterize whether the absence of methylation had an effect on phenotypic 
traits and relate the phenotypic alterations to the differences observed in gene expression. With that 
purpose, we planned to characterize four H. pylori wild type and mutant strains with several 
phenotypic assays and to analyze whether adherence to host cells, natural competence for DNA 
uptake, bacterial cell shape, or susceptibility to copper were affected by the absence of methylation.  
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5. RESULTS 
 
Contributions of the authors to the manuscripts 
 
Manuscript I: S.N., I.E. and J.K. are joint first authors and contributed equally. The study was initiated 
by S.S., experiments and analyses were planned by S.N., I.E, J.K. and S.S.  
 S.N., J.K. and S.S. wrote the first version of the manuscript, while the rewriting of the revised version 
was jointly done by I.E. and S.S., with input from all coauthors. B.B., C.S., J.O., Y.S., performed PacBio 
SMRT® sequencing. S.N, J.K. and I.E. analyzed the genome and methylome data and performed the 
experiments.  
D.Y.G. provided strain BCM-300. T.W. and P.M. performed the clinical vaccine trial from which the 
bacterial isolates were obtained.  
 
Manuscript II: I.E. is the sole first author of this study. C.J. and S.S. shared senior authorship.  
S.S. initiated the study. Experiments were planned by I.E., C.J. and S.S., and performed by I.E. and 
A.O. Data were analyzed by I.E., F.A., C.J. and S.S.  
I.E., S.S. and C.J. wrote and revised the manuscript with input from all coauthors. 
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Short summary 
In this article, we studied genome and methylome evolution of 12 H. pylori isolates obtained 12 
weeks (62 weeks in one case) after the challenge of human volunteers with a fully virulent H. pylori 
strain during a vaccination trial. Whole genomes comparisons showed sequence modifications 
between the isolates, many of them affecting virulence factors and adhesins. Differences in the 
methylomes were due to changes in the activity of phase-variable MTases. The study provides 
evidence of rapid mutational and epigenetic adaptation of H. pylori during the first weeks of human 
infection. 
 
 
 
 
 
 
 
 
Genome and Methylome Variation in Helicobacter pylori With a
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BACKGROUND & AIMS: Helicobacter pylori is remarkable for its
genetic variation; yet, little is known about its genetic changes
during early stages of human infection, as the bacteria adapt to
their new environment. We analyzed genome and methylome
variations in a fully virulent strain of H pylori during experi-
mental infection. METHODS: We performed a randomized
Phase I/II, observer-blind, placebo-controlled study of 12
healthy, H pylori–negative adults in Germany from October 2008
through March 2010. The volunteers were given a prophylactic
vaccine candidate (n¼ 7) or placebo (n¼ 5) and then challenged
withHpylori strain BCM-300. Biopsy sampleswere collected and
H pylori were isolated. Genomes of the challenge strain and 12
reisolates, obtained 12 weeks after (or in 1 case, 62 weeks after)
infection were sequenced by single-molecule, real-time tech-
nology, which, in parallel, permitted determination of genome-
wide methylation patterns for all strains. Functional effects of
genetic changes observed in H pylori strains during human
infection were assessed by measuring release of interleukin 8
from AGS cells (to detect cag pathogenicity island function),
neutral red uptake (to detect vacuolating cytotoxin activity), and
adhesion assays. RESULTS: The observed mutation rate was in
agreement with rates previously determined from patients with
chronicH pylori infections, without evidence of a mutation burst.
A loss of cag pathogenicity island function was observed in 3
reisolates. In addition, 3 reisolates from the vaccine group ac-
quired mutations in the vacuolating cytotoxin gene vacA,
resulting in loss of vacuolization activity. We observed inter-
strain variation in methylomes due to phase variation in genes
encoding methyltransferases. CONCLUSIONS: We analyzed
adaptation of a fully virulent strain of H pylori to 12 different
volunteers to obtain a robust estimate of the frequency of genetic
and epigenetic changes in the absence of interstrain recombi-
nation. Our findings indicate that the large amount of genetic
variation in H pylori poses a challenge to vaccine development.
ClinicalTrials.gov no: NCT00736476.
Keywords: Microbe; Stomach; Pathogen; Cancer.
Helicobacter pylori is a highly prevalent bacterialpathogen that infects the human stomach. If
untreated, H pylori can establish a lifelong infection that can
either remain asymptomatic, or lead to severe sequelae,
including peptic ulcer disease and gastric cancer.1 The
species H pylori is notable for its exceptionally high genetic
diversity and variability. Elevated rates of spontaneous
mutations are attributed to the lack of a number of classic
DNA repair genes,2–4 in combination with specific muta-
genic properties of its DNA polymerase I.5 In addition,
recombination during mixed infections with multiple
H pylori strains within one stomach was shown to be the
dominant driving force of genetic variability.6–8 The genetic
variability of H pylori is thought to be important for its
adaptation to different individual hosts, and to the
constantly changing conditions of the gastric niche.2 To date,
in vivo genome evolution of H pylori has been mainly
studied in isolates obtained from chronically infected indi-
viduals.6,9–12 These studies showed that outer membrane
protein (OMP) encoding genes were more frequently
affected by genomic changes than other genes, pointing to a
strong selection for the diversification of proteins that
interact with the host during chronic infection.10 Immune
evasion is suggested to be one potential driving force for the
diversification of H pylori in vivo.
H pylori therapy aims at the eradication of infection, yet
the increasing spread of antibiotic resistance necessitates the
development of alternative approaches for the control of H
pylori infection. Therefore, since the early 1990s, multiple
attempts have beenmade to develop a vaccine, but to date, no
effective therapeutic or prophylactic vaccine is commercially
available,13–16 and the high genetic diversity and variability of
H pylori may have contributed to this situation.
*Authors share co-first authorship.
Abbreviations used in this paper: ANOVA, analysis of variance; cagPAI,
cag pathogenicity island; IL, interleukin; MTases, methyltransferases;
OMP, outer membrane protein; PCR, polymerase chain reaction; R-M,
Restriction-Modification; SMRT sequencing, single-molecule, real-time
sequencing; SNPs, single-nucleotide polymorphisms; T4SS, type IV
secretion system; UBT, urea breath test.
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The analysis of strains from chronically infected in-
dividuals, as performed previously,6,8–10,12 does not permit
investigation of the in vivo diversification of OMPs and other
important virulence genes during early colonization, because
infections might have been established for many years and
initial changes aremost likelymasked by subsequent changes
and purifying selection. Experimental infections of H pylori–
negative individuals with a defined strain are better suited to
specifically investigate early adaptation to the individual
host. So far, only 2 studies have analyzed genomic changes of
H pylori isolates obtained during the initial phase of an
experimental human infection in 1 and 2 volunteers,
respectively.10,17 Although Kennemann and coworkers10
found only marginal genomic changes and not a single
recombination event, Linz and coworkers17 reported rapid
genome evolution through a mutation burst and numerous
recombination events. The reason for the discrepancy be-
tween the 2 studies was unknown.
Methylation of DNA is an important form of epigenetic
modification catalyzed by methyltransferases (MTases).
H pylori is characterized by a striking abundance and sub-
stantial interstrain diversity of MTases and restriction-
modification systems.18–22 Recent studies have taken
advantage of the Single-Molecule, Real-Time (SMRT)
sequencing technology to characterize the genome-wide DNA
methylation in multiple H pylori strains.19,20,23 However, to
date, no study has investigated methylation in the context of
functional adaptation during human infection in vivo.
In this study, we applied SMRT sequencing to analyze
both genome and methylome variation in 12 H pylori isolates
obtained after experimental infection of human volunteers
during a vaccine trial withH pylori challenge strain BCM-300.
This babA-positive strain has the vacA s1m1 genotype,
carries an intact cag pathogenicity island (cagPAI) and
expresses the effector protein CagA. We identify individual
sequence differences in all reisolates, many of which affect
virulence and host interaction factors, such as cagA and vacA.
Variations in the methylome were likewise detected, result-
ing from phase-variable expression of 2 MTase genes.
Materials and Methods
H pylori Strains and Ethics Statement
The experimental human infection study was a randomized
Phase I/II, observer-blind, placebo-controlled, single-center
study performed in healthy H pylori–negative adults from
October 2008 toMarch 2010 (ClinicalTrials.gov: NCT00736476).
The study was performed at the Clinic of Gastroenterology,
Hepatology and Infectious Diseases at the Otto-von-Guericke
University of Magdeburg, Germany; it followed all good clinical
practice criteria and International Conference on Harmonization
guidelines, and received the approval from the local ethical
committee and written informed consent from all subjects.
The challenge strain H pylori BCM-300 that was used for
experimental human infection24 was originally isolated from an
asymptomatic volunteer with mild superficial gastritis (ATCC
BAA-1606). Gastric biopsies obtained from study participants
were subjected to culture with single colony purification for
isolation of H pylori. The histological typing and grading of
gastritis was performed according to the recommendations of
the updated Sydney classification.25 Inflammation and all
other parameters were semiquantitatively scored as either
0 (absent), 1 (mild), 2 (moderate), or 3 (severe).
Microbiological and Molecular Biology
Techniques
Details of the culture conditions for H pylori isolates and
mutants as well as Escherichia coli strains, DNA preparation,
Sanger sequencing, quantitative polymerase chain reaction
(PCR), neutral red uptake assay, IL8 induction, BabA expres-
sion, Le(b) binding, insertion mutagenesis in H pylori, over-
expression of Hpy300XI in E coli, and restriction analyses are
described in Supplementary Materials and Methods.
SMRT Sequencing and Base
Modification Analysis
Total genomic DNA was extracted using QIAGEN Genomic-
tip 100/G columns (QIAGEN, Hilden, Germany). BCM-300 and
10 reisolates were genome-sequenced at Pacific Biosciences
(Menlo Park, CA). SMRTbell template library construction of
15-kb shotgun libraries was performed as previously
described.26 Genomes were sequenced on the Pacific Bio-
sciences RSII instrument using 1 SMRT Cell per strain applying
P4/C2 chemistry. Strains HE134/09 and HE178/09, H pylori
mutant strains and E coli expression strains were sequenced at
DSMZ (Braunschweig, Germany) as follows: SMRTbell template
libraries were prepared according to the instructions from
Pacific Biosciences following the Procedure & Checklist for 10
kb Template Preparation and Sequencing. Sequencing of 2
SMRT Cells per strain was performed using the Pacific Bio-
sciences RSII instrument and P6/C4 chemistry. De novo
genome assembly was carried out with HGAP2 (Pacific Bio-
sciences) and HGAP3 (DSMZ)27 and genome consensus using
EDITOR’S NOTES
BACKGROUND AND CONTEXT
Helicobacter pylori bacteria have been shown to evolve
and diversify in chronically infected patients. Little has
been known about the genetic adaptation of H pylori in
the early phase infection following the initial acquisition.
NEW FINDINGS
The researchers determined the genome sequences of
H pylori before challenge and after several months
of infection, permitting to precisely determine rates of
mutations in early-stage infections, and to identify the
bacterial genes affected by the mutations.
LIMITATIONS
Only one bacterial re-isolate clone was available for each
volunteer. Thus, an assessment of the variability within
the individual stomach was not possible. The number of
volunteers in the vaccinated and non-vaccinated
subgroups were relatively small.
IMPACT
The findings indicate that the large amount of genetic
variation in H pylori poses a challenge to vaccine
development.
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Quiver.27 Genome-wide detection of base modification and
motif analysis was performed using the standard settings in the
“RS_Modification_and_Motif_Analysis.1” protocol.
Genome Analyses
The genome of BCM-300 was annotated using Prokka
version 1.7.28 Whole-genome comparison was performed using
Kodon (Applied Math, Austin, TX) with BCM-300 as reference.
Sequence differences, including single-nucleotide poly-
morphisms (SNPs), indels, and intrachromosomal rearrange-
ments, were identified (Supplementary Data 1). SNPs defined
as base substitutions flanked by identical sequence of at least
200 bp10 were validated by targeted Sanger sequencing
(Table 1). The mutation rate of each reisolate was calculated by
the following formula: no. of SNPs/genome length of BCM-300
[nt]/time of infection [d] * 365 d.
Identification and Assignment of MTase Genes
The annotation of the genomes revealed numerous putative
Type I, II, and III restriction-modification (R-M) genes. In
addition, the genome sequence of BCM-300 was scanned for the
presence of R-M genes as previously described.29 The speci-
ficities of most identified putative MTase genes were predicted
by homology search using the REBASE BLAST tool.21 These
predicted specificities were subsequently matched with the
motifs identified through base modification analyses from
SMRT sequencing data. In addition, several putative MTase
genes showed strong homology to not yet functionally charac-
terized enzymes, only very weak homology to characterized
enzymes, or no homology at all. These MTases represented
strong candidates for the assignment of the novel recognition
sites detected through SMRT sequencing.
Detection of Antibody Responses Against
Vaccine Antigens
IgG antibody responses against the 3 vaccine antigens were
determined using an enzyme-linked immunosorbent assay
described previously.15 The data presented in Supplementary
Figure 1 are a subset of the full dataset reported in the full
description of the clinical trial (Malfertheiner et al., submitted).
Statistical Analyses
GraphPad Prism 6 (La Jolla, CA) was used for statistical
analyses and generation of graphs.
Data Availability
Genome sequence data of all strains have been deposited in the
EuropeanNucleotideArchivewith the studynumberPRJEB17945.
The authors declare that all other data supporting the findings of
this study are available within the article and its Supplementary
Information, or from the corresponding author on request.
Results
Prophylactic Vaccination, Challenge of Human
Volunteers, and Recovery of H pylori Reisolates
In a clinical trial that will be publishedwith full details in a
separate article (Malfertheiner et al., submitted), 12 human
volunteers who had been tested negative for H pylori infec-
tion by both urea breath test (UBT) and bacterial culture of
gastric tissue biopsies were either administered a prophy-
lactic tricomponent vaccine candidate (n¼ 7) that contained
3 recombinant H pylori proteins, the translocated effector
CagA, the vaculating cytotoxin VacA, and the neutrophil-
activating protein NAP, or placebo (n ¼ 5), respectively.
The volunteers were subsequently challenged with the
cagPAI-positiveH pylori strain BCM-300.24 Twelve weeks, or,
in 1 case, 62 weeks post challenge, gastric biopsies were
taken from all study participants during gastroendoscopy,
and H pylori cultures were performed (Figure 1). To enable
follow-up investigations on reisolates, 1 single H pylori strain
was isolated and archived for each study participant. Gastric
biopsies obtained during initial screening and after challenge
with H pylori were analyzed by histopathology (Figure 1).
Although none of the participants showed any sign of
inflammation before infection, various levels of gastric
Table 1. In Vivo Mutation Rates of H pylori Challenge Strain BCM-300 in 12 Infected Human Volunteers
Group Strain
Gastroendoscopy,
wpc
Chromosome
Size, bp
No. of
SNPs
Mutation rate,
mutations site1 year1
Challenge strain BCM-300 - 1,667,883 -
Placebo HE136/09 12 1,667,978 2 5.2 x 10–6
HE141/09 12 1,670,384 2 5.2 x 10–6
HE143/09 12 1,667,804 2 5.2 x 10–6
HE147/09 12 1,667,712 4 1.0 x 10–5
HE170/09 12 1,670,321 1 2.6 x 10–6
Vaccine HE93/10 62 1,682,800a 4 2.0 x 10–6
HE101/09 12 1,667,821 1 2.6 x 10–6
HE132/09 12 1,668,174 3 7.8 x 10–6
HE134/09 12 1,667,858 2 5.2 x 10–6
HE142/09 12 1,667,936 3 7.8 x 10–6
HE171/09 12 1,667,625 1 2.6 x 10–6
HE178/09 12 1,667,894 2 5.2 x 10–6
wpc, weeks post challenge.
aThis chromosome is not closed due to a long repeat element at the end of the genome sequence.
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inflammation ranging from mild to severe were detected 12
weeks post challenge, without any significant difference be-
tween the vaccine and placebo groups. UBTs were performed
regularly during the study to test for H pylori infection
(Figure 1). All UBTs performed before challenge were nega-
tive, as expected. Most UBTs remained negative after the
challenge, in some cases even at the time point when positive
H pylori culture was achieved from biopsies.
Genome Evolution of BCM-300 in Different
Human Volunteers
The genomes of challenge strain H pylori BCM-300 and
1 reisolate from each of the 12 volunteers were sequenced
by SMRT technology27,30 (Table 1). All but 1 reisolate
genome could be assembled into a closed single chromo-
some. Annotation with Prokka28 identified 1576 coding
sequences in BCM-300. Genome analysis of the challenge
strain showed the presence of a complete cagPAI, 5 copies
of the insertion element ISHp609,31 the major adhesin
babA, and the vacA s1m1 genotype. Although the genome
sizes of most reisolates varied only slightly, 3 reisolates
differed considerably. Two isolates (HE141/09, HE170/
09) harbored an additional copy of ISHp609 (2398 bp)
each located in the cagPAI. Strain HE93/10 harbored a
long repeat element at both remaining contig ends, ac-
counting for the difference in genome length of 14.9 kb. As
Figure 1. Schematic representation of study design and parameters. After a gastroendoscopy demonstratingH pylori negativity,
study participants received 3 doses of vaccine or placebo and were subsequently challenged with H pylori strain BCM-300.
Participants were monitored with regular UBTs and underwent gastroendoscopy for cultivation of H pylori (12 or 62 wpc) and
histology. C, challenge; cfu, colony-forming units; G, gastroendoscopy; V, vaccination; wpc, weeks post challenge.
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a result, we were not able to close this genome during the
assembly process. The repeat element was located at the 3’
end of the cagPAI and consisted of 4 repeats of approxi-
mately 4.2 kb containing the cagA gene (Figure 2A). Three
cagA copies were identical to BCM-300, whereas 1 copy
differed by six 1-bp deletions. The presence of multiple
consecutive cagA copies in strain HE93/10 was confirmed
by PCR amplification (Figure 2B and C). To determine the
number of cagA gene copies in the genome sequence, the
copy number of cagA was quantified by quantitative PCR
(Figure 2D). The data indicated the presence of 7 cagA
copies in the HE93/10 genome.
Whole-genome comparison of all reisolates with BCM-
300 identified genomic changes including SNPs, insertions
or deletions (indels), and intrachromosomal rearrange-
ments (Supplementary Data 1). The reisolates harbored
between 1 and 4 SNPs (Table 2), yielding an average mu-
tation rate of 5.2 x 10–6 per year per site (range 0.2 x 106
to 1.0 x 105) (Table 1). All SNPs were confirmed by Sanger
sequencing. Twenty-three SNPs were located in open
reading frames, resulting in 6 synonymous and 17 non-
synonymous mutations, whereas 4 SNPs were found in
intergenic regions. Interestingly, some genes including the
OMP-encoding gene hopF and the important virulence genes
vacA and cagA were affected in multiple reisolates. Most
predicted indels were located in homopolymeric or dinu-
cleotide repeats. Selected insertions/deletions in homopol-
ymeric sequences were confirmed by Sanger sequencing
(eg, in R-M systems or virulence genes, see later in this
article); however, the length of homopolymeric repeats is
not reliably determined by SMRT sequencing, and we chose
not to systematically resequence all predicted indels.
Resequencing was performed for 51 randomly selected
indels, confirming 31 length changes that had occurred
during infection, and 20 indels could not be confirmed. No
recombination event originating from an unrelated H pylori
strain was identified, indicating the absence of a mixed
infection in the volunteers.
Changes in cagPAI Functionality After
Short-Term Human Infection
BCM-300 harbors the cagPAI that encodes a type IV
secretion system (T4SS) associatedwith increasedvirulence.32
To check for the functionality of the cagPAI in BCM-300 and
the reisolates, we determined the ability of the strains to
induce IL8 secretion in human gastric AGS cells. Compared
with the mock-infected control, BCM-300 and most of the
reisolates were able to induce IL8 secretion (Figure 3A);
however, 3 reisolates (HE101/09, HE142/09, HE170/09) had
completely lost the ability to induce IL8 secretion. These
strains harbored differences in the cagPAI, which might
explain the impaired IL8 inductionphenotype (Supplementary
Data 1). In strainHE170/09, the insertionof anadditional copy
of ISHp609 resulted in the disruption of cagE, whereasHE101/
09 and HE142/09 had frameshift mutations in cagY. Two
further reisolates (HE132/09, HE178/10) showed a small but
significant reduction of their ability to induce IL8 secretion.
Both strains had acquired nonsynonymous mutations in cag-
PAI genes cagA or cagW that may account for these pheno-
types (Table 2). The mean IL8 induction was not significantly
different between strains isolated from vaccinated volunteers
and those isolated from placebo-treated individuals (nested
analysis of variance [ANOVA] test, P > .1).
Modulation of H pylori Cytotoxic Activity
During Infection
Three of the 7 reisolates of the vaccine group (HE93/10,
HE101/09, HE178/09) contained premature stop codons in
the vacA gene, whichwere predicted to code for nonfunctional
truncated proteins (Table 2). To test for a loss of VacA func-
tion, we analyzed the capacity of the H pylori strains to induce
Figure 2.Multiplication of cagA in reisolate HE93/10. (A) Schematic representation of repeat region of HE93/10 compared with
the BCM-300 locus. (B) Representation of multiple binding sites of primers cagA_R and O-2876 within the repeat region of
HE93/10. (C) Confirmation of the presence of at least 2 consecutive cagA copies in HE93/10 by PCR using the primers cag_R
and O-2876. NTC, no template control. (D) The genomic copy number of cagA was estimated by quantitative PCR and
normalized to reference gene efp. The cagA/efp ratio of BCM-300 was set to 1. Data are presented as mean ± standard
deviation of triplicate measurements.
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vacuoles in host cells by measuring the uptake of neutral red.
BCM-300 induced vacuolization in MKN-28 cells by approxi-
mately 1.5-fold compared with mock-infected control cells
(Figure 3B). In contrast, cells infected with the 3 reisolates
harboring a putatively nonfunctional vacA gene behaved like
the control. All other reisolates retained their ability to induce
vacuolization. The mean vacuolating activity was slightly
higher for reisolates from placebo-treated volunteers than for
vaccinated volunteers (nested ANOVA test,P¼ .0662,which is
suggestive, but not conclusive).Wenote that VacA activitywas
lost inH pylori isolates from 3 of the vaccinated vs none of the
placebo-treated individuals. Because VacA was one compo-
nent of the prophylactic vaccine, this might suggest that bac-
teria with inactivated VacA might have been selected for to
evade a vaccine-induced immune response. However, the
number of isolates was rather small, such that this difference
in VacA inactivation between the 2 groups did not reach sta-
tistical significance.
Loss of Virulence Factors During Challenge
Infection and Immune Responses Against
Vaccine Components
We analyzed serum antibody responses against the 3
vaccine antigens, VacA, CagA, and NAP, at baseline and 12
Table 2.Mutations Identified in H pylori Reisolates From Volunteers Challenged With Strain BCM-300
Group Strain ID #
Position in
BCM-300 Nt SNP type AA Annotation
BCM-300
locus tag
Placebo HE136/09 1 924452 G > A Synonymous Pantothenate kinase BCM300_00904
2 1029483 C > A Nonsynonymous K > N Hypothetical protein BCM300_00997
HE141/09 1 1029281 G > A Nonsynonymous H > Y Hypothetical protein BCM300_00997
2 1471570 C > T Synonymous ATP synthase subunit B BCM300_01431
HE143/09 1 259853 G > A Nonsynonymous G > R OMP (hopF) BCM300_00256
2 867350 C > T Nonsynonymous V > M Molybdenum cofactor biosynthesis protein C (moaC) BCM300_00842
HE147/09 1 242241 G > T Nonsynonymous A > E Beta-lactamase HcpE BCM300_00238
2 581568 C > T Nonsynonymous S > L cag pathogenicity island protein (cagA) BCM300_00568
3 934310 C > T Synonymous Hypothetical protein BCM300_00916
4 1113391 A > G Intergenic
HE170/09 1 1340881 G > A Intergenic
Vaccine HE93/10 1 258783 G > A Nonsynonymous G > D OMP (hopF) BCM300_00256
2 301606 C > T Synonymous Toxin-like outer membrane protein BCM300_00292
3 857371 C > T Nonsynonymous D > N Hypothetical protein BCM300_00828
4 949223 C > T Nonsynonymous Q > * Vacuolating cytotoxin (vacA) BCM300_00927
HE101/09 1 948014 C > T Nonsynonymous Q > * Vacuolating cytotoxin (vacA) BCM300_00927
HE132/09 1 581663 C > T Nonsynonymous R > C cag pathogenicity island protein (cagA) BCM300_00568
2 697107 A > G Synonymous Fucosyltransferase BCM300_00672
3 875914 G > A Intergenic
HE134/09 1 260916 T > C Nonsynonymous L > P OMP (hopG) BCM300_00257
2 401200 G > A Synonymous Membrane protein BCM300_00395
HE142/09 1 762531 A > G Intergenic
2 1488893 C > T Nonsynonymous Q > * Sel1 repeat-containing protein BCM300_01451
3 1540693 C > T Nonsynonymous M > I Zinc-metallo protease BCM300_01503
HE171/09 1 259244 G > A Nonsynonymous G > S OMP (hopF) BCM300_00256
HE178/09 1 563321 C > T Nonsynonymous M > I cag pathogenicity island protein (cagW) BCM300_00551
2 949904 C > T Nonsynonymous Q > * Vacuolating cytotoxin (vacA) BCM300_00927
1The genome annotation was automatically generated by Kodon based on annotation of H pylori strain 26695 (NC_000915.1),
and then manually curated if necessary.
2The genome annotation of BCM-300 was generated by Prokka (v1.7).
Figure 3. Induction of IL8 secretion and vacuolization by
H pylori BCM-300 and reisolates. (A) AGS cells were
infected with H pylori at MOI 50 for 4 hours. IL8 secretion
into cell supernatants was measured by enzyme-linked
immunosorbent assay. Data are presented as mean ±
standard deviation of at least 4 independent experiments.
BCM-300 was set to 100%. (B) MKN-28 cells were infected
with H pylori at MOI 50 for 24 hours. Cell vacuolization
was determined by uptake of neutral red. Vacuolization is
shown relative to mock-infected control cells set to
1. Data are presented as mean ± standard deviation of
at least 6 independent experiments. Statistical
significance was analyzed by 1-way ANOVA (P < .001)
followed by Bonferroni’s multiple comparison test
comparing BCM-300 with each of the reisolates (**P < .01;
***P < .001).
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weeks after challenge (ie, at the time point when the
biopsies for the reisolate cultures were taken). For all 3
vaccine antigens, mean serum antibody titers were higher in
the vaccinated subjects than in placebo-treated subjects, and
the differences were statistically highly significant for all
proteins, although 1 volunteer in the placebo group had a
high antibody titer against CagA at baseline (Supplementary
Figure 1).
We next compared antibody titers in individuals from
whom the strains that had lost cagPAI or VacA activity had
been isolated, vs the remaining individuals in whom the
functions of VacA and/or cagPAI had stayed intact.
Although the mean antibody titers were higher for those 3
individuals who lost VacA or cagPAI activity, respectively,
vs the individuals whose strains kept the activity, the
differences did not reach statistical significance
(Supplementary Figure 1).
Variation and Partial Inactivation of
OMP-Encoding Genes
Previous studies of genome evolution of H pylori during
human infection showed that genes belonging to the hop/
hof/hor family of paralogous Helicobacter OMP-encoding
genes are frequently affected by genomic changes suggest-
ing diversifying selection.9,10,17,33 Four of the 12 reisolates
contained SNPs in OMP-encoding genes, hopF or hopG
(Table 2). Additional sequence differences were identified
in other OMP genes (Supplementary Data 1), including
differences in the length of the CT dinucleotide repeats of
sabA and sabB in 3 reisolates each that led to gene inacti-
vation. Furthermore, 2 strains had undergone intra-
chromosomal recombination affecting the putative adhesin
domain of SabA (HE171/09) and SabB (HE147/09),
respectively.
In contrast, none of the isolates displayed sequence dif-
ferences in babA, the gene encoding the well-characterized
adhesin of H pylori that mediates binding to Le(b).34,35
BabA was expressed in BCM-300 and all reisolates
(Supplementary Figure 2A), and we demonstrated binding to
Le(b) for the challenge strain (Supplementary Figure 2B).
Methylome Variation During Early
H pylori Infection
SMRT sequencing allowed us to analyze the genome-
wide methylation patterns of challenge strain BCM-300
and all reisolates from human volunteers.36 Between 1.8%
and 2.3% of the genomic positions were detected as meth-
ylated, predominantly at adenosine nucleotides (87.5% ±
4.9%). Altogether, we identified 15 distinct motifs charac-
teristic for Type II and Type III R-M systems
(Supplementary Figure 3, Table 3). Most of the target se-
quences were almost fully methylated (> 90%); in 1 case of
m5C methylation, which could not be reliably detected by
SMRT sequencing,37 the methylation of the corresponding
motif was confirmed by restriction digestion analysis
(Supplementary Figure 4).
Eleven of the 15 motifs could be assigned to MTases
based on sequence homology searches using the REBASE
database.21 The specificity of 8 of these MTases in H pylori
had already been experimentally verified in previous
studies,18,20,22,38 the MTases targeting 3 additional motifs
could be predicted by homology and were functionally
confirmed in this study (Supplementary Text 1,
Supplementary Figures 5 and 6).
The MTases methylating the 4 remaining motifs could
not be reliably assigned by homology with MTases of known
specificity, indicating that BCM-300 contained yet unchar-
acterized H pylori MTases. Inactivation of selected candidate
Table 3.Methylated Sequence Motifs Detected by SMRT Sequencing in H pylori BCM-300 and Reisolates
No.
MTase
specificitya Assignment
BCM-300
locus tag
Type/subtype of
R-M system
Presence
of motifs
1 50-Cm6ATG-30 M.Hpy300I BCM300_01150 II, alpha All strains
2 50-TGC m6A-30 M.Hpy300II BCM300_01310 II, gamma All strains
3 50-GA m6ATTC-30 M.Hpy300III BCM300_01060 II All strains
4 50-TCNNG m6A-30 M.Hpy300IV BCM300_01490 II, gamma All strains
5 50- m4CCGG-30 M.Hpy300V BCM300_00266 II, beta All strains
6 50-CC m6ATC-30 M1.Hpy300VI BCM300_01363 II, alpha All strains
7 50-G m6ATGG-30 M2.Hpy300VI BCM300_01364 II, alpha All strains
8 50-G m6AGG-30 M1.Hpy300VII BCM300_00054 II, beta All strains
9 50-AGG m6AG-30b Hpy300VIII BCM300_01346 IIG All strains
10 50-G m6ATC-30 M.Hpy300IX BCM300_00102 II, beta All strains
11 50-G m6ACY-30b M.Hpy300X BCM300_01342 III Not present in HE93/10, HE147/09, HE171/09
12 50-CCTYN m6A-30b Hpy300XI BCM300_01297 IIG Only present in HE143/09
13 50-G m5CGC-30c M.Hpy300XII BCM300_01446 II All strains
14 50-GTS m6AC-30 M.Hpy300XIII BCM300_00056 II, beta All strains
15 50-CAC m6AT-30b — — — All strains
aThe methylated position within the motif is highlighted in bold. Underlining indicates the modified base in the complementary
strand of palindromic sites.
bMotifs are methylated by previously uncharacterized MTases.
cThis motif was not reliably detected by SMRT sequencing, but methylation was experimentally confirmed by restriction
digestion analysis.
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genes by insertion mutagenesis and subsequent analysis of
the methylation profiles of the isogenic mutants by SMRT
sequencing permitted us to assign 3 novel MTases to 3 of
the remaining motifs (Table 3, Supplementary Text 1).
We next focused on differences of methylation patterns
between the BCM-300 challenge strain and reisolates from
volunteers (Supplementary Data 2). Thirteen of the 15
methylated sequence motifs were detected as methylated in
all strains. In contrast, the motif 50-Gm6ACY-30 lacked
methylation in 3 of the reisolates (HE93/10, HE147/09, and
HE171/09), and the motif 50-CCTYNm6A-30 was unmethy-
lated in BCM-300 and 11 reisolates, and only became meth-
ylated in reisolate HE143/09 (Table 3). Changes in H pylori
methylation patterns have been shown to be frequently due
to frameshifts in MTase genes. Two putative MTases,
M.Hpy300X and Hpy300XI, displayed phase variation be-
tween the challenge strain and reisolates, suggesting that
these might be responsible for the observed changes in
methylation patterns. Sanger sequencing of the repeat se-
quences permitted to confirm this hypothesis in both cases
(Supplementary Figure 7, Table 3). Hpy300XI shows sub-
stantial homology to the recently characterized systems
HpyAXVI (H pylori 26695) and Hpy99XIV (H pylori J99-R3),
respectively, which both were recently shown to undergo a
unique frameshift-mediated switch of sequence specificity.20
We were able to confirm that length variation of the second
repeat in Hpy300XI (which was, however, not observed
among the reisolates) had a similar impact on sequence
specificity (SupplementaryText 1, Supplementary Figure 7B).
Discussion
Genome evolution of H pylori during the initial phase of
human infection has so far only been analyzed by 2 recent
studies that differed considerably in the number of
observed genomic changes.10,17 In the present study, we
used SMRT sequencing to comprehensively characterize
both genome and methylome evolution of the cagPAI-
positive H pylori challenge strain BCM-300 in the early
phase of experimental human infection. Additionally, the
administration of a prophylactic vaccine to some of the
volunteers enabled us to study genomic changes under
vaccine-induced selective pressure.
The average mutation rate of 5.2  106 mutations per
site per year calculated from this dataset is in good agree-
ment with previous estimates observed during chronic hu-
man infection6,9,10,12 that exceeded the mutation rates of
many other bacterial species.39 Studies on the genome
evolution of H pylori during the initial phase of human
infection are scarce, because natural acute H pylori
infections are almost never diagnosed and they therefore
require experimental infection of human volunteers with a
defined H pylori strain. The only 2 previous studies of this
kind were based on a very small number of isolates, and
came to substantially different conclusions.10,17 In the first
study that was based on 1 reisolate obtained 12 weeks post
volunteer infection with cagPAI-negative challenge strain
BCS 100, we calculated a mutation rate of 2.6 x 106
mutations per site per year.10 This is in good agreement
with the results of the present study. These results are in
marked contrast with the second study that analyzed 2
reisolates originating from 2 volunteers, who had been
reinfected with their own strains after eradication of their
natural H pylori infection.17 The average mutation rate of 7.3
x 104 mutations per site per year was approximately
140-fold higher than our previous estimate. In addition to
this presumed mutation burst, Linz et al17 also observed a
high recombination rate, which is strong evidence for the
presence of a mixed infection. Although acquisition of an
unrelated H pylori strain after reinfection and subsequent
recombinational exchange between strains cannot be
excluded, the substantial amount of recombination may also
point to an ongoing low-level preestablished infection at the
time of reinfection. Although eradication of the natural
H pylori infection had been followed up by 2 consecutive
negative UBTs, this observation does not unequivocally
exclude the presence of a low-level H pylori infection. Note
that in our study, H pylori was successfully cultured from
gastric tissue biopsies of all volunteers, despite negative
UBTs. Sampling of a strain from the preexisting natural
infection instead of a descendant of the reinfecting strain
would be a plausible alternative explanation for the high
number of mutations and import events. Our earlier study10
and the present study agree in that mutations occur at a
similar rate during early and chronic infection. A similar low
sensitivity of UBTs to detect experimental infections was
previously reported in rhesus macaques.40
We observed changes in 2 major virulence factors of
H pylori, the cagPAI and vacA, which were accompanied by
functional consequences. Both virulence factors play a
central role in the pathogenesis of H pylori.41,42 The cagPAI-
encoded T4SS mediates translocation of the oncoprotein
CagA into gastric epithelial cells leading to a multitude of
downstream effects on host cellular physiology43–46 and is
required for the induction of the proinflammatory cytokine
IL8.47 Three of 12 reisolates lost the function of this
important virulence module during early-phase infection of
volunteers. There was no significant difference between
placebo and vaccine groups in their rates of cagPAI function
loss. Loss of cagPAI function was due to frameshift muta-
tions in cagY and insertion of a mobile element in cagE,
respectively. Both genes were previously shown to be
essential for IL8 induction in vitro.48,49 A link between
recombination in cagY and loss of T4SS function had
recently been demonstrated in both rhesus macaques and
mice.50,51 Loss of cagPAI activity through inactivation of
cagY had also been observed in 1 of 14 pairs of sequential
isolates obtained from chronically infected human in-
dividuals.51 Our data thus confirm and extend previous
evidence that cagY plays an important role in the adaptation
of cagPAI function to the individual host, probably facili-
tated by its length and high content of repeats. In addition,
our previous analysis of the genetic diversity of individual
cagPAI genes indicated that cagY is under diversifying se-
lection.52 Our observations indicate a selection against
cagPAI function during acute human infection, at least in the
genetic context of strain BCM-300, and in the absence of
mixed infection. In addition to the complete loss of cagPAI
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function, we observed also a slight but significant reduction
in IL8 induction in 2 isolates that contained nonsynonymous
SNPs in the cagPAI genes cagA and cagW, respectively. The
functional relevance of these amino acid exchanges remains
to be addressed. The same is true for the multiplication of
cagA in strain HE93/10, which is in agreement with 2 recent
studies that also reported dynamic changes of cagA copy
numbers during infection.53,54
A further remarkable finding of this study was the
inactivation of VacA that occurred exclusively in 3 reisolates
cultured from volunteers who had received the candidate
vaccine (which contained VacA). Although this difference
between vaccine and placebo groups, as well as the differ-
ence of antibody titers between those individuals whose
strains had lost VacA vs those who had not were both not
statistically significant due to the small number of
individuals in both groups, this may point to a specific
selection in response to vaccine-induced selective pressure
(ie, possibly to evade host immunity).
Infection with BCM-300 led to mild to severe levels of
gastric inflammation in all individuals. The fact that we did
not detect significant differences in inflammation levels for
individuals harboring a strain with a nonfunctional cagPAI
or VacA (and in 1 case, both) could be attributable to the
presence of further proinflammatory bacterial traits, such as
strength of bacterial adhesion and various bacterial MAMPs
activating Toll-like receptors or NOD-like receptors/
inflammasomes.10,55–57 Moreover, because only 1 reisolate
per individual was archived and available for genome
characterization, we cannot exclude the possibility that
bacteria with functional VacA or with an intact cagPAI were
still present in the respective volunteers. Loss of cagPAI and
VacA activity may have occurred after the challenge had
induced strong inflammation that did not have sufficient
time to resolve. Finally, vaccination itself may have an
impact on the inflammatory response to the challenge in
some individuals, potentially obscuring the effect of the
deletion of virulence factors. Such inflammation-enhancing
effects of vaccines have been described for animal models
in the literature,58 although a previous study using a chal-
lenge in humans did not observe an exacerbation of gastritis
in vaccinated vs nonvaccinated subjects.14
Previous studies about the in vivo evolution of H pylori
showed that OMP-encoding genes, in particular members of
the hop family, were significantly affected by genomic
changes.10,11,17,59 It was proposed that surface-exposed
proteins with a role in pathogen-host interactions undergo
diversifying selection to facilitate host adaptation.10 In this
study, we observed a number of genomic changes in hop
family genes, including SNPs, repeat length changes, and
intrachromosomal rearrangements. The adhesin genes sabA
and sabB were subject to both inactivating frameshift mu-
tations and intrachromosomal rearrangements, whereas we
detected no changes in babA, the gene encoding the Le(b)
binding adhesin BabA.
Considering the overall low degree of genome variation
detected in our study, the striking incidence of sequence
differences in the cagPAI, vacA, and OMP-encoding genes
strongly points to specific adaptation processes of the
isolates to their individual host. Genetic diversification of
these targets likely contributes to natural and vaccine-
induced immune evasion and the modulation of adherence
properties of H pylori to the changing conditions in the
gastric environment.
To our knowledge, this is the first study to analyze
in vivo methylome variation of H pylori during human
infection. Investigation of the BCM-300 methylome identi-
fied dense genome-wide methylation at 15 distinct motifs,
including 4 novel MTase recognition sequences. This is in
agreement with several recent methylome analyses of other
H pylori strains that also reported dense methylation, a
similar number of methylated motifs, and substantial strain-
specific differences.19,20,23 The biological functions of the
strain-specific large R-M system portfolios remain unknown.
We recently showed that methylation-dependent restriction
of heterologous DNA sequences limits the import of
nonhomologous sequences into the H pylori genome.60
H pylori MTases were also found to participate in various
processes, such as cell cycle control, and DNA replication
and repair.61 Although genome comparisons did not reveal
differences in the overall R-M gene content between BCM-
300 and the reisolates, we noticed variations in the
genome-wide methylation patterns. Although methylation of
13 motifs was shared between all strains, phase-variable
expression of 2 MTase genes (M.Hpy300X, Hpy300XI)
accounted for the observed interstrain variability. Phase
variation is a common mechanism of host-adapted bacterial
pathogens to generate genetic heterogeneity by high-
frequency, reversible ON/OFF switching of gene expres-
sion via simple sequence repeats.62 Phenotypic variation in
H pylori was suggested to promote the generation of a
heterogeneous population capable of rapid host adaptation.2
Remarkably, random switching of the genome-wide
methylation status through phase variation of MTase
genes was recently shown to coordinate the expression of
multiple genes in H pylori and other bacteria, thereby
modulating their virulence.63 These so-called phasevarions
(phase-variable regulon) were proposed to affect host
colonization and adaptation in vivo, for example by regu-
lating gene expression via differential methylation of pro-
moter sequences.63 In our study, 3 reisolates lost expression
of the Type III MTase M.Hpy300X and strain HE143/09
gained function of the Type IIG system Hpy300XI. Because
of the random nature of phase variation, we cannot exclude
that ON/OFF switching of MTase gene expression also
occurred during isolation and cultivation of the reisolates.
Nevertheless, this finding indicates that switching of the
genome-wide methylation status during the initial human
infection might facilitate host colonization, and should be
further studied by functional approaches.
The biological significance of variable DNA methylation
in H pylori, in particular its impact on functional adaptation
in vivo, will be subject to further study.
Conclusion
The striking genetic variability of H pylori has been
known for decades. Although it has been widely assumed
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that it would pose a challenge to vaccine development, the
current study is the first to clearly demonstrate the poten-
tial of H pylori to use this genetic variation to adapt to
challenges during the adaptation to new hosts, and to
vaccine-induced selection pressure by inactivating nones-
sential functions, including major virulence modules, and
potentially also by modulation of its methylome.
Supplementary Material
Note: To access the supplementary material accompanying
this article, visit the online version of Gastroenterology at
www.gastrojournal.org, and at https://doi.org/10.1053/
j.gastro.2017.10.014.
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Supplementary Materials and Methods
Culture Conditions
Strains were cultured from frozen stocks on blood agar
plates with antibiotic supplements as previously described.1
Mutant strains were grown on blood agar plates additionally
supplementedwith kanamycin (20mg/mL), chloramphenicol
(20 mg/mL), or both antibiotics as required. Liquid cultures
were performed in brain heart infusion (BD Difco,
Heidelberg, Germany) with yeast extract (2.5 g/L), 10%
heat-inactivated horse serum, and a mix of antibiotics
(vancomycin (10 mg/L), polymyxin B (3.2 mg/L), amphoter-
icin B (4 mg/L), and trimethoprim (5 mg/L). Cultivation was
performed at 175 rpm and 37C in microaerobic atmosphere
using air-tight jars (Oxoid, Wesel, Germany) and Anaerocult C
gas-generating bags (Merck, Darmstadt, Germany).
Escherichia coli strains MC1061 and ER2683
(Supplementary Table 1) were grown under aerobic con-
ditions at 37C on LB agar plates or in LB broth (Lennox L
Broth; Thermo Fisher Scientific, Darmstadt, Germany)
supplemented with ampicillin (200 mg/mL), kanamycin
(20 mg/mL), and/or chloramphenicol (20 mg/mL), as
required.
DNA Preparation
Bacterial chromosomal DNA was extracted with the
QIAamp DNA Minikit (QIAGEN, Hilden, Germany). Prepa-
ration of plasmid DNA was performed using QIAprep Spin
Miniprep Kit (QIAGEN).
Sanger Sequencing
PCRs were performed according to standard protocols.
Primers were designed using Primer3.2 Amplification
products were purified using the QIAquick PCR purification
kit (QIAGEN). PCR amplicons were sequenced bidirection-
ally using the BigDye terminator v1.1 cycle sequencing kit
and the 3130xl genetic analyzer (Thermo Fisher Scientific).
Sequence data were analyzed using BioNumerics v6.01
(Applied Maths, Sint-Martens-Latem, Belgium).
Quantitative PCR
The genomic copy number of cagA and efp was deter-
mined by quantitative PCR using the standard curve
method. Quantitative PCR was performed in the CFX96
Real-Time PCR Detection System (Bio-Rad, Munich, Ger-
many) with the QuantiTect SYBR Green PCR Kit (QIAGEN)
according to manufacturer’s information. Primer sequences
are shown in Supplementary Table 2.
Neutral Red Uptake Assay
Induction of vacuolization in MKN-28 cells by H pylori
was analyzed by neutral red uptake assay.3 Briefly, 1 x 104
cells/well were seeded into 96-well plates in RPMI 1640
with 10% fetal calf serum (FCS) (Biochrom, Berlin, Ger-
many). After 24 hours, cells were infected with H pylori
strains at MOI 50 in RPMI 1640 with 1% FCS and incubated
for 24 hours. After removal of medium, cells were incubated
with 100 mL/well neutral red medium (40 mg/mL) for at
least 2 hours at 37C. After washing, the incorporated dye
was solubilized by adding 150 mL/well neutral red destain
solution (50% ethanol [96%], 49% deionized water, 1%
glacial acetic acid). Absorbance at 540/690 nm was
measured using a microplate reader.
IL8 Induction
Briefly, 1.5 x 105 AGS cells/well were seeded into
24-well plates in RPMI 1640 with 10% FCS (Biochrom).
After 24 hours, cells were infected with H pylori strains at
MOI 50 in RPMI 1640 with 10% FCS and incubated for 4
hours. The IL8 concentration in the cell culture superna-
tants was determined with the BD OptEIA Human IL8
Enzyme-Linked Immunosorbent Assay Set (BD Bio-
sciences, San Jose, CA).
BabA Expression
H pylori was harvested from 24-hour-old blood agar
plates in phosphate-buffered saline (PBS) and centrifuged
(5000g, 4C, 10 minutes). Pellets were homogenized
in Tris buffer pH 7.4 by sonication. Equal amounts of
protein were separated by sodium dodecyl sulfate–
polyacrylamide gel electrophoresis (10%), and analyzed
by Western blotting. BabA antibody was kindly provided
by Thomas Borén. Peroxidase-labeled AffiniPure goat
anti-rabbit IgG (HþL) (Jackson ImmunoResearch Labora-
tories, West Grove, PA) was used as secondary antibody.
Western blots were developed with SuperSignal West Pico
chemiluminescent substrate (Thermo Fisher Scientific,
Waltham, MA) and chemiluminescence was detected using
the LAS-3000 imaging system (Fujifilm Life Science,
Tokyo, Japan).
Le(b) Binding
Le(b) binding of H pylori was determined by an enzyme-
linked immunosorbent assay, as previously described.4
Briefly, H pylori was harvested from 24-hour-old blood
agar plates in PBS by centrifugation (2795g, 5 minutes,
4C); 2 x 108 bacteria were biotinylated with 125 mg NHS-
LC-biotin for 1 hour. A 96-well Universal Covalent micro-
titer plate (Corning Costar, Corning, NY) was coated with
250 ng bovine serum albumin (BSA), or 250 ng Le(b)-BSA.
Afterward, the plate was exposed to UV light for 30 seconds
in a Stratalinker (Stratagene, Penzberg, Germany). After
blocking of the plate with 5% BSA in PBS, 1 x 107
biotinylated bacteria/well were coincubated for 1 hour.
Adherent bacteria were fixed with 100 mL para-
formaldehyde (2% in 100 mM potassium phosphate, pH 7).
After washing with 0.05% Tween 20 in PBS, blocking with
10% FCS in PBS and repeated washing, the plate was
incubated with neutravidin-horseradish peroxidase-conju-
gate in PBS plus 10% FCS. After final washing, the plate was
incubated with 100 mL/well 3,3’,5,5’-tetramethylbenzidine
(BD Biosciences). The reaction was stopped by addition of 1
M H3PO4 (50
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mL/well), and the extinction at 450 nm was measured using
a microplate reader.
Insertion Mutagenesis in H pylori
Mutants in putative R-M genes were generated by nat-
ural transformation-mediated allelic exchange5 of the cor-
responding target genes. Oligonucleotides used for
mutagenesis are provided in Supplementary Table 2. Mutant
alleles were constructed by overlap PCR. Briefly, 2 frag-
ments of approximately 500 bp omitting a region within the
central part of each of the target genes and the aphA-3 and
the CAT cassette were amplified via PCR. The resulting
overlap fragments were ligated into the plasmid pUC19 via
PstI and BamHI restriction sites and propagated in E coli
MC1061. The constructed plasmids (Supplementary
Table 3) were used for natural transformation of H pylori
isolates BCM-300 and HE143/09. PCR amplification of the
relevant loci confirmed the successful chromosomal
replacement of the target gene with the respective mutant
allele.
Overexpression of Hpy300XI in E coli
The Type IIG R-M system Hpy300XI (BCM300_01297) of
BCM-300 was amplified via PCR and ligated to pRRS
(a pUC19 derivative). Oligonucleotides are listed in
Supplementary Table 2. Frameshift correction and stabili-
zation by site-specific mutagenesis was performed as
described previously.6 Briefly, in both allele variants, the
first repeat region was modified to a nonrepeat sequence of
11 nucleotides in length (CCT CCA CCG CC) to allow stable
expression of Hpy300XI in ON status. Additionally, the
second repeat in variant 1 was modified to stably comprise
14 nucleotides (CCG CCA CCT CCA CC), which allowed stable
expression of the full-length protein containing the naturally
occurring C-terminal additional target recognition domain.
In variant 2, the second repeat region was modified to a
nonrepeat sequence of 12 nucleotides (CCG CCA CCT CCA),
resulting in a premature stop codon to prevent full-length
translation. All sequence alterations were designed to pre-
serve amino acid sequence. Sequence accuracy was
confirmed by Sanger sequencing. The resulting constructs
(Supplementary Table 3) were expressed in E coli ER2683
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methylome of the human gastric pathogen Helicobacter
pylori. Nucleic Acids Res 2014;42:2415–2432.
(damþ dcmþ) under the regulation of the Plac promoter
present on pRRS. Genomic DNA of the E coli host ER2683
expressing the modified Hpy300XI alleles was subjected to
SMRT sequencing to analyze the resulting methylation
profile.
Restriction Analysis
MTase activity for BCM-300 mutant strains disrupted in
BCM300_01060 (Hpy300III, M.EcoRI homolog) and
BCM300_01362-01364 (Hpy300VI, BccI homolog) was
assayed by incubation of 300 ng genomic DNA with EcoRI
and BccI, respectively, in 1x CutSmart Buffer (New England
Biolabs, Ipswich, MA) for 1 hour at 37C. H pylori 26695,
which is naturally deficient for both MTase activities, and
wild-type BCM-300 were included as controls. All DNA
samples were also incubated without the addition of the
respective REase as a negative control. Reactions were
analyzed by agarose gel electrophoresis (1% wt/vol).
February 2018 Genetic Variation in Helicobacter pylori 623.e2
36
Supplementary Text 1: Assignment of
Known MTase Specificities and
Identification of Functionally
Uncharacterized MTases
Based on sequence homology search using the REBASE
database,21 11 of the 15 methylated sequence motifs were
assigned to Type II MTases. Although the specificity of 8 of
these MTases was already experimentally verified in pre-
vious studies,18,20,22,38 the MTases targeting 5’-GAm6ATTC-
3’ and 5’-CCm6ATC-3’ (methylated base in bold face,
underlined base indicates methylated base on complemen-
tary DNA strand) had not been functionally characterized in
H pylori so far (Table 3).
The EcoRI MTase homolog M.Hpy300III
(BCM300_01060) was predicted to methylate
5’-GAm6ATTC-3’. Methylation of this motif was recently
detected in H pylori strains P12 and F30, and assigned by
homology.19 We inactivated BCM300_01060 by insertion
mutagenesis and subsequently showed that the mutant
DNA became susceptible to cleavage by EcoRI, confirming
loss of 5’-GAm6ATTC-3’ methylation (Supplementary
Figure 5).
The R-M system Hpy300VI is homologous to the BccI
system and was suggested to methylate 5’-CCm6ATC-3’.
Hpy300VI consists of a REase (BCM300_01362) and 2
MTases (BCM300_01363, BCM300_01364) each expected to
methylate 1 of these motifs (Supplementary Figure 6A). To
analyze the functionality and specificity of this system, we
constructed a BCM-300 triple mutant disrupting all 3 loci as
well as a REase/MTase 1 double mutant (BCM300_01362-
01363). Restriction analysis showed that the genomic DNA
of the triple mutant was completely digested after BccI
treatment, confirming a lack of methylation of the BccI re-
striction site (Supplementary Figure 6B). In contrast, the
DNA of the double mutant was not susceptible to cleavage,
demonstrating that the second MTase encoded by
BCM300_01364 is active. To elucidate which MTase is
responsible for methylation of each of the 2 motifs, we
performed SMRT sequencing of the REase/MTase 1 double
mutant. A lack of 5’-CCm6ATC-3’ methylation showed that
M1.Hpy300VI (BCM300_01363) is responsible for methyl-
ation of this motif. Therefore, we conclude that
M2.Hpy300VI catalyzes methylation of 50-Gm6ATGG-30.
Four methylated motifs could not be assigned to the
responsible MTase by homology (indicated by superscript b
in Table 3). Analysis of the BCM-300 genome identified a
number of putative MTases. To investigate which MTases
are responsible for methylation of these motifs, we inacti-
vated selected candidates by insertion mutagenesis and
analyzed the methylation profiles of the isogenic mutants by
SMRT sequencing.
(i) 5’-AGGm6AG-3’: Hpy300VIII (BCM300_01346). Inac-
tivation of BCM300_01346 resulted in a complete loss of
5’-AGGm6AG-3’methylation. This ORF encodes a Type IIG R-M
system, combining REase and MTase activity with a shared
target recognition domain. Methylation of this motif was
also detected for H pylori F30,19 but the respective MTase
was not identified. Yet, sequence comparisons showed that
Hpy300VIII shares 79% amino acid identity with
Hpy30ORF1390P (HPF30_RS07180) of strain F30. Most
differences were located in the N-terminal REase domain
while the C-terminus was highly conserved. This
strongly indicates that Hpy30ORF1390P is responsible for
5’-AGGm6AG-3’ methylation in H pylori F30.
(ii) 5’-Gm6ACY-3’: M.Hpy300X (BCM300_01342). Func-
tional inactivation of BCM300_01342 led to abrogation of
methylation of 5’-Gm6ACY-3’. Methylation of this motif has
not been described before. Methylation of 5’-Gm6ACY-3’ was
not found in 3 of the reisolates, namely HE93/10 and
HE171/09 from the vaccine group and HE147/09 from the
placebo group. BCM300_01342 contains 1 homopolymeric
nucleotide repeat that is prone to phase variation by slipped
strand mispairing. Analysis of the SMRT sequence data
revealed differences in repeat length; however, these did
not correspond to the observed phenotypes. Resequencing
by Sanger technology revealed that BCM-300 and all rei-
solates showing 5’-Gm6ACY-3’ methylation had a repeat
length of 13 G nucleotides allowing full-length translation of
the MTase. In contrast, the 3 reisolates lacking the meth-
ylated motif had a repeat length of 12 and 14 G nucleotides,
respectively, causing frameshift mutations that rendered
the MTase nonfunctional (Supplementary Figure 7A). Of
note, methylation of 5’-Gm6ACC-3’, which is 1 of the 2 motifs
covered by the degenerate 5’-Gm6ACY-3’ site (Y ¼ C/T), was
also detected for H pylori P12,19 but the corresponding
MTase was not identified. Analysis of the P12 genome
indicated sequence homology to the putative mod gene
HPP12_1497 (M.Hpy1497P). This gene also contains an in-
frame G-repeat, and shows 76% amino acid identity with
M.Hpy300X. Most differences are located in the region
containing the putative target recognition domain, which
might either account for the slight difference in the recog-
nition sequence or point to a completely different
specificity.
(iii) 5’-CCTYNm6A-3’: Hpy300XI (BCM300_01297).
Methylation of 5’-CCTYNm6A-3’ was solely detected for
isolate HE143/09. As the subset of R-M systems did not
differ between BCM-300 and its reisolates, we assumed the
presence of a further active phase-variable MTase.
BCM300_01297, which encodes a putative Type IIG R-M
system, contains 2 homopolymeric nucleotide repeats
(Supplementary Figure 7B). Analysis of the genome se-
quences did not reveal any correlation between repeat
lengths and methylation status. Thus, resequencing of both
repeat regions was performed and showed that only
HE143/09 had both repeats in-frame allowing expression of
the full-length protein. In all other isolates, this R-M system
was inactivated by frameshift mutations in the first repeat
region resulting in a premature stop codon. In line with
these results, functional inactivation of BCM300_01297 in
HE143/09 resulted in a lack of 5’-CCTYNm6A-3’ methyl-
ation, confirming the specificity of this novel system
(Table 3).
Interestingly, this system shows 83% and 81% aa
identity to the recently characterized systems HpyAXVI
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(H pylori 26695) and Hpy99XIV (H pylori J99-R3),
respectively, for which a unique frameshift-mediated
sequence specificity switch was discovered.20 Both sys-
tems each contain 2 homopolymeric repeat regions, and
although the first region was shown to mediate a revers-
ible ON/OFF switching of enzyme activity, the length of the
second region determines sequence specificity. Thus, we
were interested to investigate whether length variation of
the second repeat in Hpy300XI also has an impact on
sequence specificity. For this, 2 different variants of the
wild-type allele of BCM-300 were constructed for recom-
binant expression in Escherichia coli (Figure 7B). In both
variants, the first repeat was changed to be in-frame to
putatively activate the enzyme. The second repeat, which
is in-frame in the wild-type allele, was additionally
mutated in variant 2 to prevent full-length translation of
the protein. SMRT sequencing of the E coli host DNAs
showed that both alleles encode active MTases, yet
revealed slightly different recognition sequences. Expres-
sion of variant 1 resulted in methylation of 5’-CCTTNm6A-
3’ (87% detected), whereas variant 2 showed methylation
of 5’-CCTNCm6A-3’ (98%) and 5’-CCTTTm6A-3’ (74%)
(Figure 7B). Methylation of 5’-CCTTNm6A-3’ by the full-
length enzyme expressed in E coli differed somewhat
from the 5’-CCTYNm6A-3’ methylation (Y ¼ C/T) detected
for H pylori strain HE143/09. This finding might be due to
the overexpression in E coli, as a similar phenomenon had
also been observed for the homologous system Hpy99XIV
of H pylori J99-R3.20 Nevertheless, as reported for
HpyAXVI and Hpy99XIV, alteration of protein length
mediated by the second repeat region affects the speci-
ficity of the positions –1 and –2 relative to the modified A.
Thus, Hpy300XI represents a further example of a
remarkable Type IIG R-M system showing a frameshift-
mediated sequence specificity switch.
(iv) 5’-CACm6AT-3’: Inactivation of Type II MTase
candidate genes encoded by BCM300_00688-00689,
BCM300_01392, and BCM300_01574 did not reveal a
change in the methylation profile of the mutant strains,
indicating that all enzymes are not active in BCM-300. Thus,
methylation of the novel motif 5’-CACm6AT-3’ could not be
assigned to one of the analyzed putative MTase genes.
Supplementary Table 1.Bacterial Strains
Strain Genotype Source
Escherichia coli
ER2683 fhuA2 glnV44 e14- rfbD1? relA1? endA1 spoT1? thi-1 D (mcrC-mrr) 114::IS10 D (lacI-
lacA) 200/F0proAB lacIq DlacZM15 zzf::miniTn10 (KanR)
Reference 1
MC1061 araD139, D(ara, leu)7697, DlacX74, galU, galK, hsr, hsm, strA Reference 2
Helicobacter pylori
BCM-300 H pylori challenge strain (ATCC® BAA-1606TM), CagA protein, babA2, and cag
pathogenicity island positive, vacA s1-m1 type, oipA functional
D. Y. Graham
BCM-300 BCM300_01060 BCM300_01060 (predicted M.EcoRI homolog) from BCM-300 inactivated with
aphA-3
This study
BCM-300 BCM300_01362-01363 BCM300_01363 (predicted M1.BccI homolog) and BCM300_01362 (predicted R.BccI
homolog) from BCM-300 jointly inactivated with aphA-3
This study
BCM-300 BCM300_01362-01364 BCM-300 BCM300_01362-01363 derivative containing a BCM300_01362::CAT
disruption (predicted M2-BccI homolog)
This study
BCM-300 BCM300_01574 BCM300_01574 (predicted Type II R-M modification protein) from BCM-300
inactivated with aphA-3
This study
HE143/09 BCM300_01297 BCM300_01297 (predicted Type IIG R-M modification system) from HE143/09
inactivated with aphA-3
This study
BCM-300 BCM300_01342 BCM300_01342 (predicted Type III R-M modification protein) from BCM-300
inactivated with aphA-3
This study
BCM-300 BCM300_01346 BCM300_01346 (predicted Type IIG R-M modification system) from BCM-300
inactivated with aphA-3
This study
BCM-300 BCM300_00688-00689 BCM300_00688 and BCM300_00689 (predicted Type IIG R-M modification system)
from BCM-300 inactivated with aphA-3
This study
BCM-300 BCM300_01392 BCM300_01392 (predicted Type IIG R-M specificity protein) from BCM-300
inactivated with aphA-3
This study
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Supplementary Table 2.Oligonucleotide Primers
Primer Target gene 5’ / 3’ sequence RS Application
cagA analysis
cagA_R cagA GGGTTGTATGATATTTTCCATAA - Detection of multiple cagA copies
O-2876 GTGCCTRCTAGTTTGTCAGCGA -
cagA_F2 cagA GCGATCAAAAATCCTACCAAA - Quantification of cagA by qPCR
cagA_R GGGTTGTATGATATTTTCCATAA -
HPefpF01 efp GGCAATTGGGATGAGCGAGCTC - Quantification of efp by qPCR
HPefp_R2 CGCACTTATCCCCCGCATGGA -
Methylome analysis
Km8_OL1_for aphA3 gcactgtccgatccgAGCGAACCATTTGAGGTG - Amplification of aphA3 cassette with random overhangs
Km9_OL2_rev gcaaggctaccgagcATCATCGATAAGCTTTTTAGAC -
pCAT-uniOL-fwd cat gcactgtccgatccgAGAGTCAACCGTGATATAGATTGAAA Amplification of cat cassette with random overhangs
pCAT-uniOL-rev gcaaggctaccgagcGACAGAGAGTATAGAAGTGCGC
BCM300_gene1_PstI_for BCM300_01060 atactgcagTTGGTAAAAACAATGTCAAGAAAAG PstI Insertion mutagenesis
BCM300_gene1_OL1_rev cggatcggacagtgcCTTTTAGCAATTGAATGCTCTCC -
BCM300_gene1_OL2_for gctcggtagccttgcCGCAATTGATCGAACACAGC -
BCM300_gene1_BamHI_rev ataggatccCTAAAATAGGGGCATTTACC BamHI
BCM300_gene2_PstI_for BCM300_01362_01363 atactgcagTGAAAAAAAGTATTCGTTCTCC PstI Insertion mutagenesis
BCM300_gene2_OL1_rev cggatcggacagtgcAAATCTACATTACCCACAGG -
BCM300_gene2_REase_OL2_for gctcggtagccttgcCCATAAGGCTTTTAAAGGGG -
BCM300_gene2_REase_BamHI_rev ataggatccCATGGATATTTGGAGCCAC BamHI
BCM300_gene2_MT2_PstI_for BCM300_01364 atactgcagGATTTAATCTAAAAAACCGCC PstI Insertion mutagenesis
BCM300_gene2_MT2_OL1_rev cggatcggacagtgcACCTTAAAATCAGCGTCTTG -
BCM300_gene2_MT2_OL2_for cggatcggacagtgcGAGAGAAAAGACGCTAACGA -
BCM300_gene2_MT2_BamHI_rev ataggatccCTATGAGCCTTTTCTTTAACGC BamHI
BCM300_gene3_PstI_for BCM300_01574 atactgcagGTGTTTTATCATAGCAGCGC PstI Insertion mutagenesis
BCM300_gene3_OL1_rev cggatcggacagtgcCACGCCGATAAATTCTATAG -
BCM300_gene3_OL2_for gctcggtagccttgcGTTTGCGTGAATATAGACGG -
BCM300_gene3_BamHI_rev ataggatccCAATGCCTAGAGTCATTTAC BamHI
BCM300_gene4_PstI_for BCM300_01297 atactgcagATGCTAAAAGAATATTTAGAAGGC PstI Insertion mutagenesis
BCM300_gene4_OL1_rev cggatcggacagtgcCTTAATGCGTTTGCGAAATC -
BCM300_gene4_OL2_for gctcggtagccttgcCACCATAGGCGAATCTTAC -
BCM300_gene4_BamHI_rev ataggatccTTAGGTAATACAGAATAAAGGGAAG BamHI
BCM300_gene4_pRRS_PstI_for BCM300_01297 tgcctgcagttaaggtttaacatATGCTAAAAGAATATTTAGAAGGC PstI Expression and frameshift correction
BCM300_gene4_fix_fs1_for CCGCCAACAAACCCTAAAACACC -
BCM300_gene4_fix_fs1_rev TGGAGGTAACATGTGCTTGAATAC -
BCM300_gene4_fix_fs2_for CCTCCACCATTTAATACCAATATCGC -
BCM300_g4_fix_fs2_for2 CCTCCAATTTAATACCAATATCGCC -
BCM300_gene4_fix_fs2_rev TGGCGGTGGATTTTGCAAGATTTC -
BCM300_gene5_PstI_for BCM300_01342 atactgcagGCAAAATAAAGAAATGGATC PstI Insertion mutagenesis
BCM300_gene5_OL1_rev cggatcggacagtgcCAATCTGGGATACATGAAAC -
BCM300_gene5_OL2_for gctcggtagccttgcGCACGCATGATTTTTGTTTG -
BCM300_gene5_BamHI_rev ataggatccCTACCCCCTAATCTTTAAATC BamHI
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Supplementary Table 2.Continued
Primer Target gene 5’ / 3’ sequence RS Application
BCM300_gene6_PstI_for BCM300_01346 atactgcagCCCAACACAAACTACCCAAG PstI Insertion mutagenesis
BCM300_gene6_OL1_rev cggatcggacagtgcCCCTTTCTATCGTAGCAATC -
BCM300_gene6_OL2_for gctcggtagccttgcGATAATCAGATCACTCAAC -
BCM300_gene6_BamHI_rev ataggatccCCCGTCTTCAATGGTTTTG BamHI
BCM300_g10_RM_PstI_for BCM300_00688 atactgcagATGCAAGAAATCAGCGCCTAC PstI Insertion mutagenesis
BCM300_g10_RM_OL1_rev cggatcggacagtgcGGGCGCGGCCTTTTCTTAT -
BCM300_g10_RM_OL2_for gctcggtagccttgcATCGCTCGGTTGCTTTCCAA -
BCM300_g10_RM_BamHI_rev ataggatccTAACAACATCGCTCGCCTGC BamHI
BCM300_g10_S_PstI_for BCM300_00689 atactgcagGTGATAGGCTTTGTGGTGA PstI Insertion mutagenesis
BCM300_g10_S_OL1_rev cggatcggacagtgcACCCCATTAGAATTGAGATC -
BCM300_g10_S_OL2_for gctcggtagccttgcTCCACCATAAAGGCTATTTG -
BCM300_g10_S_BamHI_rev ataggatccTCAAACCTCTTCTCGCTGAT BamHI
BCM300_g11_S_EcoRI_for BCM300_01392 atagaattcTGATTGGCCCCCTTAGTAG EcoRI Insertion mutagenesis
BCM300_g11_S_OL1_rev cggatcggacagtgcCTCAAGTTCGGCTATGAAT -
BCM300_g11_S_OL2_for gctcggtagccttgcATCAGATCACTTATAGCGATA -
BCM300_g11_S_BamHI_rev ataggatccTTAAAATAACGAGTCTTTTTGAAC BamHI
qPCR, quantitative PCR; RS, restriction site.
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Supplementary Table 3.Plasmids
Plasmids Genotype Source
pBHpC8 Cmr, Source of the cat cassette Reference 3
pILL600 Ampr, Kmr, Source of the aphA-3 cassette Reference 4
pRRS pUC19 derivative, retroregulator structure from B. thuringiensis inserted into the BglII linker of pBBO
(pUC19 modified by insertion of a BglII linker at the SacI site)
Reference 5
pSUS3133 Ampr, Kmr, pUC19 derivative with a BCM300_01060::ahpA3 disruption This study
pSUS3135 Ampr, Kmr, pUC19 derivative with a BCM300_01574::ahpA3 disruption This study
pSUS3136 Ampr, Kmr, pUC19 derivative with a BCM300_01342::ahpA3 disruption This study
pSUS3138 Ampr, Kmr, pUC19 derivative with a BCM300_01297::ahpA3 disruption This study
pSUS3139 Ampr, pRRS derivative containing BCM300_01297 This study
pSUS3140 Ampr, Kmr, pUC19 derivative with a BCM300_01346::ahpA3 disruption This study
pSUS3141 Ampr, Kmr, pUC19 derivative with BCM300_01362-01363::ahpA3 disruption (gene 2RM) This study
pSUS3142 Ampr, pSUS3139 derivative with frameshift 1 corrected This study
pSUS3144 Ampr, Cmr, pUC19 derivative with a BCM300_01364::cat disruption This study
pSUS3145 Ampr, pSUS3142 derivative with both frameshifts corrected This study
pSUS3146 Ampr, pRRS derivative containing BCM300_01574) This study
pSUS3151 Ampr, pSUS3142 derivative with frameshift 1 corrected and frameshift 2 mutation stabilised This study
pSUS3158 Ampr, Cmr, pUC19 derivative with a BCM300_00688::cat disruption This study
pSUS3159 Ampr, Kmr, pUC19 derivative with a BCM300_00689::ahpA3 disruption This study
pSUS3160 Ampr, Kmr, pUC19 derivative with a BCM300_01392::ahpA3 disruption This study
pUC19 Ampr, Colx101, MCS within lacZ: blue/white selection Reference 6
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Supplementary Figure 1. IgG antibody responses to vaccine components. (A) Increases of 
antibody titers against each of the three vaccine antigens 12 weeks after challenge over 
baseline titers. (B) Increases of antibody titers against CagA (left) or VacA (right) 12 weeks after 
challenge over baseline titers for volunteers harboring the three isolates not able to induce IL-8 
vs. the rest of the isolates (left), or the three isolates with an inactivation of vacA vs. the rest of 
the isolates (right). Statistical significance was analyzed by Mann Whitney test (**P < 0.01). 
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Supplementary Figure 2. BabA protein expression and Le(b) binding. (A) Whole cell extracts 
of H. pylori strains were analyzed for protein expression of BabA. (B) Le(b) binding of BCM-300 
was determined by ELISA. H. pylori strain J99 and its isogenic babA mutant were used as 
positive and negative controls, respectively. Le(b) binding is depicted relative to J99 set to 
100%. Data are presented as mean ± SD from three independent experiments. 
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Supplementary Figure 3. Circular representation of H. pylori BCM-300 genome displaying the 
distribution of methylated bases. The representation was generated using Circos1. The 
outmost circle displays the localization of the cagPAI (black) and the five copies of ISHp609 
(dark grey), followed by circles depicting ORFs on plus and minus strand (both dark orange), 
and methylated motifs (see legend). Please note, that methylation of two motifs is not 
depicted: 5´-CCTYNm6A-3´ was only detected in strain HE143/09 and 5’-Gm5CGC-3’ was not 
detected by SMRT sequencing. 
Outwards to inwards 
1. cagPAI, ISHp609 
2. ORFs plus strand 
3. ORFs minus strand 
4. AGGm6AG 
5. CACm6AT 
6. Cm6ATG 
7. CCm6ATC 
8. m4CCGG 
9. GAm6ATTC 
10. Gm6ACY 
11. Gm6AGG 
12. Gm6ATC 
13. Gm6ATGG 
14. GTSm6AC 
15. TCNNGm6A 
16. TGCm6A 
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Supplementary Figure 4. Confirmation of 5´-Gm5CGC-3´ MTase activity. Genomic DNA (300 
ng) of H. pylori BCM-300 and the reisolates were either incubated without (-) or with (+) the 
restriction endonuclease HhaI cleaving non-methylated GCGC sites. Plasmid DNA of pCJ535 
lacking 5´-Gm5CGC-3´ methylation was used as control for HhaI activity. L, 1 kb Plus DNA Ladder 
(Invitrogen). 
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Supplementary Figure 5. Functionality of the Hpy300III R-M system (EcoRI homolog). 
Analysis of BCM300_01060 MTase activity was determined by DNA restriction digestion 
experiment. Genomic DNA (300 ng) of H. pylori wild type and isogenic mutant strains was 
either incubated without (-) or with (+) EcoRI (GAATTC). H. pylori 26695 was used as control as 
it is known to be susceptible to EcoRI cleavage. Two independent clones were assayed for 
MTase activity. L, 1 kb Plus DNA Ladder (Invitrogen). 
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Supplementary Figure 6. Organization and functionality of the Hpy300VI R-M system (BccI 
homolog). (A) Genetic organization of the BccI locus: MTase genes (M) are depicted in light 
grey and the REase gene in dark grey. (B) Analysis of MTase activity was determined by DNA 
restriction digestion experiments. Genomic DNA (300 ng) of H. pylori wild type and isogenic 
mutant strains was either incubated without (-) or with (+) BccI (CCATC). H. pylori 26695 was 
used as control as it is known to be susceptible to BccI cleavage. Two independent clones were 
assayed for MTase activity. L, 1 kb Plus DNA Ladder (Invitrogen).  
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Supplementary Figure 7. Functional characterization of phase-variable R-M systems 
M.Hpy300X and Hpy300XI. Genes are depicted as grey arrows and proteins as grey (expressed 
in H. pylori) or blue bars (expressed in E. coli). Triangles plus vertical lines highlight the position 
of homopolymeric repeat tracts and the letter above indicates the type of nucleotide. MTase 
activities were analyzed by SMRT sequencing of either H. pylori or E. coli genomic DNA (dashed 
lines indicate that methylation of the relevant motif was not detected). (A) The phase-variable 
expression of the MTase M.Hpy300X is mediated by length variation of a homopolymeric G 
repeat. Deviations in nucleotide number inhibit translation of a full-length protein for isolates 
HE93/10, HE147/09 and HE171/09, for which methylation of 5´-Gm6ACY-3´ was not detected 
by SMRT sequencing of the H. pylori genomic DNAs. (B) For HE143/09 both repeat tracts are in 
frame and the full-length MTase mediates methylation of 5´-CCTYNm6A-3´. In BCM-300, an 
authentic frameshift within the first repeat prevents translation of a full-length protein 
resulting in a lack of methylation. Two different alleles of BCM-300 Hpy300XI were constructed 
by frameshift correction and repeat stabilization through site-directed mutagenesis. Both 
alleles were recombinantly expressed and methylation pattern of the E. coli genomic DNAs was 
analyzed by SMRT sequencing confirming the specificity switch at positions -1 and -2 relative to 
the modified A (indicated by green color). 
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Supplementary Dataset 1: 
List of genomic differences between H. pylori  challenge strain BCM-300 and reisolates 
1
The genome annotation was automatically generated by Kodon based on annotation of H. pylori strain 26695 (NC_000915.1), and then manually curated if necessary.
2
The genome annotation of BCM-300 was generated by Prokka (v1.7).
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HE101/09
No. BCM-300
2
Start End BCM-300 Reisolate Gene description Gene name Locus tag Locus tag
1 25796 25800 5 Cs 4 Cs indel 1 bp deletion intergenic: no annotation - - intergenic: no annotation
2 28076 28091 16 As 15 As indel 1 bp deletion intergenic: no annotation - - intergenic: no annotation
3 32486 32490 5 Gs 6 Gs indel 1 bp insertion ATP-dependent dethiobiotin synthetase BioD bioD hp0029 BCM300_00035
4 71801 71806 6 Gs 5 Gs indel 1 bp deletion intergenic: no annotation - - intergenic: no annotation
5 98334 98339 6 As 5 As indel 1 bp deletion type II restriction enzyme M protein (hsdM) M.HpyAIII hp0092 BCM300_00102
6 99174 99185 12 Gs 11 Gs indel 1 bp deletion alpha-1,2-fucosyltransferase futC hp0094 BCM300_00103
7 169575 169588 14 Gs 13 Gs indel 1 bp deletion signal-transducing protein, histidine kinase - hp0164 BCM300_00169
8 177965 177971 7 As 6 As indel 1 bp deletion hypothetical protein - hp0174 BCM300_00178
9 178003 178009 7 As 6 As indel 1 bp deletion hypothetical protein - hp0174 BCM300_00178
10 193058 193066 9 As 8 As indel 1 bp deletion hypothetical protein - hp0190 BCM300_00191
11 222870 222881 12 Gs 11 Gs indel 1 bp deletion beta-1,4-N-acetylgalactosamyltransferase cgtA hp0217 BCM300_00220
12 229250 229255 6 Ts 5 Ts indel 1 bp deletion bifunctional methionine sulfoxide reductase subunits A/BmsrA hp0224 intergenic: no annotation
13 231460 231466 7 Cs 6 Cs indel 1 bp deletion membrane protein - hp0226 BCM300_00228
14 350265 350279 15 As 14 As indel 1 bp deletion intergenic: no annotation - - intergenic: no annotation
15 450369 450379 11 Gs 12 Gs indel 1 bp insertion type I restriction-modification system endonuclease hsdR hp0464 BCM300_00442
16 486962 486966 5 Cs 6 Cs indel 1 bp insertion intergenic: no annotation - - BCM300_00476
17 504277 504281 5 Ts 4 Ts indel 1 bp deletion virB4 homolog (virB4) virB4 hp0459 BCM300_00493
18 516061 516067 7 As 6 As indel 1 bp deletion hypothetical protein - hp0488 BCM300_00507
19 526366 526372 7 Gs 8 Gs indel 1 bp insertion phospholipase A1 precursor (DR-phospholipase A) pldA hp0499 BCM300_00519
20 559284 559291 8 Ts 7 Ts indel 1 bp deletion cag pathogenicity island protein (cag7) cagY hp0527 BCM300_00549
21 604505 604511 7 Gs 6 Gs indel 1 bp deletion aminopeptidase a/i (pepA) pepA hp0570 BCM300_00591
22 663718 663732 15 Cs 14 Cs indel 1 bp deletion predicted LPS biosynthesis protein - hp0619 BCM300_00638
23 727943 727947 5 Cs 6 Cs indel 1 bp insertion methylated-DNA--protein-cysteine methyltransferase dat1 hp0676 BCM300_00697
24 780145 780159 15 Ts 14 Ts indel 1 bp deletion intergenic: no annotation - - intergenic: no annotation
25 786911 786928 18 As 17 As indel 1 bp deletion intergenic: no annotation - - intergenic: no annotation
26 862628 862631 4 Gs 5 Gs indel 1 bp insertion sigma-54 interacting protein comM hp0792 BCM300_00832
27 864414 864418 5 As 6 As indel 1 bp insertion trigger factor (tig) tig hp0795 BCM300_00836
28 864639 1 C 2 Cs indel 1 bp insertion trigger factor (tig) tig hp0795 intergenic: no annotation
29 864688 864691 4 Ts 5 Ts indel 1 bp insertion trigger factor (tig) tig hp0795 BCM300_00837
30 864943 864944 2 Cs 3 Cs indel 1 bp insertion trigger factor (tig) tig hp0795 BCM300_00838
31 865147 865148 2 Ts 3 Ts indel 1 bp insertion trigger factor (tig) tig hp0795 BCM300_00839
32 877934 877946 13 Ts 12 Ts indel 1 bp deletion intergenic: no annotation - - BCM300_00856
33 936941 936954 14 Ts 13 Ts indel 1 bp deletion intergenic: no annotation - - intergenic: no annotation
34 948014 C T SNP non-synonymous vacuolating cytotoxin vacA hp0887 BCM300_00927
35 960612 960615 4 Cs 5 Cs indel 1 bp insertion intergenic: no annotation - - intergenic: no annotation
36 979321 979335 15 Ts 14 Ts indel 1 bp deletion intergenic: no annotation - - intergenic: no annotation
37 985093 985106 14 As 13 As indel 1 bp deletion intergenic: no annotation - - intergenic: no annotation
38 1081106 1081409 38 x 8-nt repeat 39 x 8-nt repeat indel 8 bp insertion [repeat: CATTCTAT] hypothetical protein - hp0427 BCM300_01049
39 1081414 1081415 T indel 1 bp insertion hypothetical protein - hp0427 BCM300_01049
40 1081419 1081420 T indel 1 bp insertion hypothetical protein - hp0427 BCM300_01049
41 1081421 1 A 2 As indel 1 bp insertion hypothetical protein - hp0427 BCM300_01049
42 1222342 1222346 5 Cs 6 Cs indel 1 bp insertion intergenic: no annotation - - intergenic: no annotation
43 1222580 1222585 6 Cs 5 Cs indel 1 bp deletion intergenic: no annotation - - intergenic: no annotation
44 1224971 1224985 15 Ts 14 Ts indel 1 bp deletion intergenic: no annotation - - intergenic: no annotation
45 1225114 1225253 14 x 10-nt repeat 13 x 10-nt repeat indel 10 bp deletion [repeat: intergenic: no annotation - - intergenic: no annotation
46 1236530 1236534 5 Cs 4 Cs indel 1 bp deletion protein translocation protein, low temperature (secG)secG hp1255 BCM300_01197
47 1256981 1256995 15 As 14 As indel 1 bp deletion intergenic: no annotation - - intergenic: no annotation
48 1287348 1287387 5 x 8-nt repeat 6 x 8-nt repeat indel 8 bp insertion [repeat: GTATTTAT] intergenic: no annotation - - intergenic: no annotation
49 1304687 1304701 15 As 14 As indel 1 bp deletion intergenic: no annotation - - intergenic: no annotation
50 1317399 1317412 14 Gs 15 Gs indel 1 bp insertion putative adenine specific DNA methyltransferase - hp1354 BCM300_01297
51 1318224 1318234 11 Gs 12 Gs indel 1 bp insertion putative adenine specific DNA methyltransferase - hp1354 BCM300_01297
52 1343408 1343418 11 Ts 10 Ts indel 1 bp deletion intergenic: no annotation - - intergenic: no annotation
53 1419748 1419752 5 Gs 4 Gs indel 1 bp deletion hypothetical protein - hp1479 BCM300_01384
54 1478232 1478238 7 As 6 As indel 1 bp deletion hypothetical protein - hp1127 BCM300_01439
55 1488920 1488926 7 As 8 As indel 1 bp insertion Sel1 repeat-containing protein hcpX hp1117 BCM300_01451
56 1503023 1503044 22 Ts 20 Ts indel 2 bp deletion intergenic: no annotation - - intergenic: no annotation
57 1517648 1517721  -74 bp indel 74 bp deletion UDP-glucose 4-epimerase galE hp0360 BCM300_01480
58 1536449 1536458 10 As 9 As indel 1 bp deletion fucosyltransferase futA hp0379 BCM300_01500
59 1562284 1562289 6 Ts 5 Ts indel 1 bp deletion phenylalanyl-tRNA synthetase, beta subunit (pheT) pheT hp0402 BCM300_01523
60 1587896 1588151 32 x 8-nt repeat 35 x repeat indel 24 bp insertion [repeat: GAATGATA] hypothetical protein - hp0427 BCM300_01551
61 1652479 1652486 8 As 7 As indel 1 bp deletion GTP-binding protein EngB engB hp1567 BCM300_01607
Position in BCM-300      Sequence in          Type of difference     Annotation
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HE132/09
No. BCM-300
2
Start End BCM-300 Reisolate Gene description Gene name Locus tag Locus tag
1 9816 9829 14 Ts 15 Ts indel 1 bp insertion intergenic: no annotation - - intergenic: no annotation
2 32486 32490 5 Gs 6 Gs indel 1 bp insertion ATP-dependent dethiobiotin synthetase BioD bioD hp0029 BCM300_00035
3 61680 61688 9 Cs 10 Cs indel 1 bp insertion intergenic: no annotation - - BCM300_00061
4 71831 71835 5 Gs 6 Gs indel 1 bp insertion intergenic: no annotation - - intergenic: no annotation
5 110540 110553 14 Cs 15 Cs indel 1 bp insertion intergenic: no annotation - - intergenic: no annotation
6 166606 166821  +216 bp indel duplication of 216-bp sequence beta-lactamase HcpD hcpD hp0160 BCM300_00166
7 222870 222881 12 Gs 11 Gs indel 1 bp deletion beta-1,4-N-acetylgalactosamyltransferase cgtA hp0217 BCM300_00220
8 450369 450379 11 Gs 13 Gs indel 2 bp insertion type I restriction-modification system endonuclease hsdR hp0464 BCM300_00442
9 486962 486966 5 Cs 6 Cs indel 1 bp insertion intergenic: no annotation - - BCM300_00476
10 526366 526372 7 Gs 8 Gs indel 1 bp insertion phospholipase A1 precursor (DR-phospholipase A) pldA hp0499 BCM300_00519
11 581663 C T SNP non-synonymous cag pathogenicity island protein (cag26) cagA hp0547 BCM300_00568
12 662004 662235 intrachromosomal recombination232-bp fragment recombined; 
source: 663338-663572
intergenic: no annotation - - BCM300_00637
13 697107 A G SNP synonymous fucosyltransferase futB hp0651 BCM300_00672
14 727943 727947 5 Cs 6 Cs indel 1 bp insertion methylated-DNA--protein-cysteine methyltransferase dat1 hp0676 BCM300_00697
15 780276 780291 8 x CT repeat 9 x CT repeat indel 2 bp insertion outer membrane protein (omp17) sabA hp0725 BCM300_00748
16 786776 786793 9 x GA repeat 8 x GA repeat indel 2 bp deletion outer membrane protein (omp16) sabB hp0722 BCM300_00751
17 862628 862631 4 Gs 5 Gs indel 1 bp insertion sigma-54 interacting protein comM hp0792 BCM300_00832
18 864414 864418 5 As 6 As indel 1 bp insertion trigger factor (tig) tig hp0795 BCM300_00836
19 864639 1 C 2 Cs indel 1 bp insertion trigger factor (tig) tig hp0795 intergenic: no annotation
20 864688 864691 4 Ts 5 Ts indel 1 bp insertion trigger factor (tig) tig hp0795 BCM300_00837
21 864943 864944 2 Cs 3 Cs indel 1 bp insertion trigger factor (tig) tig hp0795 BCM300_00838
22 865147 865148 2 Ts 3 Ts indel 1 bp insertion trigger factor (tig) tig hp0795 BCM300_00839
23 875914 G A SNP intergenic intergenic: no annotation - - intergenic: no annotation
24 877934 877946 13 Ts 14 Ts indel 1 bp insertion intergenic: no annotation - - BCM300_00856
25 960612 960615 4 Cs 5 Cs indel 1 bp insertion intergenic: no annotation - - intergenic: no annotation
26 1081369 1081370  +37 bp indel 37 bp insertion hypothetical protein - hp0427 BCM300_01049
27 1081414 1081415 T indel 1 bp insertion hypothetical protein - hp0427 BCM300_01049
28 1081419 1081420 T indel 1 bp insertion hypothetical protein - hp0427 BCM300_01049
29 1081421 1 A 2 As indel 1 bp insertion hypothetical protein - hp0427 BCM300_01049
30 1222342 1222346 5 Cs 6 Cs indel 1 bp insertion intergenic: no annotation - - intergenic: no annotation
31 1317399 1317412 14 Gs 13 Gs indel 1 bp deletion putative adenine specific DNA methyltransferase - hp1354 BCM300_01297
32 1318224 1318234 11 Gs 12 Gs indel 1 bp insertion putative adenine specific DNA methyltransferase - hp1354 BCM300_01297
33 1370527 1370539 13 Gs 14 Gs indel 1 bp insertion predicted type III R-M system modification enzyme - hp1522 BCM300_01342
34 1488920 1488926 7 As 8 As indel 1 bp insertion Sel1 repeat-containing protein hcpX hp1117 BCM300_01451
35 1587927 1587928  +12 bp indel 12 bp insertion hypothetical protein - hp0427 BCM300_01551
36 1592310 1592315 6 Gs 7 Gs indel 1 bp insertion intergenic: no annotation - - intergenic: no annotation
Position in BCM-300      Sequence in          Type of difference     Annotation
1
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HE134/09
No. BCM-300
2
Start End BCM-300 Reisolate Gene description Gene name Locus tag Locus tag
1 9816 9829 14 Ts 13 Ts indel 1 bp deletion intergenic: no annotation - - intergenic: no annotation
2 32486 32490 5 Gs 6 Gs indel 1 bp insertion ATP-dependent dethiobiotin synthetase BioD bioD hp0029 BCM300_00035
3 71831 71835 5 Gs 6 Gs indel 1 bp insertion intergenic: no annotation - - intergenic: no annotation
4 99174 99185 12 Gs 13 Gs indel 1 bp insertion alpha-1,2-fucosyltransferase futC hp0094 BCM300_00103
5 169575 169588 14 Gs 13 Gs indel 1 bp deletion signal-transducing protein, histidine kinase - hp0164 BCM300_00169
6 222870 222881 12 Gs 11 Gs indel 1 bp deletion beta-1,4-N-acetylgalactosamyltransferase cgtA hp0217 BCM300_00220
7 260916 T C SNP non-synonymous outer membrane protein (omp8) hopG hp0253-254 BCM300_00257
8 365123 365129 7 Gs 6 Gs indel 1 bp deletion cell division protein (ftsK) ftsK hp1090 BCM300_00358
9 401200 G A SNP synonymous membrane protein - hp1055 BCM300_00395
10 450369 450379 11 Gs 12 Gs indel 1 bp insertion type I restriction-modification system endonuclease hsdR hp0464 BCM300_00442
11 486962 486966 5 Cs 6 Cs indel 1 bp insertion intergenic: no annotation - - BCM300_00476
12 526366 526372 7 Gs 8 Gs indel 1 bp insertion phospholipase A1 precursor (DR-phospholipase A) pldA hp0499 BCM300_00519
13 662803 662807 5 As 3 As indel 2 bp deletion intergenic: no annotation - - BCM300_00637
14 663718 663732 15 Cs 13 cs indel 2 bp deletion predicted LPS biosynthesis protein - hp0619 BCM300_00638
15 705587 705595 9 Gs 8 Gs indel 1 bp deletion processing protease (ymxG) ymxG hp0657 BCM300_00678
16 727943 727947 5 Cs 6 Cs indel 1 bp insertion methylated-DNA--protein-cysteine methyltransferase dat1 hp0676 BCM300_00697
17 826877 826887 11 Cs 10 Cs indel 1 bp deletion intergenic: no annotation - - intergenic: no annotation
18 862628 862631 4 Gs 5 Gs indel 1 bp insertion sigma-54 interacting protein comM hp0792 BCM300_00832
19 864414 864418 5 As 6 As indel 1 bp insertion trigger factor (tig) tig hp0795 BCM300_00836
20 864639 1 C 2 Cs indel 1 bp insertion trigger factor (tig) tig hp0795 intergenic: no annotation
21 864688 864691 4 Ts 5 Ts indel 1 bp insertion trigger factor (tig) tig hp0795 BCM300_00837
22 864943 864944 2 Cs 3 Cs indel 1 bp insertion trigger factor (tig) tig hp0795 BCM300_00838
23 865147 865148 2 Ts 3 Ts indel 1 bp insertion trigger factor (tig) tig hp0795 BCM300_00839
24 960612 960615 4 Cs 5 Cs indel 1 bp insertion intergenic: no annotation - - intergenic: no annotation
25 985093 985106 14 As 15 As indel 1 bp insertion intergenic: no annotation - - intergenic: no annotation
26 1081106 1081409 38 x 8-nt repeat 37 x 8-nt repeat indel 8 bp deletion [repeat: CATTCTAT] hypothetical protein - hp0427 BCM300_01049
27 1081414 1081415 T indel 1 bp insertion hypothetical protein - hp0427 BCM300_01049
28 1081419 1081420 T indel 1 bp insertion hypothetical protein - hp0427 BCM300_01049
29 1081421 1 A 2 As indel 1 bp insertion hypothetical protein - hp0427 BCM300_01049
30 1221905 1221912 8 Cs 7 Cs indel 1 bp deletion intergenic: no annotation - - intergenic: no annotation
31 1222342 1222346 5 Cs 6 Cs indel 1 bp insertion intergenic: no annotation - - intergenic: no annotation
32 1309317 1309324 8 Cs 7 Cs indel 1 bp deletion phosphoglycerate kinase pgk hp1345 BCM300_01287
33 1317399 1317412 14 Gs 13 Gs indel 1 bp deletion putative adenine specific DNA methyltransferase - hp1354 BCM300_01297
34 1347536 1347549 14 As 15 As indel 1 bp insertion intergenic: no annotation - - intergenic: no annotation
35 1503023 1503044 22 Ts 21 Ts indel 1 bp deletion intergenic: no annotation - - intergenic: no annotation
36 1587896 1588151 32 x 8-nt repeat 29 x 8-nt repeat indel 24 bp deletion [repeat: GAATGATA] hypothetical protein - hp0427 BCM300_01551
37 1592310 1592315 6 Gs 7 Gs indel 1 bp insertion intergenic: no annotation - - intergenic: no annotation
Position in BCM-300      Sequence in          Type of difference     Annotation
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No. BCM-300
2
Start End BCM-300 Reisolate Gene description Gene name Locus tag Locus tag
1 32486 32490 5 Gs 6 Gs indel 1 bp insertion ATP-dependent dethiobiotin synthetase BioD bioD hp0029 BCM300_00035
2 61680 61688 9 Cs 10 Cs indel 1 bp insertion intergenic: no annotation - - BCM300_00061
3 71831 71835 5 Gs 6 Gs indel 1 bp insertion intergenic: no annotation - - intergenic: no annotation
4 99174 99185 12 Gs 14 Gs indel 2 bp insertion alpha-1,2-fucosyltransferase futC hp0094 BCM300_00103
5 110540 110553 14 Cs 15 Cs indel 1 bp insertion intergenic: no annotation - - intergenic: no annotation
6 230344 230351 8 Gs 9 Gs indel 1 bp insertion intergenic: no annotation - - intergenic: no annotation
7 344681 344689 9 Gs 10 Gs indel 1 bp insertion intergenic: no annotation - - intergenic: no annotation
8 381791 381797 7 Gs 8 Gs indel 1 bp insertion nickel transport protein (nixA) nixA hp1077 BCM300_00373
9 427626 427630 5 Gs 6 Gs indel 1 bp insertion recombination factor protein RarA - hp1026 BCM300_00423
10 450369 450379 11 Gs 12 Gs indel 1 bp insertion type I restriction-modification system endonuclease hsdR hp0464 BCM300_00442
11 486962 486966 5 Cs 6 Cs indel 1 bp insertion intergenic: no annotation - - BCM300_00476
12 526366 526372 7 Gs 8 Gs indel 1 bp insertion phospholipase A1 precursor (DR-phospholipase A) pldA hp0499 BCM300_00519
13 535902 535907 6 Gs 7 Gs indel 1 bp insertion glycolate oxidase subunit (glcD) glcD hp0509 BCM300_00530
14 653515 653521 7 Gs 8 Gs indel 1 bp insertion toxin-like outer membrane protein - hp0610 BCM300_00631
15 662723 662731 9 As 8 As indel 1 bp deletion intergenic: no annotation - - BCM300_00637
16 727943 727947 5 Cs 6 Cs indel 1 bp insertion methylated-DNA--protein-cysteine methyltransferase dat1 hp0676 BCM300_00697
17 729048 729053 6 Cs 7 Cs indel 1 bp insertion conserved hypothetical integral membrane protein - hp0677 BCM300_00698
18 739831 739838 8 Cs 9 Cs indel 1 bp insertion iron(II) transport protein (feoB) feoB hp0687 BCM300_00706
19 752910 752916 7 Cs 8 Cs indel 1 bp insertion conserved hypothetical integral membrane protein atoE hp0693 BCM300_00722
20 839307 839313 7 Gs 8 Gs indel 1 bp insertion aconitase B (acnB) acnB hp0779 BCM300_00809
21 839961 839967 7 Gs 8 Gs indel 1 bp insertion aconitase B (acnB) acnB hp0779 BCM300_00809
22 847847 847851 5 Gs 6 Gs indel 1 bp insertion preprotein translocase subunit (secA) secA hp0786 BCM300_00816
23 862628 862631 4 Gs 5 Gs indel 1 bp insertion sigma-54 interacting protein comM hp0792 BCM300_00832
24 864414 864418 5 As 6 As indel 1 bp insertion trigger factor (tig) tig hp0795 BCM300_00836
25 864639 1 C 2 Cs indel 1 bp insertion trigger factor (tig) tig hp0795 intergenic: no annotation
26 864688 864691 4 Ts 5 Ts indel 1 bp insertion trigger factor (tig) tig hp0795 BCM300_00837
27 864943 864944 2 Cs 3 Cs indel 1 bp insertion trigger factor (tig) tig hp0795 BCM300_00838
28 865147 865148 2 Ts 3 Ts indel 1 bp insertion trigger factor (tig) tig hp0795 BCM300_00839
29 924452 G A SNP synonymous pantothenate kinase - hp0862 BCM300_00904
30 960612 960615 4 Cs 5 Cs indel 1 bp insertion intergenic: no annotation - - intergenic: no annotation
31 985093 985106 14 As 13 As indel 1 bp deletion intergenic: no annotation - - intergenic: no annotation
32 1029483 C A SNP non-synonymous hypothetical protein - hp0953 BCM300_00997
33 1081106 1081409 38 x 8-nt repeat 40 x 8-nt repeat indel 16 bp insertion [repeat: CATTCTAT] hypothetical protein - hp0427 BCM300_01049
34 1081414 1081415 T indel 1 bp insertion hypothetical protein - hp0427 BCM300_01049
35 1081419 1081420 T indel 1 bp insertion hypothetical protein - hp0427 BCM300_01049
36 1081421 1 A 2 As indel 1 bp insertion hypothetical protein - hp0427 BCM300_01049
37 1189877 1189883 7 Cs 8 Cs indel 1 bp insertion ulcer associated adenine specific DNA methyltransferaseM.HpyAI hp1208 BCM300_01150
38 1222342 1222346 5 Cs 6 Cs indel 1 bp insertion intergenic: no annotation - - intergenic: no annotation
39 1304687 1304701 15 As 16 As indel 1 bp insertion intergenic: no annotation - - intergenic: no annotation
40 1318224 1318234 11 Gs 12 Gs indel 1 bp insertion putative adenine specific DNA methyltransferase - hp1354 BCM300_01297
41 1370527 1370539 13 Gs 14 Gs indel 1 bp insertion predicted type III R-M system modification enzyme - hp1522 BCM300_01342
42 1426091 1426096 6 Gs 7 Gs indel 1 bp insertion thymidylate kinase (tmk) tmk hp1474 BCM300_01389
43 1486540 1486548 9 Gs  10 Gs indel 1 bp insertion gamma-glutamyltranspeptidase (ggt) ggt hp1118 BCM300_01449
44 1537936 1537942 7 Cs 8 Cs indel 1 bp insertion glutamate dehydrogenase (gdhA) gdhA hp0380 BCM300_01501
45 1587896 1588151 32 x 8-nt repeat 37 x 8-nt repeat indel 40 bp insertion [repeat: GAATGATA] hypothetical protein - hp0427 BCM300_01551
46 1592310 1592315 6 Gs 7 Gs indel 1 bp insertion intergenic: no annotation - - intergenic: no annotation
Position in BCM-300      Sequence in          Type of difference     Annotation
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No. BCM-300
2
Start End BCM-300 Reisolate Gene description Gene name Locus tag Locus tag
1 28076 28091 16 As 15 As indel 1 bp deletion intergenic: no annotation - - intergenic: no annotation
2 32486 32490 5 Gs 6 Gs indel 1 bp insertion ATP-dependent dethiobiotin synthetase BioD bioD hp0029 BCM300_00035
3 71786 71791 6 Gs 5 Gs indel 1 bp deletion intergenic: no annotation - - intergenic: no annotation
4 71801 71806 6 Gs 5 Gs indel 1 bp deletion intergenic: no annotation - - intergenic: no annotation
5 71831 71835 5 Gs 6 Gs indel 1 bp insertion intergenic: no annotation - - intergenic: no annotation
6 99174 99185 12 Gs 13 Gs indel 1 bp insertion alpha-1,2-fucosyltransferase futC hp0094 BCM300_00103
7 110540 110553 14 Cs 15 Cs indel 1 bp insertion intergenic: no annotation - - intergenic: no annotation
8 169575 169588 14 Gs 13 Gs indel 1 bp deletion signal-transducing protein, histidine kinase - hp0164 BCM300_00169
9 222870 222881 12 Gs 11 Gs indel 1 bp deletion beta-1,4-N-acetylgalactosamyltransferase cgtA hp0217 BCM300_00220
10 256678 256684 7 Ts 6 Ts indel 1 bp deletion oligopeptide ABC transporter, ATP-binding protein (oppD)oppD hp0250 BCM300_00253
11 450369 450379 11 Gs 12 Gs indel 1 bp insertion type I restriction-modification system endonuclease hsdR hp0464 BCM300_00442
12 486962 486966 5 Cs 6 Cs indel 1 bp insertion intergenic: no annotation - - BCM300_00476
13 526366 526372 7 Gs 8 Gs indel 1 bp insertion phospholipase A1 precursor (DR-phospholipase A) pldA hp0499 BCM300_00519
14 573786 573792 7 Cs 8 Cs indel 1 bp insertion cag pathogenicity island protein (cag19) cagI hp0540 BCM300_00560
15 581292 581293  +2398 bp indel transposon insertion intergenic: no annotation - - intergenic: no annotation
16 727943 727947 5 Cs 6 Cs indel 1 bp insertion methylated-DNA--protein-cysteine methyltransferase dat1 hp0676 BCM300_00697
17 780276 780291 8 x CT repeat 7 x CT repeat indel 2 bp deletion outer membrane protein (omp17) sabA hp0725 BCM300_00748
18 786776 786793 9 x GA repeat 8 x GA repeat indel 2 bp deletion outer membrane protein (omp16) sabB hp0722 BCM300_00751
19 862628 862631 4 Gs 5 Gs indel 1 bp insertion sigma-54 interacting protein comM hp0792 BCM300_00832
20 864414 864418 5 As 6 As indel 1 bp insertion trigger factor (tig) tig hp0795 BCM300_00836
21 864639 1 C 2 Cs indel 1 bp insertion trigger factor (tig) tig hp0795 intergenic: no annotation
22 864688 864691 4 Ts 5 Ts indel 1 bp insertion trigger factor (tig) tig hp0795 BCM300_00837
23 864943 864944 2 Cs 3 Cs indel 1 bp insertion trigger factor (tig) tig hp0795 BCM300_00838
24 865147 865148 2 Ts 3 Ts indel 1 bp insertion trigger factor (tig) tig hp0795 BCM300_00839
25 903106 903113 8 Gs 7 Gs indel 1 bp deletion outer membrane protein P1 (ompP1) ompP1 hp0839 BCM300_00884
26 960239 960323 5 x 17-nt repeat 6 x 17-nt repeat indel 17 bp insertion [repeat: 
CAAAGAAAAAGGGAGTT]
intergenic: no annotation - - intergenic: no annotation
27 960612 960615 4 Cs 5 Cs indel 1 bp insertion intergenic: no annotation - - intergenic: no annotation
28 979321 979335 15 Ts 16 Ts indel 1 bp insertion intergenic: no annotation - - intergenic: no annotation
29 985093 985106 14 As 13 As indel 1 bp deletion intergenic: no annotation - - intergenic: no annotation
30 1002974 1002980 7 Cs 8 Cs indel 1 bp insertion recombinational DNA repair protein (recR) recR hp0925 BCM300_00967
31 1029281 G A SNP non-synonymous hypothetical protein - hp0953 BCM300_00997
32 1081106 1081409 38 x 8-nt repeat 47 x 8-nt repeat indel 72 bp insertion [repeat: CATTCTAT] hypothetical protein - hp0427 BCM300_01049
33 1081414 1081415 T indel 1 bp insertion hypothetical protein - hp0427 BCM300_01049
34 1081419 1081420 T indel 1 bp insertion hypothetical protein - hp0427 BCM300_01049
35 1081421 1 A 2 As indel 1 bp insertion hypothetical protein - hp0427 BCM300_01049
36 1218049 1218061 13 Ts 14 Ts indel 1 bp insertion intergenic: no annotation - - intergenic: no annotation
37 1222342 1222346 5 Cs 6 Cs indel 1 bp insertion intergenic: no annotation - - intergenic: no annotation
38 1304687 1304701 15 As 14 As indel 1 bp deletion intergenic: no annotation - - intergenic: no annotation
39 1318224 1318234 11 Gs 12 Gs indel 1 bp insertion putative adenine specific DNA methyltransferase - hp1354 BCM300_01297
40 1471570 C T SNP synonymous ATP synthase F0, subunit b (atpF) atpF hp1136 BCM300_01431
41 1503023 1503044 22 Ts 23 Ts indel 1 bp insertion intergenic: no annotation - - intergenic: no annotation
42 1592310 1592315 6 Gs 7 Gs indel 1 bp insertion intergenic: no annotation - - intergenic: no annotation
43 1594330 1594344 15 Cs 16 Cs indel 1 bp insertion intergenic: no annotation - - intergenic: no annotation
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1 32486 32490 5 Gs 6 Gs indel 1 bp insertion ATP-dependent dethiobiotin synthetase BioD bioD hp0029 BCM300_00035
2 71786 71859 5 x 15-nt repeat 6 x 15-nt repeat indel 15 bp insertion [repeat: 
GGGGGGTTAAAAAAA]
intergenic: no annotation - - intergenic: no annotation
3 71831 71835 5 Gs 6 Gs indel 1 bp insertion intergenic: no annotation - - intergenic: no annotation
4 99174 99185 12 Gs 13 Gs indel 1 bp insertion alpha-1,2-fucosyltransferase futC hp0094 BCM300_00103
5 222870 222881 12 Gs 11 Gs indel 1 bp deletion beta-1,4-N-acetylgalactosamyltransferase cgtA hp0217 BCM300_00220
6 233960 233973 14 As 13 As indel 1 bp deletion intergenic: no annotation - - intergenic: no annotation
7 450369 450379 11 Gs 12 Gs indel 1 bp insertion type I restriction-modification system endonuclease hsdR hp0464 BCM300_00442
8 486962 486966 5 Cs 6 Cs indel 1 bp insertion intergenic: no annotation - - BCM300_00476
9 557853 557859 7 Ts 8 Ts indel 1 bp insertion cag pathogenicity island protein (cag7) cagY hp0527 BCM300_00549
10 663718 663732 15 Cs 16 Cs indel 1 bp insertion predicted LPS biosynthesis protein - hp0619 BCM300_00638
11 727943 727947 5 Cs 6 Cs indel 1 bp insertion methylated-DNA--protein-cysteine methyltransferase dat1 hp0676 BCM300_00697
12 762531 A G SNP intergenic intergenic: no annotation - - intergenic: no annotation
13 862628 862631 4 Gs 5 Gs indel 1 bp insertion sigma-54 interacting protein comM hp0792 BCM300_00832
14 864414 864418 5 As 6 As indel 1 bp insertion trigger factor (tig) tig hp0795 BCM300_00836
15 864639 1 C 2 Cs indel 1 bp insertion trigger factor (tig) tig hp0795 intergenic: no annotation
16 864688 864691 4 Ts 5 Ts indel 1 bp insertion trigger factor (tig) tig hp0795 BCM300_00837
17 864943 864944 2 Cs 3 Cs indel 1 bp insertion trigger factor (tig) tig hp0795 BCM300_00838
18 865147 865148 2 Ts 3 Ts indel 1 bp insertion trigger factor (tig) tig hp0795 BCM300_00839
19 936941 936954 14 Ts 13 Ts indel 1 bp deletion intergenic: no annotation - - intergenic: no annotation
20 943555 943559 5 Cs 6 Cs indel 1 bp insertion hypothetical protein - hp0884 BCM300_00924
21 960612 960615 4 Cs 5 Cs indel 1 bp insertion intergenic: no annotation - - intergenic: no annotation
22 979321 979335 15 Ts 14 Ts indel 1 bp deletion intergenic: no annotation - - intergenic: no annotation
23 1078938 1078943 6 Cs 7 Cs indel 1 bp insertion intergenic: no annotation - - BCM300_01048
24 1081369 1081370  +12 bp indel 12 bp insertion hypothetical protein - hp0427 BCM300_01049
25 1081414 1081415 T indel 1 bp insertion hypothetical protein - hp0427 BCM300_01049
26 1081419 1081420 T indel 1 bp insertion hypothetical protein - hp0427 BCM300_01049
27 1081421 1 A 2 As indel 1 bp insertion hypothetical protein - hp0427 BCM300_01049
28 1222342 1222346 5 Cs 6 Cs indel 1 bp insertion intergenic: no annotation - - intergenic: no annotation
29 1236438 1236444 7 As 6 As indel 1 bp deletion protein translocation protein, low temperature (secG) secG hp1255 BCM300_01197
30 1287348 1287387 5 x 8-nt repeat 6 x 8-nt repeat indel 8 bp insertion [repeat: GTATTTAT] intergenic: no annotation - - intergenic: no annotation
31 1370527 1370539 13 Gs 14 Gs indel 1 bp insertion predicted type III R-M system modification enzyme - hp1522 BCM300_01342
32 1488893 C T SNP non-synonymous Sel1 repeat-containing protein hcpX hp1117 BCM300_01451
33 1540693 C T SNP non-synonymous zinc-metallo protease (YJR117W) YJR117W hp0382 BCM300_01503
34 1587896 1588151 32 x 8-nt repeat 31 x 8-nt repeat indel 8 bp deletion [repeat: GAATGATA] hypothetical protein - hp0427 BCM300_01551
35 1592310 1592315 6 Gs 7 Gs indel 1 bp insertion intergenic: no annotation - - intergenic: no annotation
36 1594330 1594344 15 Cs 16 Cs indel 1 bp insertion intergenic: no annotation - - intergenic: no annotation
Position in BCM-300      Sequence in          Type of difference     Annotation
1
56
HE143/09
No. BCM-300
2
Start End BCM-300 Reisolate Gene description Gene name Locus tag Locus tag
1 7503 7510 8 As 7 As indel 1 bp deletion intergenic: no annotation - - intergenic: no annotation
2 7558 7563 6 Cs 5 Cs indel 1 bp deletion intergenic: no annotation - - intergenic: no annotation
3 32486 32490 5 Gs 6 Gs indel 1 bp insertion ATP-dependent dethiobiotin synthetase BioD bioD hp0029 BCM300_00035
4 71816 71821 6 Gs 5 Gs indel 1 bp deletion intergenic: no annotation - - intergenic: no annotation
5 137983 1 T 2 Ts indel 1 bp insertion hypothetical protein - hp0130 BCM300_00136
6 157600 157606 7 As 6 As indel 1 bp deletion hypothetical protein - hp0150 BCM300_00156
7 167711 167716 6 Cs 5 Cs indel 1 bp deletion intergenic: no annotation - - intergenic: no annotation
8 169575 169588 14 Gs 13 Gs indel 1 bp deletion signal-transducing protein, histidine kinase - hp0164 BCM300_00169
9 220712 220718 7 Gs 6 Gs indel 1 bp deletion CDP-diglyceride synthetase (cdsA) cdsA hp0215 BCM300_00218
10 221283 221285 3 Gs 2 Gs indel 1 bp deletion CDP-diglyceride synthetase (cdsA) cdsA hp0215 BCM300_00218
11 228036 228042 7 Gs 6 Gs indel 1 bp deletion ATP-dependent protease (sms) sms hp0223 BCM300_00226
12 233960 233973 14 As 13 As indel 1 bp deletion intergenic: no annotation - - intergenic: no annotation
13 259853 G A SNP non-synonymous outer membrane protein (omp7) hopF hp0252 BCM300_00256
14 263848 263853 6 Cs 5 Cs indel 1 bp deletion hypothetical protein - hp0257 BCM300_00260
15 289362 289368 7 As 6 As indel 1 bp deletion 3-dehydroquinate synthase (aroB) aroB hp0283 BCM300_00286
16 344826 344829 4 Gs 3 Gs indel 1 bp deletion beta-lactamase HcpC hcpC hp1098 intergenic: no annotation
17 377230 377235 6 Gs 5 Gs indel 1 bp deletion multidrug resistance protein (msbA) msbA hp1082 BCM300_00366
18 439295 439300 6 Cs 5 Cs indel 1 bp deletion 4-hydroxy-tetrahydrodipicolinate synthase dapA hp1013 BCM300_00435
19 454861 454866 6 Gs 5 Gs indel 1 bp deletion hypothetical protein HP0468 - hp0468 BCM300_00446
20 486962 486966 5 Cs 6 Cs indel 1 bp insertion intergenic: no annotation - - BCM300_00476
21 526366 526372 7 Gs 8 Gs indel 1 bp insertion phospholipase A1 precursor (DR-phospholipase A) pldA hp0499 BCM300_00519
22 535707 535713 7 Gs 6 Gs indel 1 bp deletion glycolate oxidase subunit (glcD) glcD hp0509 BCM300_00530
23 549054 549061 8 As 7 As indel 1 bp deletion intergenic: no annotation - - BCM300_00543
24 581210 1 A 2 As indel 1 bp insertion intergenic: no annotation - - intergenic: no annotation
25 595619 595625 7 Cs 6 Cs indel 1 bp deletion 3-ketoacyl-acyl carrier protein reductase (fabG) fabG hp0561 BCM300_00581
26 609222 609226 5 Gs 4 Gs indel 1 bp deletion methylene-tetrahydrofolate dehydrogenase (folD) folD hp0577 BCM300_00598
27 663718 663732 15 Cs 13 Cs indel 2 bp deletion predicted LPS biosynthesis protein - hp0619 BCM300_00638
28 695168 695174 7 Gs 6 Gs indel 1 bp deletion aspartate ammonia-lyase (aspA) aspA hp0649 BCM300_00670
29 705587 705595 9 Gs 8 Gs indel 1 bp deletion processing protease (ymxG) ymxG hp0657 BCM300_00678
30 780145 780159 15 Ts 14 Ts indel 1 bp deletion intergenic: no annotation - - intergenic: no annotation
31 782006 782009 TTCC CTCT intrachromosomal recombination4-bp fragme t recombined outer membrane protein (omp17) sabA hp0725 BCM300_00748
32 786911 786928 18 As 17 As indel 1 bp deletion intergenic: no annotation - - intergenic: no annotation
33 810228 810235 8 As 7 As indel 1 bp deletion cell division membrane protein (ftsX) ftsX hp0749 BCM300_00778
34 814668 814676 9 As 8 As indel 1 bp deletion flagellar hook-associated protein 2 (fliD) fliD hp0752 BCM300_00781
35 826877 826887 11 Cs 10 Cs indel 1 bp deletion intergenic: no annotation - - intergenic: no annotation
36 862628 862631 4 Gs 5 Gs indel 1 bp insertion sigma-54 interacting protein comM hp0792 BCM300_00832
37 864414 864418 5 As 6 As indel 1 bp insertion trigger factor (tig) tig hp0795 BCM300_00836
38 864639 1 C 2 Cs indel 1 bp insertion trigger factor (tig) tig hp0795 intergenic: no annotation
39 864688 864691 4 Ts 5 Ts indel 1 bp insertion trigger factor (tig) tig hp0795 BCM300_00837
40 864943 864944 2 Cs 3 Cs indel 1 bp insertion trigger factor (tig) tig hp0795 BCM300_00838
41 865147 865148 2 Ts 3 Ts indel 1 bp insertion trigger factor (tig) tig hp0795 BCM300_00839
42 867194 867200 7 Ts 6 Ts indel 1 bp deletion intergenic: no annotation - - intergenic: no annotation
43 867350 C T SNP non-synonymous molybdenum cofactor biosynthesis protein C (moaC) moaC hp0798 BCM300_00842
44 936941 936954 14 Ts 13 Ts indel 1 bp deletion intergenic: no annotation - - intergenic: no annotation
45 960192 960199 8 As 7 As indel 1 bp deletion intergenic: no annotation - - intergenic: no annotation
46 960612 960615 4 Cs 5 Cs indel 1 bp insertion intergenic: no annotation - - intergenic: no annotation
47 1081106 1081409 38 x 8-nt repeat 39 x 8-nt repeat indel 8 bp insertion [repeat: CATTCTAT] hypothetical protein - hp0427 BCM300_01049
48 1081414 1081415 T indel 1 bp insertion hypothetical protein - hp0427 BCM300_01049
49 1081419 1081420 T indel 1 bp insertion hypothetical protein - hp0427 BCM300_01049
50 1081421 1 A 2 As indel 1 bp insertion hypothetical protein - hp0427 BCM300_01049
51 1089108 1089112 5 Cs 4 Cs indel 1 bp deletion tRNA delta(2)-isopentenylpyrophosphate transferase (miaA)miaA hp1415 BCM300_01058
52 1116806 1116812 7 As 6 As indel 1 bp deletion intergenic: no annotation - - intergenic: no annotation
53 1168491 1168652 3 x 54-nt repeat 2 x 54-nt repeat indel 54 bp deletion [repeat: 
TCTTTGTGAGCCACTAATTGAGGGCTT
AACTCAGGTTTTTTGGCGTCTTTTTTA]
hypothetical protein - hp1192 BCM300_01130
54 1218049 1218061 13 Ts 12 Ts indel 1 bp deletion intergenic: no annotation - - intergenic: no annotation
55 1221905 1221912 8 Cs 7 Cs indel 1 bp deletion intergenic: no annotation - - intergenic: no annotation
56 1222342 1222346 5 Cs 6 Cs indel 1 bp insertion intergenic: no annotation - - intergenic: no annotation
57 1256981 1256995 15 As 14 As indel 1 bp deletion intergenic: no annotation - - intergenic: no annotation
58 1287348 1287387 5 x 8-nt repeat 6 x 8-nt repeat indel 8 bp insertion [repeat: GTATTTAT] intergenic: no annotation - - intergenic: no annotation
59 1296246 1296250 5 Gs 4 Gs indel 1 bp deletion cation efflux system protein (czcA) czcA hp1329 BCM300_01272
60 1304687 1304701 15 As 14 As indel 1 bp deletion intergenic: no annotation - - intergenic: no annotation
61 1317399 1317412 14 Gs 13 Gs indel 1 bp deletion putative adenine specific DNA methyltransferase - hp1354 BCM300_01297
62 1318224 1318234 11 Gs 10 Gs indel 1 bp deletion putative adenine specific DNA methyltransferase - hp1354 BCM300_01297
63 1347536 1347549 14 As 13 As indel 1 bp deletion intergenic: no annotation - - intergenic: no annotation
64 1370527 1370539 13 Gs 12 Gs indel 1 bp deletion predicted type III R-M system modification enzyme - hp1522 BCM300_01342
65 1503023 1503044 22 Ts 19 Ts indel 3 bp deletion intergenic: no annotation - - intergenic: no annotation
66 1512216 1512222 7 Gs 6 Gs indel 1 bp deletion 2-keto-3-deoxy-6-phosphogluconate aldolase (eda) eda hp1099 BCM300_01471
67 1539899 1539906 8 Cs 7 Cs indel 1 bp deletion SAM-dependent methyltransferase hemK hp0381 BCM300_01502
68 1578463 1578467 5 As 4 As indel 1 bp deletion methionyl-tRNA synthetase (metS) metS hp0417 BCM300_01539
69 1592191 1592246 8 x 7-nt repeat 7 x 7-nt repeat indel 7 bp deletion [repeat: TTATTCT] intergenic: no annotation - - intergenic: no annotation
70 1628666 1628673 8 Ts 7 Ts indel 1 bp deletion lipoprotein - hp1546 BCM300_01585
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1 23007 23084 6 x 13-nt repeat 7 x 13-nt repeat indel 13 bp insertion [repeat: 
AAGGTTTTTAATT]
intergenic: no annotation - - intergenic: no annotation
2 32486 32490 5 Gs 6 Gs indel 1 bp insertion ATP-dependent dethiobiotin synthetase BioD bioD hp0029 BCM300_00035
3 71831 71835 5 Gs 6 Gs indel 1 bp insertion intergenic: no annotation - - intergenic: no annotation
4 99174 99185 12 Gs 11 Gs indel 1 bp deletion alpha-1,2-fucosyltransferase futC hp0094 BCM300_00103
5 169575 169588 14 Gs 13 Gs indel 1 bp deletion signal-transducing protein, histidine kinase - hp0164 BCM300_00169
6 220712 220718 7 Gs 6 Gs indel 1 bp deletion CDP-diglyceride synthetase (cdsA) cdsA hp0215 BCM300_00218
7 222870 222881 12 Gs 11 Gs indel 1 bp deletion beta-1,4-N-acetylgalactosamyltransferase cgtA hp0217 BCM300_00220
8 242241 G T SNP non-synonymous beta-lactamase HcpE hcpE hp0235 BCM300_00238
9 283039 283045 7 Cs 6 Cs indel 1 bp deletion guanosine pentaphosphate phosphohydrolase (gppA) gppA hp0278 BCM300_00281
10 340352 340356 5 Gs 4 Gs indel 1 bp deletion NH(3)-dependent NAD+ synthetase (nadE) nadE hp0329 BCM300_00331
11 366392 366395 4 Gs 3 Gs indel 1 bp deletion cell division protein (ftsK) ftsK hp1090 BCM300_00358
12 393772 393776 5 Gs 4 Gs indel 1 bp deletion hypothetical protein - hp1064 BCM300_00386
13 486962 486966 5 Cs 6 Cs indel 1 bp insertion intergenic: no annotation - - BCM300_00476
14 581568 C T SNP non-synonymous cag pathogenicity island protein (cag26) cagA hp0547 BCM300_00568
15 615059 615063 5 Gs 4 Gs indel 1 bp deletion periplasmic protein TonB tonB1 hp0582 BCM300_00603
16 615076 615081 6 Gs 5 Gs indel 1 bp deletion periplasmic protein TonB tonB1 hp0582 BCM300_00603
17 615086 615090 5 Gs 4 Gs indel 1 bp deletion periplasmic protein TonB tonB1 hp0582 BCM300_00603
18 663718 663732 15 Cs 14 Cs indel 1 bp deletion predicted LPS biosynthesis protein - hp0619 BCM300_00638
19 727943 727947 5 Cs 6 Cs indel 1 bp insertion methylated-DNA--protein-cysteine methyltransferase dat1 hp0676 BCM300_00697
20 785086 785089 CTCT TTCC intrachromosomal recombination4-bp fragme t recombined outer membrane protein (omp16) sabB hp0722 BCM300_00751
21 786553 786637 intrachromosomal recombination85-bp fragment recombined; source: 
780431-780515
outer membrane protein (omp16) sabB hp0722 BCM300_00751
22 786776 786793 9 x GA repeat 8 x GA repeat indel 2 bp deletion outer membrane protein (omp16) sabB hp0722 BCM300_00751
23 862628 862631 4 Gs 5 Gs indel 1 bp insertion sigma-54 interacting protein comM hp0792 BCM300_00832
24 864414 864418 5 As 6 As indel 1 bp insertion trigger factor (tig) tig hp0795 BCM300_00836
25 864639 1 C 2 Cs indel 1 bp insertion trigger factor (tig) tig hp0795 intergenic: no annotation
26 864688 864691 4 Ts 5 Ts indel 1 bp insertion trigger factor (tig) tig hp0795 BCM300_00837
27 864943 864944 2 Cs 3 Cs indel 1 bp insertion trigger factor (tig) tig hp0795 BCM300_00838
28 865147 865148 2 Ts 3 Ts indel 1 bp insertion trigger factor (tig) tig hp0795 BCM300_00839
29 875404 875408 5 Cs 4 Cs indel 1 bp deletion iron(III) dicitrate transport protein (fecA) fecA hp0807 BCM300_00851
30 934310 C T SNP synonymous hypothetical protein - hp0874 BCM300_00916
31 953010 953022 13 Gs 11 Gs indel 2 bp deletion intergenic: no annotation - - intergenic: no annotation
32 960612 960615 4 Cs 5 Cs indel 1 bp insertion intergenic: no annotation - - intergenic: no annotation
33 979321 979335 15 Ts 14 Ts indel 1 bp deletion intergenic: no annotation - - intergenic: no annotation
34 1042698 1042715 9 x GA repeat 8 x GA repeat indel 2 bp deletion intergenic: no annotation - - intergenic: no annotation
35 1081106 1081409 38 x 8-nt repeat 37 x 8-nt repeat indel 8 bp deletion [repeat: CATTCTAT] hypothetical protein - hp0427 BCM300_01049
36 1081414 1081415 T indel 1 bp insertion hypothetical protein - hp0427 BCM300_01049
37 1081419 1081420 T indel 1 bp insertion hypothetical protein - hp0427 BCM300_01049
38 1081421 1 A 2 As indel 1 bp insertion hypothetical protein - hp0427 BCM300_01049
39 1083785 1083789 5 Gs 4 Gs indel 1 bp deletion hypothetical protein - hp0425 BCM300_01052
40 1113391 A G SNP intergenic intergenic: no annotation - - intergenic: no annotation
41 1198194 1198199 6 Cs 5 Cs indel 1 bp deletion phosphoribosylamine--glycine ligase purD hp1218 BCM300_01160
42 1218049 1218061 13 Ts 12 Ts indel 1 bp deletion intergenic: no annotation - - intergenic: no annotation
43 1222342 1222346 5 Cs 6 Cs indel 1 bp insertion intergenic: no annotation - - intergenic: no annotation
44 1317399 1317412 14 Gs 13 Gs indel 1 bp deletion putative adenine specific DNA methyltransferase - hp1354 BCM300_01297
45 1318224 1318234 11 Gs 12 Gs indel 1 bp insertion putative adenine specific DNA methyltransferase - hp1354 BCM300_01297
46 1370527 1370539 13 Gs 12 Gs indel 1 bp deletion predicted type III R-M system modification enzyme - hp1522 BCM300_01342
47 1408373 1408377 5 Gs 4 Gs indel 1 bp deletion phosphate permease - hp1491 BCM300_01372
48 1408833 1408836 4 Gs 3 Gs indel 1 bp deletion phosphate permease - hp1491 BCM300_01372
49 1409245 1409251 7 As 6 As indel 1 bp deletion phosphate permease - hp1491 BCM300_01372
50 1462751 1462934  -184 bp indel 184 bp deletion intergenic: no annotation - - intergenic: no annotation
51 1488895 1 G 2 Gs indel 1 bp insertion Sel1 repeat-containing protein hcpX hp1117 BCM300_01451
52 1570250 1570256 7 Gs 6 Gs indel 1 bp deletion GMP synthase (guaA) guaA hp0409 BCM300_01530
53 1587896 1588151 32 x 8-nt repeat 34 x 8-nt repeat indel 16 bp insertion [repeat: GAATGATA] hypothetical protein - hp0427 BCM300_01551
54 1588129 1588130 ATG indel 3 bp insertion hypothetical protein - hp0427 BCM300_01551
55 1592310 1592315 6 Gs 7 Gs indel 1 bp insertion intergenic: no annotation - - intergenic: no annotation
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1 32486 32490 5 Gs 6 Gs indel 1 bp insertion ATP-dependent dethiobiotin synthetase BioD bioD hp0029 BCM300_00035
2 71816 71821 6 Gs 5 Gs indel 1 bp deletion intergenic: no annotation - - intergenic: no annotation
3 99174 99185 12 Gs 13 Gs indel 1 bp insertion alpha-1,2-fucosyltransferase futC hp0094 BCM300_00103
4 222870 222881 12 Gs 10 Gs indel 2 bp deletion beta-1,4-N-acetylgalactosamyltransferase cgtA hp0217 BCM300_00220
5 257813 257817 5 Cs 4 Cs indel 1 bp deletion oligopeptide ABC transporter, permease protein (oppC)oppC hp0251 BCM300_00254
6 450369 450379 11 Gs 12 Gs indel 1 bp insertion type I restriction-modification system endonuclease hsdR hp0464 BCM300_00442
7 486962 486966 5 Cs 6 Cs indel 1 bp insertion intergenic: no annotation - - BCM300_00476
8 577318 577319  +2398 bp indel transposon insertion cag pathogenicity island protein (cag23) cagE hp0544 BCM300_00564
9 615096 615100 5 Gs 4 Gs indel 1 bp deletion periplasmic protein TonB tonB1 hp0582 BCM300_00603
10 727943 727947 5 Cs 6 Cs indel 1 bp insertion methylated-DNA--protein-cysteine methyltransferase dat1 hp0676 BCM300_00697
11 804754 804757 4 Cs 3 Cs indel 1 bp deletion intergenic: no annotation - - intergenic: no annotation
12 862628 862631 4 Gs 5 Gs indel 1 bp insertion sigma-54 interacting protein comM hp0792 BCM300_00832
13 864414 864418 5 As 6 As indel 1 bp insertion trigger factor (tig) tig hp0795 BCM300_00836
14 864639 1 C 2 Cs indel 1 bp insertion trigger factor (tig) tig hp0795 intergenic: no annotation
15 864688 864691 4 Ts 5 Ts indel 1 bp insertion trigger factor (tig) tig hp0795 BCM300_00837
16 864943 864944 2 Cs 3 Cs indel 1 bp insertion trigger factor (tig) tig hp0795 BCM300_00838
17 865147 865148 2 Ts 3 Ts indel 1 bp insertion trigger factor (tig) tig hp0795 BCM300_00839
18 960612 960615 4 Cs 5 Cs indel 1 bp insertion intergenic: no annotation - - intergenic: no annotation
19 960782 960786 5 Cs 4 Cs indel 1 bp deletion intergenic: no annotation - - intergenic: no annotation
20 1081106 1081409 38 x 8-nt repeat 40 x 8-nt repeat indel 16 bp insertion [repeat: CATTCTAT] hypothetical protein - hp0427 BCM300_01049
21 1081414 1081415 T indel 1 bp insertion hypothetical protein - hp0427 BCM300_01049
22 1081419 1081420 T indel 1 bp insertion hypothetical protein - hp0427 BCM300_01049
23 1081421 1 A 2 As indel 1 bp insertion hypothetical protein - hp0427 BCM300_01049
24 1221905 1221912 8 Cs 7 Cs indel 1 bp deletion intergenic: no annotation - - intergenic: no annotation
25 1222342 1222346 5 Cs 6 Cs indel 1 bp insertion intergenic: no annotation - - intergenic: no annotation
26 1318224 1318234 11 Gs 12 Gs indel 1 bp insertion putative adenine specific DNA methyltransferase - hp1354 BCM300_01297
27 1340881 G A SNP intergenic intergenic: no annotation - - intergenic: no annotation
28 1347536 1347549 14 As 13 As indel 1 bp deletion intergenic: no annotation - - intergenic: no annotation
29 1385328 1385332 5 Cs 4 Cs indel 1 bp deletion iron-regulated outer membrane protein (frpB) frpB hp1512 BCM300_01350
30 1503023 1503044 22 Ts 21 Ts indel 1 bp deletion intergenic: no annotation - - intergenic: no annotation
31 1587896 1588151 32 x 8-nt repeat 34 x 8-nt repeat indel 16 bp insertion [repeat: GAATGATA] hypothetical protein - hp0427 BCM300_01551
32 1592310 1592315 6 Gs 7 Gs indel 1 bp insertion intergenic: no annotation - - intergenic: no annotation
33 1594330 1594344 15 Cs 16 Cs indel 1 bp insertion intergenic: no annotation - - intergenic: no annotation
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1 9816 9829 14 Ts 15 Ts indel 1 bp insertion intergenic: no annotation - - intergenic: no annotation
2 32486 32490 5 Gs 6 Gs indel 1 bp insertion ATP-dependent dethiobiotin synthetase BioD bioD hp0029 BCM300_00035
3 71831 71835 5 Gs 6 Gs indel 1 bp insertion intergenic: no annotation - - intergenic: no annotation
4 99174 99185 12 Gs 13 Gs indel 1 bp insertion alpha-1,2-fucosyltransferase futC hp0094 BCM300_00103
5 169575 169588 14 Gs 12 Gs indel 2 bp deletion signal-transducing protein, histidine kinase - hp0164 BCM300_00169
6 222870 222881 12 Gs 10 Gs indel 2 bp deletion beta-1,4-N-acetylgalactosamyltransferase cgtA hp0217 BCM300_00220
7 259244 G A SNP non-synonymous outer membrane protein (omp7) hopF hp0252 BCM300_00256
8 350265 350279 15 As 16 As indel 1 bp insertion intergenic: no annotation - - intergenic: no annotation
9 450369 450379 11 Gs 12 Gs indel 1 bp insertion type I restriction-modification system endonuclease hsdR hp0464 BCM300_00442
10 486962 486966 5 Cs 6 Cs indel 1 bp insertion intergenic: no annotation - - BCM300_00476
11 662731 663008  -278 bp indel 278 bp deletion intergenic: no annotation - - BCM300_00637
12 663718 663732 15 Cs 13 Cs indel 2 bp deletion predicted LPS biosynthesis protein - hp0619 BCM300_00638
13 727943 727947 5 Cs 6 Cs indel 1 bp insertion methylated-DNA--protein-cysteine methyltransferase dat1 hp0676 BCM300_00697
14 781175 781235 intrachromosomal recombination61-bp fragment recombined; source: 
c785860-785920 (sabB)
outer membrane protein (omp17) sabA hp0725 BCM300_00748
15 782006 782009 TTCC CTCT intrachromosomal recombination4-bp fragme t recombined outer membrane protein (omp17) sabA hp0725 BCM300_00748
16 862628 862631 4 Gs 5 Gs indel 1 bp insertion sigma-54 interacting protein comM hp0792 BCM300_00832
17 864414 864418 5 As 6 As indel 1 bp insertion trigger factor (tig) tig hp0795 BCM300_00836
18 864639 1 C 2 Cs indel 1 bp insertion trigger factor (tig) tig hp0795 intergenic: no annotation
19 864688 864691 4 Ts 5 Ts indel 1 bp insertion trigger factor (tig) tig hp0795 BCM300_00837
20 864943 864944 2 Cs 3 Cs indel 1 bp insertion trigger factor (tig) tig hp0795 BCM300_00838
21 865147 865148 2 Ts 3 Ts indel 1 bp insertion trigger factor (tig) tig hp0795 BCM300_00839
22 960612 960615 4 Cs 5 Cs indel 1 bp insertion intergenic: no annotation - - intergenic: no annotation
23 979321 979335 15 Ts 16 Ts indel 1 bp insertion intergenic: no annotation - - intergenic: no annotation
24 1081106 1081409 38 x 8-nt repeat 37 x 8-nt repeat indel 8 bp deletion [repeat: CATTCTAT] hypothetical protein - hp0427 BCM300_01049
25 1081414 1081415 T indel 1 bp insertion hypothetical protein - hp0427 BCM300_01049
26 1081419 1081420 T indel 1 bp insertion hypothetical protein - hp0427 BCM300_01049
27 1081421 1 A 2 As indel 1 bp insertion hypothetical protein - hp0427 BCM300_01049
28 1222342 1222346 5 Cs 6 Cs indel 1 bp insertion intergenic: no annotation - - intergenic: no annotation
29 1224971 1224985 15 Ts 16 Ts indel 1 bp insertion intergenic: no annotation - - intergenic: no annotation
30 1256981 1256995 15 As 14 As indel 1 bp deletion intergenic: no annotation - - intergenic: no annotation
31 1370527 1370539 13 Gs 12 Gs indel 1 bp deletion predicted type III R-M system modification enzyme - hp1522 BCM300_01342
32 1503023 1503044 22 Ts 20 Ts indel 2 bp deletion intergenic: no annotation - - intergenic: no annotation
33 1587896 1588151 32 x 8-nt repeat 34 x 8-nt repeat indel 16 bp insertion [repeat: GAATGATA] hypothetical protein - hp0427 BCM300_01551
34 1592310 1592315 6 Gs 7 Gs indel 1 bp insertion intergenic: no annotation - - intergenic: no annotation
Position in BCM-300      Sequence in          Type of difference     Annotation
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HE178/09
No. BCM-300
2
Start End BCM-300 Reisolate Gene description Gene name Locus tag Locus tag
1 32486 32490 5 Gs 6 Gs indel 1 bp insertion ATP-dependent dethiobiotin synthetase BioD bioD hp0029 BCM300_00035
2 71831 71835 5 Gs 6 Gs indel 1 bp insertion intergenic: no annotation - - intergenic: no annotation
3 75512 75516 5 As 4 As indel 1 bp deletion intergenic: no annotation - - intergenic: no annotation
4 99174 99185 12 Gs 11 Gs indel 1 bp deletion alpha-1,2-fucosyltransferase futC hp0094 BCM300_00103
5 110540 110553 14 Cs 13 Cs indel 1 bp deletion intergenic: no annotation - - intergenic: no annotation
6 169575 169588 14 Gs 13 Gs indel 1 bp deletion signal-transducing protein, histidine kinase - hp0164 BCM300_00169
7 210809 210824 8 x CT repeat 9 x CT repeat indel 2 bp insertion lipopolysaccharide 1,2-glucosyltransferase (rfaJ) rfaJ hp0159 BCM300_00211
8 210990 211003 14 Ts 15 Ts indel 1 bp insertion intergenic: no annotation - - intergenic: no annotation
9 222870 222881 12 Gs 11 Gs indel 1 bp deletion beta-1,4-N-acetylgalactosamyltransferase cgtA hp0217 BCM300_00220
10 255365 255368 4 Cs 3 Cs indel 1 bp deletion hypothetical protein - hp0249 BCM300_00252
11 450369 450379 11 Gs 12 Gs indel 1 bp insertion type I restriction-modification system endonuclease hsdR hp0464 BCM300_00442
12 479548 479552 5 As 4 As indel 1 bp deletion hypothetical protein - hp0990 BCM300_00468
13 482354 482358 5 Ts 4 Ts indel 1 bp deletion intergenic: no annotation - - BCM300_00471
14 486962 486966 5 Cs 6 Cs indel 1 bp insertion intergenic: no annotation - - BCM300_00476
15 542103 542111 9 As 8 As indel 1 bp deletion hypothetical protein - hp0513 BCM300_00535
16 563321 C T SNP non-synonymous cag pathogenicity island protein (cag9) cagW hp0529 BCM300_00551
17 580121 580128 8 As 7 As indel 1 bp deletion cag pathogenicity island protein (cag24) cagD hp0545 BCM300_00565
18 727943 727947 5 Cs 6 Cs indel 1 bp insertion methylated-DNA--protein-cysteine methyltransferase dat1 hp0676 BCM300_00697
19 780276 780291 8 x CT repeat 9 x CT repeat indel 2 bp insertion outer membrane protein (omp17) sabA hp0725 BCM300_00748
20 862628 862631 4 Gs 5 Gs indel 1 bp insertion sigma-54 interacting protein comM hp0792 BCM300_00832
21 864414 864418 5 As 6 As indel 1 bp insertion trigger factor (tig) tig hp0795 BCM300_00836
22 864639 1 C 2 Cs indel 1 bp insertion trigger factor (tig) tig hp0795 intergenic: no annotation
23 864688 864691 4 Ts 5 Ts indel 1 bp insertion trigger factor (tig) tig hp0795 BCM300_00837
24 864943 864944 2 Cs 3 Cs indel 1 bp insertion trigger factor (tig) tig hp0795 BCM300_00838
25 865147 865148 2 Ts 3 Ts indel 1 bp insertion trigger factor (tig) tig hp0795 BCM300_00839
26 949904 C T SNP non-synonymous vacuolating cytotoxin vacA hp0887 BCM300_00927
27 960192 960199 8 As 7 As indel 1 bp deletion intergenic: no annotation - - intergenic: no annotation
28 960208 960215 8 As 7 As indel 1 bp deletion intergenic: no annotation - - intergenic: no annotation
29 960224 960231 8 As 7 As indel 1 bp deletion intergenic: no annotation - - intergenic: no annotation
30 960612 960615 4 Cs 5 Cs indel 1 bp insertion intergenic: no annotation - - intergenic: no annotation
31 985093 985106 14 As 13 As indel 1 bp deletion intergenic: no annotation - - intergenic: no annotation
32 1049275 1049282 8 Ts 7 Ts indel 1 bp deletion glycyl-tRNA synthetase, beta subunit (glyS) glyS hp0972 BCM300_01019
33 1081106 1081409 38 x 8-nt repeat 39 x 8-nt repeat indel 8 bp insertion [repeat: CATTCTAT] hypothetical protein - hp0427 BCM300_01049
34 1081414 1081415 A indel 1 bp insertion hypothetical protein - hp0427 BCM300_01049
35 1081419 1081420 T indel 1 bp insertion hypothetical protein - hp0427 BCM300_01049
36 1081421 1 A 2 As indel 1 bp insertion hypothetical protein - hp0427 BCM300_01049
37 1081422 1081425 TCAT GCAA intrachromosomal recombination4-bp fragme t recombined hypothetical protein - hp0427 BCM300_01049
38 1222342 1222346 5 Cs 6 Cs indel 1 bp insertion intergenic: no annotation - - intergenic: no annotation
39 1257481 1257487 7 As 6 As indel 1 bp deletion intergenic: no annotation - - BCM300_01220
40 1304687 1304701 15 As 14 As indel 1 bp deletion intergenic: no annotation - - intergenic: no annotation
41 1309317 1309324 8 Cs 7 Cs indel 1 bp deletion phosphoglycerate kinase pgk hp1345 BCM300_01287
42 1318224 1318234 11 Gs 12 Gs indel 1 bp insertion putative adenine specific DNA methyltransferase - hp1354 BCM300_01297
43 1347536 1347549 14 As 15 As indel 1 bp insertion intergenic: no annotation - - intergenic: no annotation
44 1468210 1468215 6 Ts 5 Ts indel 1 bp deletion methionyl-tRNA formyltransferase (fmt) fmt hp1141 BCM300_01426
45 1502614 1502619 6 Cs 5 Cs indel 1 bp deletion hypothetical protein - hp1106 BCM300_01463
46 1503023 1503044 22 Ts 21 Ts indel 1 bp deletion intergenic: no annotation - - intergenic: no annotation
47 1504362 1504373 12 Ts 13 Ts indel 1 bp insertion intergenic: no annotation - - intergenic: no annotation
48 1544143 1544150 8 As 7 As indel 1 bp deletion primosomal protein replication factor (priA) priA hp0387 BCM300_01508
49 1592310 1592315 6 Gs 7 Gs indel 1 bp insertion intergenic: no annotation - - intergenic: no annotation
Position in BCM-300      Sequence in          Type of difference     Annotation
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HE93/10
No. BCM-300
2
Start End BCM-300 Reisolate Gene description Gene name Locus tag Locus tag
1 23007 23084 6 x 13-nt repeat 5 x 13-nt repeat indel 13 bp deletion [repeat: 
AAGGTTTTTAATT]
intergenic: no annotation - - intergenic: no annotation
2 28076 28091 16 As 15 As indel 1 bp deletion intergenic: no annotation - - intergenic: no annotation
3 32486 32490 5 Gs 6 Gs indel 1 bp insertion ATP-dependent dethiobiotin synthetase BioD bioD hp0029 BCM300_00035
4 71831 71835 5 Gs 6 Gs indel 1 bp insertion intergenic: no annotation - - intergenic: no annotation
5 108138 108144 7 Cs 8 Cs indel 1 bp insertion glycosyltransferase - hp0102 BCM300_00111
6 110540 110553 14 Cs 13 Cs indel 1 bp deletion intergenic: no annotation - - intergenic: no annotation
7 169575 169588 14 Gs 12 Gs indel 2 bp deletion signal-transducing protein, histidine kinase - hp0164 BCM300_00169
8 222870 222881 12 Gs 11 Gs indel 1 bp deletion beta-1,4-N-acetylgalactosamyltransferase cgtA hp0217 BCM300_00220
9 258783 G A SNP non-synonymous outer membrane protein (omp7) hopF hp0252 BCM300_00256
10 301606 C T SNP synonymous toxin-like outer membrane protein - hp0289 BCM300_00292
11 450369 450379 11 Gs 12 Gs indel 1 bp insertion type I restriction-modification system endonuclease hsdR hp0464 BCM300_00442
12 486962 486966 5 Cs 6 Cs indel 1 bp insertion intergenic: no annotation - - BCM300_00476
13 526366 526372 7 Gs 8 Gs indel 1 bp insertion phospholipase A1 precursor (DR-phospholipase A) pldA hp0499 BCM300_00519
14 580805 585875 5071 bp  +19950 bp indel insertion in cagPAI
15 727943 727947 5 Cs 6 Cs indel 1 bp insertion methylated-DNA--protein-cysteine methyltransferase dat1 hp0676 BCM300_00697
16 780145 780159 15 Ts 14 Ts indel 1 bp deletion intergenic: no annotation - - intergenic: no annotation
17 786911 786928 18 As 17 As indel 1 bp deletion intergenic: no annotation - - intergenic: no annotation
18 826877 826887 11 Cs 10 Cs indel 1 bp deletion intergenic: no annotation - - intergenic: no annotation
19 857371 C T SNP non-synonymous hypothetical protein - hp1005 BCM300_00828
20 862628 862631 4 Gs 5 Gs indel 1 bp insertion sigma-54 interacting protein comM hp0792 BCM300_00832
21 864414 864418 5 As 6 As indel 1 bp insertion trigger factor (tig) tig hp0795 BCM300_00836
22 864639 1 C 2 Cs indel 1 bp insertion trigger factor (tig) tig hp0795 intergenic: no annotation
23 864688 864691 4 Ts 5 Ts indel 1 bp insertion trigger factor (tig) tig hp0795 BCM300_00837
24 864943 864944 2 Cs 3 Cs indel 1 bp insertion trigger factor (tig) tig hp0795 BCM300_00838
25 865147 865148 2 Ts 3 Ts indel 1 bp insertion trigger factor (tig) tig hp0795 BCM300_00839
26 940491 940498 ATATTTTC indel 8 bp deletion hypothetical protein - hp0879 BCM300_00920
27 949223 C T SNP non-synonymous vacuolating cytotoxin vacA hp0887 BCM300_00927
28 953010 953022 13 Gs 14 Gs indel 1 bp insertion intergenic: no annotation - - intergenic: no annotation
29 960612 960615 4 Cs 5 Cs indel 1 bp insertion intergenic: no annotation - - intergenic: no annotation
30 979321 979335 15 Ts 13 Ts indel 2 bp deletion intergenic: no annotation - - intergenic: no annotation
31 1081106 1081409 38 x 8-nt repeat 39 x 8-nt repeat indel 8 bp insertion [repeat: CATTCTAT] hypothetical protein - hp0427 BCM300_01049
32 1081414 1081415 A indel 1 bp insertion hypothetical protein - hp0427 BCM300_01049
33 1081419 1081420 T indel 1 bp insertion hypothetical protein - hp0427 BCM300_01049
34 1081421 1 A 2 As indel 1 bp insertion hypothetical protein - hp0427 BCM300_01049
35 1081422 1081425 TCAT GCAA intrachromosomal recombination4-bp fragme t recombined hypothetical protein - hp0427 BCM300_01049
36 1218049 1218061 13 Ts 14 Ts indel 1 bp insertion intergenic: no annotation - - intergenic: no annotation
37 1222342 1222346 5 Cs 6 Cs indel 1 bp insertion intergenic: no annotation - - intergenic: no annotation
38 1224868 1224885 9 x GA repeat 10 x GA repeat indel 2 bp insertion intergenic: no annotation - - intergenic: no annotation
39 1224971 1224985 15 Ts 13 Ts indel 2 bp deletion intergenic: no annotation - - intergenic: no annotation
40 1225114 1225253 14 x 10-nt repeat 15 x 10-nt repeat indel 10 bp insertion [repeat: 
AAGATTAAAC]
intergenic: no annotation - - intergenic: no annotation
41 1293053 1293059 7 Gs 8 Gs indel 1 bp insertion predicted cobalt-zinc-cadmium resistance protein/cation efflux system proteinczcB hp1328 BCM300_01271
42 1318224 1318234 11 Gs 12 Gs indel 1 bp insertion putative adenine specific DNA methyltransferase - hp1354 BCM300_01297
43 1370527 1370539 13 Gs 14 Gs indel 1 bp insertion predicted type III R-M system modification enzyme - hp1522 BCM300_01342
44 1488899 1488901 3 Gs 4 Gs indel 1 bp insertion Sel1 repeat-containing protein hcpX hp1117 BCM300_01451
45 1503023 1503044 22 Ts 20 Ts indel 2 bp deletion intergenic: no annotation - - intergenic: no annotation
46 1587943 1587944  +26 bp indel 26 bp insertion hypothetical protein - hp0427 BCM300_01551
47 1592310 1592315 6 Gs 7 Gs indel 1 bp insertion intergenic: no annotation - - intergenic: no annotation
48 1594330 1594344 15 Cs 16 Cs indel 1 bp insertion intergenic: no annotation - - intergenic: no annotation
49 1600696 1600702 7 Cs 8 Cs indel 1 bp insertion prephenate dehydrogenase (tyrA) tyrA hp1380 BCM300_01560
Position in BCM-300      Sequence in          Type of difference     Annotation
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Supplementary Dataset 2: Percentages of methyltransferase recognition sequences detected as methylated by SMRT sequencing
Motif Modification % of motifs detected
type BCM-300 HE93/10 HE101/09 HE132/09 HE134/09 HE136/09 HE141/09 HE142/09 HE143/09 HE147/09 HE170/09 HE171/09 HE178/09 Min Max mean SD
AGGAG m6A 99.3 99.3 98.9 99.7 99.9 99.3 99.5 98.8 99.5 99.3 99.4 99.8 99.8 98.8 99.9 99.4 0.3
CACAT m6A 98.0 98.7 97.9 99.4 100.0 98.8 98.7 97.8 98.5 98.7 98.0 99.8 100.0 97.8 100.0 98.8 0.7
CATG m6A 99.9 99.9 99.9 100.0 100.0 100.0 100.0 99.8 100.0 100.0 99.9 100.0 100.0 99.8 100.0 99.9 0.1
CCATC m6A 99.6 99.8 99.6 99.8 100.0 99.9 99.8 99.1 99.8 99.7 99.5 99.9 100.0 99.1 100.0 99.7 0.2
CCGG m4C 72.3 92.0 72.1 88.2 99.9 85.3 87.8 62.2 88.1 88.0 72.9 93.2 99.9 62.2 99.9 84.8 11.1
CCTYNA
1
m6A 3.1 2.4 3.1 3.3 3.3 3.2 3.2 3.1 89.5 2.4 3.1 2.8 3.2 2.4 89.5 9.7 23.1
GAATTC m6A 99.1 100.0 98.9 99.4 100.0 99.7 99.1 98.6 99.1 99.1 99.1 100.0 100.0 98.6 100.0 99.4 0.5
GACY
2
m6A 99.4 4.0 98.9 99.7 100.0 99.5 99.7 98.7 99.7 3.8 99.3 4.1 100.0 3.8 100.0 77.4 40.3
GAGG m6A 98.6 98.9 98.4 99.3 99.6 98.9 99.2 98.2 99.3 99.4 98.9 99.8 99.5 98.2 99.8 99.1 0.5
GATC m6A 99.4 99.8 99.3 99.9 100.0 99.8 99.9 99.1 99.7 99.8 99.5 100.0 100.0 99.1 100.0 99.7 0.3
GATGG m6A 99.9 100.0 99.8 100.0 100.0 100.0 100.0 99.5 100.0 100.0 99.9 100.0 100.0 99.5 100.0 99.9 0.1
GCGC
3
m5C 2.3 3.1 1.3 3.7 9.0 3.0 3.7 1.7 3.9 3.2 3.0 6.4 7.7 1.3 9.0 4.0 2.2
GTSAC m6A 99.6 100.0 99.6 100.0 100.0 99.6 100.0 98.0 99.6 100.0 100.0 100.0 100.0 98.0 100.0 99.7 0.5
TCNNGA m6A 98.3 98.7 98.3 99.3 99.9 99.0 99.0 97.9 98.9 98.9 98.0 99.6 99.9 97.9 99.9 98.9 0.6
TGCA m6A 99.1 99.5 99.1 99.7 100.0 99.6 99.5 98.9 99.4 99.4 99.1 99.8 100.0 98.9 100.0 99.5 0.3
1
CCTYNA only methylated in HE143/09
2
GACY not methylated in HE93/10, HE147/09 and HE171/09
3
GCGC not reliably detected
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BCM-300
Motif Modified 
position
Modificati
on type
No. of 
motifs 
detected
No. of 
motifs in 
genome
% of 
motifs 
detected
Mean 
Score
Mean 
coverage
AGGAG 4 m6A 1504 1515 99.27 78.42 53.77
CACAT 4 m6A 2390 2438 98.03 76.74 54.78
CATG 2 m6A 15300 15320 99.87 82.19 55.06
CCATC 3 m6A 2106 2115 99.57 76.29 54.86
CCGG 1 m4C 2566 3550 72.28 44.46 54.94
CCTYNA 6 m6A 261 8388 3.11 77.50 54.92
GAATTC 3 m6A 349 352 99.15 78.11 53.61
GACY 2 m6A 8180 8229 99.40 75.53 54.75
GAGG 2 m6A 4985 5055 98.62 73.69 53.00
GATC 2 m6A 10930 10994 99.42 75.57 54.21
GATGG 2 m6A 2113 2115 99.91 78.56 54.78
GCGC 2 m5C 306 13046 2.35 41.22 56.27
GTSAC 4 m6A 249 250 99.60 77.49 54.73
TCNNGA 6 m6A 3919 3986 98.32 76.37 54.73
TGCA 4 m6A 10371 10466 99.09 77.66 55.01
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HE93/10
Motif Modified 
position
Modificati
on type
No. of 
motifs 
detected
No. of 
motifs in 
genome
% of 
motifs 
detected
Mean 
Score
Mean 
coverage
AGGAG 4 m6A 1517 1527 99.35 121.20 86.38
CACAT 4 m6A 2433 2465 98.70 117.24 86.30
CATG 2 m6A 15393 15404 99.93 127.55 87.46
CCATC 3 m6A 2123 2127 99.81 115.85 86.13
CCGG 1 m4C 3275 3558 92.05 62.84 86.02
CCTYNA 6 m6A 199 8461 2.35 120.11 87.34
GAATTC 3 m6A 364 364 100.00 119.62 84.82
GACY 2 m6A 331 8310 3.98 111.71 89.69
GAGG 2 m6A 5031 5088 98.88 111.90 85.56
GATC 2 m6A 11142 11166 99.79 115.57 86.54
GATGG 2 m6A 2126 2127 99.95 122.23 87.75
GCGC 2 m5C 401 13092 3.06 45.17 88.29
GTSAC 4 m6A 256 256 100.00 122.34 88.48
TCNNGA 6 m6A 4007 4060 98.69 117.20 88.28
TGCA 4 m6A 10471 10528 99.46 119.34 87.38
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HE101/09
Motif Modified 
position
Modificati
on type
No. of 
motifs 
detected
No. of 
motifs in 
genome
% of 
motifs 
detected
Mean 
Score
Mean 
coverage
AGGAG 4 m6A 1498 1515 98.88 75.11 48.21
CACAT 4 m6A 2388 2438 97.95 73.51 48.41
CATG 2 m6A 15302 15320 99.88 80.27 50.38
CCATC 3 m6A 2107 2115 99.62 73.15 48.60
CCGG 1 m4C 2561 3552 72.10 44.84 51.56
CCTYNA 6 m6A 260 8388 3.10 75.47 49.83
GAATTC 3 m6A 348 352 98.86 71.66 45.17
GACY 2 m6A 8140 8229 98.92 72.40 49.16
GAGG 2 m6A 4976 5055 98.44 72.19 49.31
GATC 2 m6A 10913 10992 99.28 72.70 48.80
GATGG 2 m6A 2111 2115 99.81 76.36 50.35
GCGC 2 m5C 176 13046 1.35 39.99 53.16
GTSAC 4 m6A 249 250 99.60 72.96 48.47
TCNNGA 6 m6A 3920 3986 98.34 74.09 49.81
TGCA 4 m6A 10374 10464 99.14 75.55 50.26
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HE132/09
Motif Modified 
position
Modificati
on type
No. of 
motifs 
detected
No. of 
motifs in 
genome
% of 
motifs 
detected
Mean 
Score
Mean 
coverage
AGGAG 4 m6A 1511 1516 99.67 127.75 89.92
CACAT 4 m6A 2423 2438 99.38 124.72 91.78
CATG 2 m6A 15318 15320 99.99 135.48 92.32
CCATC 3 m6A 2111 2115 99.81 123.47 90.68
CCGG 1 m4C 3133 3552 88.20 66.07 91.51
CCTYNA 6 m6A 279 8387 3.33 118.06 92.90
GAATTC 3 m6A 352 354 99.44 124.84 87.64
GACY 2 m6A 8200 8227 99.67 120.65 92.06
GAGG 2 m6A 5018 5055 99.27 119.76 90.07
GATC 2 m6A 10986 10992 99.95 122.88 91.41
GATGG 2 m6A 2115 2115 100.00 128.51 91.62
GCGC 2 m5C 478 13044 3.66 46.68 92.19
GTSAC 4 m6A 250 250 100.00 124.60 90.81
TCNNGA 6 m6A 3959 3988 99.27 123.87 92.03
TGCA 4 m6A 10432 10468 99.66 127.53 92.13
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HE134/09
Motif Modified 
position
Modificati
on type
No. of 
motifs 
detected
No. of 
motifs in 
genome
% of 
motifs 
detected
Mean 
Score
Mean 
coverage
AGGAG 4 m6A 1513 1515 99.87 128.05 93.01
CACAT 4 m6A 2437 2438 99.96 136.09 93.45
CATG 2 m6A 15320 15320 100.00 137.92 93.46
CCATC 3 m6A 2115 2115 100.00 139.85 92.94
CCGG 1 m4C 3547 3552 99.86 86.19 94.19
CCTYNA 6 m6A 278 8388 3.31 133.42 95.25
GAATTC 3 m6A 352 352 100.00 132.54 88.46
GACY 2 m6A 8229 8229 100.00 130.49 93.64
GAGG 2 m6A 5035 5055 99.60 118.91 93.09
GATC 2 m6A 10994 10994 100.00 142.55 93.48
GATGG 2 m6A 2115 2115 100.00 134.67 93.28
GCGC 2 m5C 1179 13046 9.04 52.29 95.79
GTSAC 4 m6A 250 250 100.00 132.24 94.31
TCNNGA 6 m6A 3984 3986 99.95 129.54 93.33
TGCA 4 m6A 10465 10468 99.97 133.69 93.55
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HE136/09
Motif Modified 
position
Modificati
on type
No. of 
motifs 
detected
No. of 
motifs in 
genome
% of 
motifs 
detected
Mean 
Score
Mean 
coverage
AGGAG 4 m6A 1505 1515 99.34 101.94 70.93
CACAT 4 m6A 2409 2438 98.81 100.16 71.89
CATG 2 m6A 15318 15320 99.99 107.48 72.05
CCATC 3 m6A 2112 2115 99.86 99.30 71.63
CCGG 1 m4C 3030 3552 85.30 54.37 71.94
CCTYNA 6 m6A 265 8388 3.16 98.39 71.56
GAATTC 3 m6A 351 352 99.72 101.95 71.10
GACY 2 m6A 8187 8229 99.49 97.15 71.81
GAGG 2 m6A 4998 5055 98.87 96.11 70.61
GATC 2 m6A 10970 10994 99.78 98.54 71.52
GATGG 2 m6A 2115 2115 100.00 103.33 71.98
GCGC 2 m5C 386 13044 2.96 43.34 74.42
GTSAC 4 m6A 249 250 99.60 99.57 69.86
TCNNGA 6 m6A 3946 3986 99.00 99.78 72.52
TGCA 4 m6A 10424 10466 99.60 101.36 72.32
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HE141/09
Motif Modified 
position
Modificati
on type
No. of 
motifs 
detected
No. of 
motifs in 
genome
% of 
motifs 
detected
Mean 
Score
Mean 
coverage
AGGAG 4 m6A 1507 1515 99.47 107.78 75.10
CACAT 4 m6A 2409 2441 98.69 104.67 76.18
CATG 2 m6A 15333 15334 99.99 114.42 77.19
CCATC 3 m6A 2116 2120 99.81 103.38 75.35
CCGG 1 m4C 3120 3552 87.84 59.07 77.18
CCTYNA 6 m6A 267 8399 3.18 104.51 77.31
GAATTC 3 m6A 349 352 99.15 104.18 72.86
GACY 2 m6A 8216 8243 99.67 102.33 76.69
GAGG 2 m6A 5021 5060 99.23 103.01 75.88
GATC 2 m6A 10989 11000 99.90 102.99 75.97
GATGG 2 m6A 2120 2120 100.00 110.48 77.13
GCGC 2 m5C 484 13058 3.71 45.70 77.20
GTSAC 4 m6A 250 250 100.00 105.87 76.13
TCNNGA 6 m6A 3943 3984 98.97 104.85 77.31
TGCA 4 m6A 10440 10488 99.54 106.33 76.71
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HE142/09
Motif Modified 
position
Modificati
on type
No. of 
motifs 
detected
No. of 
motifs in 
genome
% of 
motifs 
detected
Mean 
Score
Mean 
coverage
AGGAG 4 m6A 1497 1515 98.81 69.10 44.03
CACAT 4 m6A 2385 2438 97.83 68.50 44.62
CATG 2 m6A 15288 15320 99.79 72.47 45.46
CCATC 3 m6A 2096 2115 99.10 67.28 44.23
CCGG 1 m4C 2208 3552 62.16 41.98 47.26
CCTYNA 6 m6A 264 8388 3.15 68.14 44.87
GAATTC 3 m6A 347 352 98.58 66.65 41.76
GACY 2 m6A 8126 8229 98.75 66.80 44.72
GAGG 2 m6A 4963 5055 98.18 65.88 44.22
GATC 2 m6A 10889 10992 99.06 67.61 44.81
GATGG 2 m6A 2105 2115 99.53 68.64 45.19
GCGC 2 m5C 216 13048 1.66 39.28 47.86
GTSAC 4 m6A 245 250 98.00 66.36 43.14
TCNNGA 6 m6A 3904 3986 97.94 68.14 45.27
TGCA 4 m6A 10355 10466 98.94 69.27 45.27
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HE143/09
Motif Modified 
position
Modificati
on type
No. of 
motifs 
detected
No. of 
motifs in 
genome
% of 
motifs 
detected
Mean 
Score
Mean 
coverage
AGGAG 4 m6A 1507 1515 99.47 102.59 71.28
CACAT 4 m6A 2402 2438 98.52 98.83 71.58
CATG 2 m6A 15315 15322 99.95 109.13 73.52
CCATC 3 m6A 2110 2115 99.76 97.92 71.97
CCGG 1 m4C 3130 3552 88.12 58.24 72.30
CCTYNA 6 m6A 7510 8389 89.52 90.42 72.86
GAATTC 3 m6A 349 352 99.15 97.58 67.57
GACY 2 m6A 8202 8229 99.67 96.67 72.43
GAGG 2 m6A 5019 5056 99.27 97.81 71.94
GATC 2 m6A 10966 10994 99.75 97.25 71.76
GATGG 2 m6A 2115 2115 100.00 105.23 73.76
GCGC 2 m5C 503 13046 3.86 44.73 71.97
GTSAC 4 m6A 249 250 99.60 98.75 70.13
TCNNGA 6 m6A 3939 3984 98.87 98.83 72.38
TGCA 4 m6A 10404 10466 99.41 101.30 73.45
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HE147/09
Motif Modified 
position
Modificati
on type
No. of 
motifs 
detected
No. of 
motifs in 
genome
% of 
motifs 
detected
Mean 
Score
Mean 
coverage
AGGAG 4 m6A 1505 1515 99.34 91.88 62.33
CACAT 4 m6A 2406 2438 98.69 88.15 62.72
CATG 2 m6A 15315 15318 99.98 96.33 63.79
CCATC 3 m6A 2109 2115 99.72 87.98 62.46
CCGG 1 m4C 3126 3552 88.01 51.84 63.48
CCTYNA 6 m6A 203 8388 2.42 91.51 63.60
GAATTC 3 m6A 349 352 99.15 88.81 58.95
GACY 2 m6A 312 8230 3.79 88.34 62.81
GAGG 2 m6A 5023 5054 99.39 86.26 62.01
GATC 2 m6A 10968 10994 99.76 87.65 62.70
GATGG 2 m6A 2115 2115 100.00 92.45 63.00
GCGC 2 m5C 414 13046 3.17 42.62 64.11
GTSAC 4 m6A 250 250 100.00 90.14 62.63
TCNNGA 6 m6A 3943 3986 98.92 88.53 63.05
TGCA 4 m6A 10407 10466 99.44 89.95 63.52
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HE170/09
Motif Modified 
position
Modificati
on type
No. of 
motifs 
detected
No. of 
motifs in 
genome
% of 
motifs 
detected
Mean 
Score
Mean 
coverage
AGGAG 4 m6A 1506 1515 99.41 78.42 53.33
CACAT 4 m6A 2392 2441 97.99 76.53 54.87
CATG 2 m6A 15322 15334 99.92 81.34 54.71
CCATC 3 m6A 2109 2120 99.48 76.42 54.66
CCGG 1 m4C 2591 3552 72.94 44.96 55.38
CCTYNA 6 m6A 264 8399 3.14 75.43 54.71
GAATTC 3 m6A 349 352 99.15 76.91 52.86
GACY 2 m6A 8183 8243 99.27 75.65 54.46
GAGG 2 m6A 5006 5060 98.93 73.63 52.99
GATC 2 m6A 10947 11000 99.52 74.94 54.11
GATGG 2 m6A 2118 2120 99.91 78.47 54.90
GCGC 2 m5C 394 13060 3.02 42.16 54.50
GTSAC 4 m6A 250 250 100.00 76.80 53.29
TCNNGA 6 m6A 3905 3986 97.97 75.52 54.65
TGCA 4 m6A 10389 10488 99.06 76.66 54.52
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Motif Modified 
position
Modificati
on type
No. of 
motifs 
detected
No. of 
motifs in 
genome
% of 
motifs 
detected
Mean 
Score
Mean 
coverage
AGGAG 4 m6A 1510 1513 99.80 144.06 98.33
CACAT 4 m6A 2433 2438 99.79 143.53 100.20
CATG 2 m6A 15320 15320 100.00 156.29 102.16
CCATC 3 m6A 2113 2115 99.91 143.32 100.18
CCGG 1 m4C 3309 3552 93.16 79.43 100.42
CCTYNA 6 m6A 238 8387 2.84 127.51 102.37
GAATTC 3 m6A 350 350 100.00 144.07 96.17
GACY 2 m6A 334 8228 4.06 131.60 101.18
GAGG 2 m6A 5044 5054 99.80 138.28 99.16
GATC 2 m6A 10993 10994 99.99 141.45 100.54
GATGG 2 m6A 2115 2115 100.00 148.45 101.25
GCGC 2 m5C 836 13046 6.41 49.80 100.33
GTSAC 4 m6A 250 250 100.00 146.54 100.69
TCNNGA 6 m6A 3972 3986 99.65 142.17 101.31
TGCA 4 m6A 10450 10466 99.85 146.06 101.16
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Motif Modified 
position
Modificati
on type
No. of 
motifs 
detected
No. of 
motifs in 
genome
% of 
motifs 
detected
Mean 
Score
Mean 
coverage
AGGAG 4 m6A 1512 1515 99.80 112.60 83.42
CACAT 4 m6A 2437 2438 99.96 120.87 82.99
CATG 2 m6A 15320 15320 100.00 122.22 83.38
CCATC 3 m6A 2115 2115 100.00 126.46 83.66
CCGG 1 m4C 3547 3552 99.86 79.26 85.24
CCTYNA 6 m6A 269 8388 3.21 119.43 84.49
GAATTC 3 m6A 352 352 100.00 118.20 79.53
GACY 2 m6A 8225 8228 99.96 114.79 83.87
GAGG 2 m6A 5028 5055 99.47 104.19 83.55
GATC 2 m6A 10994 10994 100.00 128.41 83.91
GATGG 2 m6A 2115 2115 100.00 119.72 83.56
GCGC 2 m5C 1009 13046 7.73 51.04 86.19
GTSAC 4 m6A 250 250 100.00 117.48 85.38
TCNNGA 6 m6A 3983 3986 99.92 115.11 84.08
TGCA 4 m6A 10462 10466 99.96 118.71 84.08
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Short summary 
In this article, we functionally characterized the role of a highly conserved m5C-MTase in H. pylori 
present and putatively active in all strains. We studied the impact of this MTase on the 
transcriptomes of two H. pylori wild-type and respective MTase mutant strains, and showed that the 
MTase had both strain-specific and conserved effects. Methylation of motifs overlapping promoter 
sequences had a direct impact on gene expression. Methylation affected several phenotypic traits 
like adhesion to host cells, natural competence, copper resistance, and bacterial morphology. 
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ABSTRACT
Helicobacter pylori encodes a large number of
restriction–modification (R–M) systems despite its
small genome. R–M systems have been described
as ‘primitive immune systems’ in bacteria, but the
role of methylation in bacterial gene regulation and
other processes is increasingly accepted. Every H.
pylori strain harbours a unique set of R–M systems
resulting in a highly diverse methylome. We identi-
fied a highly conserved GCGC-specific m5C MTase
(JHP1050) that was predicted to be active in all of
459 H. pylori genome sequences analyzed. Transcrip-
tome analysis of two H. pylori strains and their re-
spective MTase mutants showed that inactivation of
the MTase led to changes in the expression of 225
genes in strain J99, and 29 genes in strain BCM-
300. Ten genes were differentially expressed in both
mutated strains. Combining bioinformatic analysis
and site-directed mutagenesis, we demonstrated that
motifs overlapping the promoter influence the ex-
pression of genes directly, while methylation of other
motifs might cause secondary effects. Thus, m5C
methylation modifies the transcription of multiple
genes, affecting important phenotypic traits that in-
clude adherence to host cells, natural competence
for DNA uptake, bacterial cell shape, and suscepti-
bility to copper.
INTRODUCTION
Epigenetics denotes inheritable mechanisms that regulate
gene expression without altering the DNA sequence. In
prokaryotes, methyltransferases (MTases) transfer methyl
groups from S-adenosyl methionine to adenines or cy-
tosines within a DNA target motif and so contribute to
changes of the epigenome (1–3). MTases either belong
to restriction–modification (R–M) systems that include
MTase and restriction endonuclease (REase) activities, or
occur as orphan MTases in the absence of a cognate restric-
tion enzyme (4). Three types of DNA methylation occur in
bacteria, N6-methyladenine (m6A), 5-methylcytosine (m5C)
and N4-methylcytosine (m4C) (1,2). So far, the major role
allocated to bacterial R–M systems is self-DNA protection
by restriction of incoming foreign un-methylated DNA (5),
and they have thus been described as ‘primitive immune
systems’ (6). Other functions have also been attributed to
prokaryotic R–M systems (7–9). For example, methylation
marks promoter sequences and alters DNA stability and
structure, modifying the affinity of DNA binding proteins
and influencing the expression of genes (10,11). Addition-
ally, disturbance of DNA strand separation by methylation
can have an effect on gene expression (12).
Methylation can be involved in multiple bacterial func-
tions. In Escherichia coli, the Dam adenine MTase plays
an essential role in DNA replication (13,14). Another well-
studied example is the CcrM MTase from Caulobacter cres-
centus that controls the progression of the cell cycle (15).
Furthermore, phase-variable MTases have been shown to
control the regulation of multiple genes in several differ-
ent pathogens, including Haemophilus influenzae, Neisseria
meningitidis and Helicobacter pylori (16–18). These MTase-
dependent regulons were termed phasevarions (19). As de-
scribed previously, adenine methylation has been shown to
play a key role in transcriptional regulation but the influ-
ence of cytosine methylation in gene expression has so far
only been investigated in very few studies (20–22).
Helicobacter pylori infection affects half of the world’s
population and is a major cause of gastric diseases that
include ulcers, gastric cancer, and MALT lymphoma (23).
This gastric pathogen has coexisted with humans since, at
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least, 88 000 years ago (24). Helicobacter pylori strains dis-
play an extraordinary genetic diversity caused in part by
a high mutation rate but especially by DNA recombina-
tion occurring during mixed infection with other H. pylori
strains within the same stomach (25–27). The very high se-
quence diversity of H. pylori and the coevolution of this
pathogen with its human host have caused its separation
into phylogeographic populations, whose distribution re-
flects human migrations (28–30).
Despite its small genome, H. pylori is one of the
pathogens with the highest number of R–M systems (31).
The development of Single Molecule, Real-Time (SMRT)
Sequencing technology has allowed genome-wide studies
of methylation patterns and strongly accelerated the func-
tional elucidation of MTases and their roles in bacterial bi-
ology (32,33). Methylome studies of several H. pylori strains
have revealed that every strain carries a different set of R–M
systems leading to highly diverse methylomes (34–37). R–
M systems in H. pylori were shown to protect the bacterial
chromosome against the integration of non-homologous
DNA (e.g. antibiotic resistance cassettes), while they had no
significant effect on recombination between highly homolo-
gous sequences, permitting efficient allelic replacement (9).
Despite the diversity of methylation patterns, a small num-
ber of target motifs were shown to be methylated in all (one
motif, GCGC) or almost all (3 motifs protected in >99% of
strains) H. pylori strains in a study by Vale et al., who tested
genomic DNAs purified from 221 H. pylori strains for sus-
ceptibility to cleavage by 29 methylation-sensitive restric-
tion enzymes, and in those studies investigating the methy-
lomes of multiple H. pylori strains (34,35,37,38). R–M sys-
tems have also previously been shown to contribute to gene
regulation in H. pylori; the phase-variable MTase ModH5
is involved in the control of the expression of virulence-
associated genes like hopG or flaA in strain P12 (39,40).
In the present study, we functionally characterized
the role of a highly conserved m5C MTase (JHP1050,
M.Hpy99III) in H. pylori (41). We show the MTase gene to
be part of the H. pylori core genome, present and predicted
to be active in all of several hundred H. pylori strains repre-
sentative of all known phylogeographic populations. Tran-
scriptome comparisons of two H. pylori wild-type strains
and their respective knockout mutants demonstrated that
JHP1050 has a strong impact on the H. pylori transcrip-
tome that includes both conserved and strain-specific regu-
latory effects. We show that m5C methylation of GCGC se-
quences, among others, affects metabolic pathways, compe-
tence and adherence to gastric epithelial cells. Moreover, we
provide evidence that methylation of GCGC motifs over-
lapping with promoter sequences can play a direct role in
gene expression, while the regulatory effects of methylated
sites outside of promoter regions may be indirect.
MATERIALS AND METHODS
Bacterial culture, growth curves and transformation experi-
ments
H. pylori strains 26695 (42), J99 (43), BCM-300 (35) and
H1 (44) were cultured on blood agar plates (45), or in liq-
uid cultures as described (9). Microaerobic conditions were
generated in airtight jars (Oxoid, Wesel, Germany) with
Anaerocult C gas producing bags (Merck, Darmstadt, Ger-
many). For growth curves, liquid cultures were inoculated
with bacteria grown on agar plates for 22–24 h to a start-
ing OD600 of ∼0.06 and incubated with shaking (37◦C, 140
rpm, microaerobic conditions). The OD600 was repeatedly
measured until a maximum incubation time of 72 hours.
The generation time for H. pylori strains J99 and 26695 was
calculated to be 3.90 and 4 h respectively, similar to previous
calculations (46).
Susceptibility to copper was tested by adding copper sul-
fate (final concentrations, 0.25 and 0.50 mM) to liquid cul-
tures. The OD600 was measured 24 h after inoculation.
For transformation experiments, liquid cultures of the re-
cipient strain were grown overnight (conditions described
above). Then, 1 g/ml of donor bacterial genomic DNA
(gDNA) was added to the cultures. The donor gDNA
for transformation experiments was purified from isogenic
H. pylori strains carrying a chloramphenicol (CAT) resis-
tance cassette within the non-essential rdxA gene (i.e. J99
rdxA::CAT). After gDNA addition, the cultures were incu-
bated for 6–8 h under the same conditions (37◦C, 140 rpm,
microaerobic atmosphere). Next, the OD600 was measured
and adjusted to the same number of cells (OD600 = 1 as
3 × 108 bacteria). Finally, 100 l of serial dilutions were
plated onto blood agar plates containing chloramphenicol,
and incubated at 37◦C under microaerobic conditions. Ap-
proximately 4–5 days later, colonies were counted and the
efficiency of transformation was calculated as cfu/ml.
DNA and RNA extraction
gDNA was isolated from bacteria grown on blood agar
plates using the Genomic-tip 100/G kit (Qiagen, Hilden,
Germany) following the manufacturer’s protocol. The
gDNA pellet was dissolved over night at room temperature
with EB buffer.
For RNA extraction, 5 ml of bacterial cells grown in liq-
uid medium were pelleted (4◦C, 6000 × g, 3 min), snap-
frozen in liquid nitrogen and stored at −80◦C. Afterwards,
bacterial pellets were disrupted with a FastPrep® FP120
Cell Disrupter (Thermo Savant) using Lysing Matrix B 2 ml
tubes containing 0.1 mm silica beads (MP Biomedicals, Es-
chwege, Germany). Isolation of RNA was performed using
the RNeasy kit (Qiagen, Hilden, Germany) and on-column
DNase digestion with DNase I. A second DNase treatment
was carried out using the TURBO DNA-free™ Kit (Am-
bion, Kaufungen, Germany). Isolated RNA was checked
for the absence of DNA contamination by PCR.
DNA and RNA concentrations were measured using a
NanoDrop 2000 spectrophotometer (Peqlab Biotechnolo-
gies). RNA quality given as RINe number was measured
with an Agilent 4200 Tape Station system using RNA
Screen Tapes (Agilent, Waldbronn, Germany). All RINe
numbers of RNA preparations used for further process-
ing were higher than 8.2, confirming high quality and little
RNA degradation.
Construction of mutants and complementation
Inactivation of the MTase or the whole R–M system genes
was carried out by insertion of an aphA3 cassette confer-
ring resistance to kanamycin (Km). A PCR product was
D
ow
nloaded from
 https://academ
ic.oup.com
/nar/advance-article-abstract/doi/10.1093/nar/gky1307/5280932 by guest on 09 January 2019
79
Nucleic Acids Research, 2019 3
constructed using a combination of primers which added
restriction sites and allowed overlap PCR with the aphA3
cassette (Q5 Polymerase, NEB, Frankfurt am Main, Ger-
many). Ligation of the overlap amplicon with a digested
pUC19 vector was done using Quick Ligase (NEB, Frank-
furt am Main, Germany). The resulting plasmids were
transformed into E. coli MC1061. Following plasmid iso-
lation, 750 ng of the plasmids were used for H. pylori trans-
formation. Functional complementation of the MTase gene
in the strains 26695-mut, J99-mut and BCM-300-mut was
achieved by means of the pADC/CAT suicide plasmid ap-
proach, as described (47). Transformation of the recipient
strains with the resulting plasmid permitted the chromoso-
mal integration of the MTase gene (from strain 26695) into
the urease locus, placing the inserted gene under the control
of the strong promoter of the H. pylori urease operon. The
complemented strains were designated 26695-compl, J99-
compl and BCM-300-compl, respectively.
Five different methylation motif mutants carrying either
a single point mutation in one of the three GCGC motifs
of gene jhp0832, or a combination of two mutations were
constructed using the Multiplex Genome editing (MuGent)
technique as described (9,48), with the exception that we
used a chloramphenicol resistance cassette within the non-
essential rdxA locus as selective marker. Sanger sequencing
was used to verify the acquisition of the desired mutations
within the GCGC motifs. The putative promoter of the gene
was predicted within the 50 bp upstream of the transcrip-
tional start site (49) using the BPROM Softberry online tool
(50) and verified manually by comparison with H. pylori
promoter consensus sequences (51). All H. pylori mutants
were checked via PCR and selected on antibiotic-containing
plates. The absence or recovery of methylation was checked
by digestion of gDNA with HhaI (NEB, Frankfurt am
Main, Germany). All plasmids and primers used in this
study are listed in Supplementary Tables S6 and S7.
Microscopy
Live and dead (L/D) staining was performed using the
BacLight Bacterial Viability kit (Thermo Fisher Scientific,
Darmstadt, Germany) according to the manufacturer’s in-
structions. Bacteria were harvested from plates incubated
for 22–24 h, and suspended in 1 ml of BHI medium without
serum to an adjusted OD600 of ∼0.1. Then, 100 l of this
dilution were mixed with the BacLight dyes, giving green
and red fluorescence for live and dead/dying bacteria, re-
spectively. After 30 minutes of incubation at room temper-
ature and in the dark, 0.5 l of the mix was suspended on
slides that were analyzed with an Olympus BX61-UCB mi-
croscope equipped with an Olympus DP74 digital camera.
Between 80 and 100 pictures from at least two independent
biological and technical replicates were obtained and ana-
lyzed with the CellSens 1.17 software (Olympus Life Sci-
ence) and ImageJ (52).
Gram staining was performed as follows: 300 l of liq-
uid cultures grown over-night were pelleted (6000 × g, 3
min, room temperature) and washed 3 times with PBS (6000
× g, 3 min, room temperature). Afterward, 100 l of the
pellets resuspended in PBS were added to a glass slide that
was dried at 37◦C during 10–15 min, heat-fixed and Gram-
stained.
Bacterial cell adherence assays
Assays for bacterial adherence to the human stomach carci-
noma cell line AGS were performed as previously described
with slight modifications (53,54). Helicobacter pylori strains
grown to an OD600 ∼1 were suspended in RPMI 1640
medium supplemented with 10% fetal calf serum (FCS).
Experiments were executed in 96-well plates containing 2
× 105 fixed AGS cells (ATCC CRL-1739) per well. AGS
cells were fixed with 2% freshly prepared paraformaldehyde
in 100 mM potassium phosphate buffer (pH 7) and subse-
quently quenched and washed as described (53). Live H. py-
lori bacteria were added to cells at a bacteria:cell ratio of
50 (54), followed by brief centrifugation (300 × g, 5 min),
and co-incubated for 1 h at 37◦C with 5% CO2. After this,
plates were washed twice with PBS, followed by overnight
fixation with 50 l of fixing solution (see above). Fixing so-
lution was renewed once and incubated for an additional
30 min, and quenched twice with 50 l of quenching buffer
for 15 min. Bacterial adherence to the AGS cells was subse-
quently quantitated using antibody-based detection as fol-
lows: cells were washed three times with washing buffer
PBS-T (PBS + 0.05% Tween20), blocked for 30 min with
200 l of the assay diluent (10% FCS in PBS-T) and washed
four times with PBS-T. Then, 100 l of a 1:2,500 dilution
of the primary antibody, -H. pylori (DAKO/Agilent Tech-
nologies, Hamburg, Germany) was added and incubated for
2 h. Afterward, cells were washed and incubated with 100
l of a 1:10 000 dilution of the secondary antibody, goat
anti-rabbit HRP-coupled (Jackson ImmunoResearch, Ely,
United Kingdom) for 1 h. After four final wash steps, the
96-well plates were finally incubated with 100 l TMB sub-
strate solution (1:1, Thermo Fisher Scientific, Darmstadt,
Germany). The color reaction was developed in the dark for
30 min and stopped with 50 l of phosphoric acid (1 M).
Absorbance was measured at 450/540 nm (Sunrise™ Ab-
sorbance Reader). Negative controls (mock-coincubated,
fixed AGS cells) were treated the same way with primary
and secondary antibody dilutions.
Bioinformatic analyses
To analyze the conservation and the genomic context of
the JHP1050 MTase gene in a diverse collection of H. py-
lori strains, we assembled a database consisting of 459 H.
pylori genomes that included strains from all known phy-
logeographic populations and subpopulations (Supplemen-
tary Table S1). Genomes and methylomes of the four strains
investigated in this study have been published previously
(34,35,42–44), with the exception of the H1 methylome
(own unpublished data). The nucleotide sequence of gene
jhp1050 from the H. pylori strain J99 was used to identify
and extract the jhp1050 homologs and the sequences of the
flanking genes. The NCBI blastn microbes and StandAlone
Blast tools were used to extract the sequences from publicly
available genomes and private genomes, respectively.
To study whether the methylated cytosines of the GCGC
motifs had a higher tendency to deaminate (m5C>T) than
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unmethylated cytosines, we compared the frequency of
C>T transitions to either C>A or C>G polymorphisms in-
side and outside of GCGC motifs among a phylogeograph-
ically distinct set of H. pylori genomes. GCGC motifs were
identified in two H. pylori genomes, 26695 and PeCan18,
which were subsequently used as reference and aligned sep-
arately against 11 other H. pylori genomes using BioNu-
merics version 7.6 (Applied Maths, Sint-Martens-Latem,
Belgium). Polymorphisms were called in both alignments
and pooled together. The percentage of mutated m5C posi-
tions within GCGC motifs was determined for each possi-
ble transition or transversion as follows:
% =number of m5C → base ∗ 100
total of motifs in the reference
Since the Gm5CGC motif is palindromic, the same analy-
sis was performed for the complementary strand, where the
position of the second G (m5C in the complementary strand)
was compared for each possible mutation and calculated as
above.
Finally, the percentage of mutated C outside GCGC mo-
tifs calculated as follows for each possible mutation:
% = (Total number of C → base − number of m5C → base) ∗100
Total number of C in the reference genome
The same analysis was performed for other m5C mo-
tifs and for non-methylated motifs as well as for the non-
methylated C of the GCGC motif.
Expected sites
The expected number of motifs per kb was calculated as fol-
lows:
Expected sites/kb =Total observed GCGC motifs ∗ 1000 (bp)
genome length (bp)
The expected number of motifs/kb was 3.89 (J99), 3.91
(BCM-300), 3.76 (26695) and 3.74 (H1). The expected num-
ber of motifs within CDS can then be calculated using the
expected number of motifs/kb and the gene length. Finally,
the ratio observed/expected (O/E) motifs within CDS was
calculated to detect genes enriched for the presence of spe-
cific sequence motifs. For example, for a given gene in J99
that is 630 bp long and has two GCGC motifs (observed),
the expected number of motifs within that gene would be:
630*3.89/1000. For this example calculation, the O/E ra-
tio would be 0.82, suggesting GCGC motifs are under-
represented in this gene.
The GCGC motif is a 4-mer palindrome. In order to cal-
culate the expected number of motifs that would randomly
occur within a genome fragment (either CDS or intergenic
region), we took into account the number of 4-mers in a
given sequence, N – K + 1 (where N means sequence length
and K the motif length, in this case 4), and the frequency of
G/C (0.2) and A/T (0.3), and calculated the expected num-
ber of motifs in a specific fragment as (N – K + 1)*(0.2)4.
RNA-Seq analysis
RNA-Seq analysis was performed on an Illumina HiSeq
sequencer obtaining single end reads of 50 bp. Ribosomal
RNA (rRNA) depletion was performed prior to cDNA syn-
thesis using a RiboZero Kit (Illumina, Germany). Isolated
RNA from a total of 6 × 108 to 1 × 109 bacterial cells cor-
responding to log phase of growth was used for sequenc-
ing. Three biological replicates were used for all the strains,
except for J99-mut since one replicate had to be discarded
during library preparation. Mapping of reads to a reference
genome was done with Geneious 11.0.2 (55). Reads map-
ping multiple locations or intersecting multiple CDS were
counted as partial matches (i.e. 0.5 read). Differential ex-
pression was calculated using DESeq2 (56). Fold change
(FC) of two and FDR adjusted P-value of 0.01 were used
as a cut-off.
Quantitative PCR (qPCR)
One g of RNA was used for cDNA synthesis using the Su-
perScript™ III Reverse Transcriptase (Thermo Fisher Scien-
tific, Darmstadt, Germany) as described before (54). qPCR
was performed with gene specific primers (Supplementary
Table S7) and SYBR Green Master Mix (Qiagen, Hilden,
Germany). Reactions were run in a BioRad CFX96 system.
Standard curves were produced and samples were run as
technical triplicates. For quantitative comparisons, samples
were normalized to an internal 16S rRNA control qPCR.
Details about the reaction conditions in compliance with
the MIQE guidelines are specified in Supplementary Meth-
ods 1.
RESULTS
Distribution of the Gm5CGC R–M system (JHP1049-1050)
within a globally representative collection of H. pylori
genomes
Despite the extensive inter-strain methylome diversity of H.
pylori, a small number of motifs have been shown to be
methylated in all or most of the strains (38). Here, we fo-
cused on the MTase JHP1050 (M.Hpy99III), which methy-
lates GCGC sequences, resulting in Gm5CGC motifs. Al-
though m5C methylation is less common in prokaryotes
than m6A methylation, based on the Restriction Enzyme
Database (REBASE) (57), this particular motif is highly
conserved in many bacterial species.
We therefore hypothesized that the GCGC-specific
MTase in H. pylori might play an important role apart from
self-DNA protection.
We first analyzed the conservation and the genomic con-
text of the MTase gene. The nucleotide sequence of gene
jhp1050 from the H. pylori strain J99 was used to identify the
jhp1050 homologs and the sequences of the flanking genes
in a collection of 458 H. pylori genomes representing all
known phylogeographic populations (Supplementary Table
S1).
Based on the gene sequences, the M.Hpy99III MTase was
predicted to be active in all H. pylori strains. The MTase se-
quence was highly conserved between all 459 strains, with
an average nucleotide sequence identity of 94.04 ± 2.03%,
and a lowest nucleotide sequence identity of 87% between
the most dissimilar alleles. The analyzed region of the chro-
mosome was also highly conserved among the strains and
all the flanking genes were present with the exception of
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Figure 1. Phylogenetic analysis of the GCGC-specific R–M system JHP1050/1049 (M.Hpy99III/Hpy99III) in H. pylori. Neighbour-Joining trees based on
the nucleotide sequences of MTase M.Hpy99III (A) and REase Hpy99III (B). In both cases, strain symbols are colored according to the phylogeographic
population assignment based on seven gene MLST and STRUCTURE analysis (see right panel for color coding). Filled circles represent strains without
REase gene, while unfilled circles are used for strains containing both MTase and REase genes.
the cognate REase gene (jhp1049) which was present in
only 61 of the 459 strains. Interestingly, the majority of the
REase-positive strains belong to populations with substan-
tial African ancestry, particularly to hpAfrica2, followed
by hspSAfrica, hspWAfrica and hpEurope. Furthermore,
none of the analyzed hspAsia2 or hspEAsia strains car-
ried the REase gene (Supplementary Table S1). Only 15
REase genes were predicted to be functional, while the oth-
ers were pseudogenes due to premature stop codons and/or
frameshift mutations (Supplementary Table S2). We identi-
fied a 10 bp repeat sequence flanking the REase gene. The
same sequence was found downstream of the MTase gene
and 48 bp upstream of jhp1048 in 15 of the REase-negative
strains. In all cases, the sequence contained a homopoly-
meric region with a variable number of adenines. This sug-
gests that the REase gene was excised from the genome. The
same sequence was found in H. cetorum and H. acinonychis,
the closest known relatives of H. pylori (Supplementary Ta-
ble S3 and Supplementary Figure S1). Moreover, the phylo-
genetic trees of MTase and REase gene sequences in general
were congruent with the global population structure of H.
pylori (Figure 1) (24). This implies that the R–M system was
acquired early in the history of this gastric pathogen. The
REase gene appears to have been lost later during species
evolution in the majority of the strains, likely before the first
modern humans left Africa. Nonetheless, the REase gene
could have been reintroduced in some strains (i.e. hpEurope
strains) via recombination of the flanking repeats.
Construction of MTase mutants and analysis of target motif
abundance
To functionally characterize this highly conserved MTase,
we constructed MTase-deficient mutants. The MTase gene
was disrupted in the strains 26695 (hpEurope), H1 (hspEA-
sia) and BCM-300 (hspWAfrica) and the whole R–M sys-
tem was inactivated in strain J99 (hspWAfrica), the only
of the four strains that contained both MTase and REase.
Genes were inactivated by insertion of an antibiotic re-
sistance cassette. The loss of methylation was verified by
restriction assays using the restriction enzyme HhaI that
only cleaves unmethylated GCGC sequences (Supplemen-
tary Figure S2). In the following text, mutants are named by
the wild type strain name followed by –mut. Complementa-
tion of the MTase in strains 26695, J99 and BCM-300 was
performed by reintroducing the MTase gene of 26695 (see
Materials and Methods). The transcription of the MTase
gene was tested in the four wild type strains and in two of
the complemented mutant strains (J99-compl and 26695-
compl). The transcript amounts of the MTase varied sub-
stantially between wild type strains (Supplementary Figure
S3). Whether these differences between mRNA amounts
have any functional implications is currently unknown.
Methylome comparison of the four strains exhibited
only four methylated motifs shared between the strains
(Gm5CGC, Gm6ATC, Cm6ATG and Gm6AGG) (Supple-
mentary Table S4). All of these motifs occur frequently in
the J99 genome (GCGC, 6399 motifs; GATC, 5479; CATG,
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Figure 2. Graphical representation of the percentage of genes with GCGC motifs 500 bp of sequence upstream of the start codon for differentially
expressed genes (DEGs) and genes not showing differential expression (Non-DEGs). Non-DEGs versus DEGs in BCM-300 (A) and J99 (C). DEGs in J99
shared with BCM-300 versus the rest of the J99 genes (B). DEGs in J99 shared with BCM-300 versus the rest of the J99 DEGs (all DEGs) (D). Statistics:
Chi-square, *P < 0.05, **P < 0.01.
7560; GAGG, 5027). The distribution of GCGC motifs
along the genomes was not uniform. We compared this
observed distribution to the motif density that would be
expected from a random distribution of motifs across the
genomes. While the number of motifs was generally higher
than expected for a random distribution, fewer motifs than
predicted were found in the cagPAI and the plasticity zones
(PZ) (Supplementary Figure S4A). Finally, we calculated
the total number of GCGC motifs that would randomly oc-
cur in the complete genomes, the coding regions and the in-
tergenic regions according to the nucleotide composition of
H. pylori. The observed number of motifs in the coding re-
gions was more than twice the expected number for all four
genomes. In contrast, the observed and expected numbers
of motifs in the intergenic regions were very similar (Table
1). Therefore, coding sequences appeared to display an over-
representation of GCGC motifs.
Comparative RNA-Seq transcriptome analysis of H. pylori
J99 and BCM-300 and their isogenic MTase mutants
Due to the extraordinary conservation of the Gm5CGC
MTase in all analyzed strains despite the absence of a cog-
nate REase, we postulated that the function of the enzyme
might be more important than simply serving for self-DNA
protection. Therefore, in order to study a putative role in
gene regulation, we performed comprehensive RNA-Seq
analysis in the strains J99, BCM-300 and the two corre-
sponding isogenic MTase mutants.
Whole transcriptome comparison of the J99-mut and J99
wild type strains exhibited 225 differentially expressed genes
(DEGs). One hundred fifteen genes were upregulated and
110 downregulated in J99-mut compared with J99 wild type
(P-adjusted value < 0.01, fold change (FC) > 2). In con-
trast to J99, the transcriptomes of the BCM-300-mut and
wild type strains showed only 29 genes that were differen-
tially expressed in the mutant, all of which were downreg-
ulated (P-adjusted value < 0.01, FC > 2) (Supplementary
Table S5). The two mutants, J99-mut and BCM-300-mut,
shared 10 downregulated genes but no upregulated genes
(Table 2). Using qPCR, we confirmed that 9 of the 10 shared
genes were significantly downregulated as shown by RNA-
Seq (Supplementary Figure S5). The gene jhp1283 showed
either upregulation or downregulation in different biologi-
cal replicates.
In order to understand how the distribution of motifs
could play a role in transcriptional regulation, we analyzed
the frequencies of GCGC motifs in a 500 bp sequence up-
stream of each DEG and compared those with sequences
upstream of genes that were not differentially regulated
(non-DEGs), and with coding sequences (CDS).
In strain BCM-300, the number of GCGC motifs located
within 500 bp upstream of the start codon was higher for
the 29 DEGs than for non-DEGs (Figure 2A). In contrast,
in strain J99, the percentage of genes with three or more
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Table 1. Observed and expected frequencies of GCGC motifs in the genome sequences of the four H. pylori strains analyzed in this study
Strain
Genome
size (bp)
Total
length of
CDS (bp)
Total
length of
intergenic
sequences
(bp)
Predicted
no. of
GCGC
sites/1 kb
No. of
motifs in
genome
Expected
no. of
motifs in
genome
No. of
motifs in
CDS
Expected
no. of
motifs in
CDS
No. of
motifs in
intergenic
sequences
Expected no.
of motifs in
intergenic
sequences
26695 1667867 1494807 173060 3.76 6269 2669 5950 2392 319 277
J99 1643831 1486413 157418 3.89 6399 2630 6110 2378 289 252
H1 1563305 1436409 126896 3.74 5846 2501 5655 2298 191 203
BCM-300 1667883 1520688 147195 3.91 6523 2669 6273 2433 250 236
Table 2. Shared differentially expressed genes (DEGs), displaying GCGC methylation-dependent transcription in H. pylori J99 and BCM-300. Positive
values for fold change (FC) indicate lower transcription in the mutants compared to the wild type strains
Gene Description J99 locus tag J99 FC BCM-300 locus tag BCM-300 FC
bioD dethiobiotin synthetase jhp 0025 2.1986 BCM 00034 2.9978
BCM 00035 2.9424
feoB iron(II) transport protein jhp 0627 3.8803 BCM 00707 4.3250
- unknown jhp 0749 3.8245 BCM 00859 3.1947
moeB molybdopterin/thiamine
biosynthesis activator
jhp 0750 4.0863 BCM 00860 3.6033
- unknown jhp 1102 2.4868 BCM 01112 2.2810
cah alpha-carbonic anhydrase jhp 1112 2.0723 BCM 01124 3.3563
trmU tRNA-methyltransferase jhp 1254 4.5288 BCM 01276 5.7005
- unknown jhp 1281 3.4690 BCM 01305 2.0216
- unknown jhp 1253 2.9141 BCM 01275 3.2789
crdR response regulator jhp 1283 2.8855 BCM 01307 3.2789
jhp 1443 2.9141
GCGC motifs within 500 bp upstream of the start codon
was similar for DEGs and non-DEGs (Figure 2C). How-
ever, the 10 DEGs of strain J99 that were shared with BCM-
300 showed the same overrepresentation of GCGC motifs
observed in strain BCM-300 (Figure 2B, D). Furthermore,
DEGs in BCM-300 displayed more motifs within their CDS
than expected if GCGC motifs were distributed randomly
across the whole genome, while the opposite effect occurred
for the non-DEGs. The same trend was evident in J99 when
we only compared the DEGs shared with BCM-300 with
the rest of the genes (Supplementary Figure S6A).
In addition, we observed that 6 of the 10 shared DEGs
harbored GCGC motifs within the 50 bp sequence up-
stream of the TSS described by Sharma and colleagues in
strain 26695 (49), called here region upstream of the TSS
(upTSS). Sequences within the putative promoter regions
immediately upstream of the TSS are likely to exert the
strongest influence on transcriptional regulation. We com-
pared the upTSS of 26695 with J99 and BCM-300 via se-
quence alignment. There were 48 genes in J99 and 45 in
BCM-300 with GCGC motifs within the 50 bp upstream
sequence (sRNA and asRNA were excluded). In J99, 13 of
the 225 DEGs contained GCGC motifs within the upTSS
sequence. In BCM-300, 11 of the 29 DEGs contained mo-
tifs within the upTSS. This proportion of DEGs with motifs
within the upTSS suggests that the window of 50 bp up-
stream of the TSS may play a role in transcription regula-
tion. Indeed, the FC was slightly increased by motifs within
the upTSS (Supplementary Figure S6B). Gene jhp1283, the
only of the 10 shared DEGs identified by RNA-Seq that was
not confirmed in qPCR assays, did not have any GCGC mo-
tif within the upTSS, suggesting that this gene might not be
directly regulated by methylation.
Direct regulation of gene expression by m5C methylation
Inactivation of the M.Hpy99III MTase had different ef-
fects on the transcriptomes of the two strains tested, with
far more genes affected in strain J99 versus the BCM-300
strain. We hypothesized that the loss of GCGC methyla-
tion might have both direct and indirect effects on transcrip-
tion. In order to demonstrate a direct association between
methylation and gene expression, we generated a set of mu-
tants in strain J99 where site-specific mutations were intro-
duced into selected GCGC motifs located within the CDS
as well as in the upstream region of one specific gene show-
ing strong differential regulation.
The selected gene for this approach (jhp0832) was down-
regulated in J99-mut (FC = 5.95). Its homolog in H. pylori
strain 26695 (HP0893) was reported to be an antitoxin from
a Type II Toxin–Antitoxin (TA) system (58). The cognate
toxin (jhp0831) was also downregulated in J99-mut (FC =
3.64). The two genes belong to the same operon where the
antitoxin is located upstream of the toxin. No homologous
genes were found in BCM-300.
Two GCGC motifs were located within the 500 bp up-
stream window of the antitoxin gene and one motif was
located within the coding sequence. Of the two upstream
motifs, one was located within the upTSS in J99 and over-
lapped with the -10 box of the predicted promoter (Figure
3). Thus, owing to the high FC and this distribution of three
GCGC motifs, jhp0832 seemed to be a good candidate to
dissect the role of different GCGC motifs in the transcrip-
tional regulation of jhp0832.
We constructed three mutants where each of the motifs
was individually changed to GAGC so that the motif could
no longer be methylated (jhp0832 mut1, jhp0832 mut2 and
jhp0832 mut3). We also constructed two mutants (jhp0832
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Figure 3. Quantification of transcript amounts of jhp0832 in H. pylori strains J99, J99-mut and the J99 mutants with point mutations within the GCGC
motifs. qPCR results are represented in the right panel, three different biological replicates were performed. Statistics: One-way ANOVA, **P < 0.01,
****P < 0.0001, bars: SD. Legend: The jhp0832 gene is shown as a gray arrow. The predicted promoter is represented by a black arrow. Crosses represent
methylated motifs while vertical lines mean unmethylated motifs (due to site-directed mutation, or to inactivation of the MTase in strain J99-mut). The
GCGC motifs appear in blue and the motifs mutated to GAGC are colored in pink.
Table 3. List of mutants carrying different point mutations modifying the
GCGC motifs within or immediately upstream of jhp0832
Mutant name
GCGC motif
mutated Plasmid
jhp0832 mut1 1 pSUS3427
jhp0832 mut2 2 pSUS3428
jhp0832 mut3 3 pSUS3429
jhp0832 mut4 1, 2 pSUS3427, pSUS3428
jhp0832 mut6 2, 3 pSUS3428, pSUS3429
All mutants were constructed using the MuGent technique (see Materi-
als and Methods) using the indicated plasmids and the rdxA::CAT PCR
product. Thus, all the mutants were resistant to chloramphenicol.
mut4 and jhp0832 mut6) where two out of the three GCGC
motifs were mutated (Figure 3A, Table 3). We were unable
to generate a triple mutant carrying combined point mu-
tations in all three motifs, which might be due to toxic dys-
regulation of the toxin–antitoxin system after removal of all
methylatable GCGC motifs.
Differential expression of jhp0832 was determined by
qPCR. Three of the mutants (jhp0832 mut2, jhp0832 mut4
and jhp0832 mut6) displayed a strong downregulation of
jhp0832 expression, similar to J99-mut. Interestingly, these
mutants shared the mutation in the GCGC motif located
within the upTSS and the predicted promoter of the gene.
In contrast, modification of the motifs outside of the upTSS
did not consistently alter the expression of the gene (Figure
3).
Phenotypes of H. pylori GCGC MTase mutants: growth, vi-
ability and shape
In order to test whether the absence of m5C methylation
and the associated differential transcriptomes had a role
in the fitness of H. pylori, we determined the growth of
the strains in liquid medium (Figure 4A). J99-mut had a
significant growth defect compared with the J99 wild type
strain. Complementation of the MTase gene restored the
observed growth phenotype. Similarly, a significant reduc-
tion in growth was shown for BCM-300-mut at stationary
phase that could be restored to wild-type growth by func-
tional complementation. Although non-significant, a slight
delay in growth was noted in 26695-mut and H1-mut com-
pared to the wild type and the complemented strains.
Bacterial morphology serves to optimize biological func-
tions and confers advantages to particular niches. H. pylori
is a spiral-shaped bacterium that can enter a coccoid state
under certain stress conditions (59). H. pylori J99-mut en-
tered a coccoid state very early in liquid cultures. A sub-
stantial proportion of coccoid forms were visible between
6 and 9 h after inoculation while they are rarely found in
the wild type strain at this time point (Supplementary Fig-
ure S7A). An effect of the inactivation of JHP1050 on the
morphology was not observed for the other three strains 24
h post-inoculation (Supplementary Figure S7B). Comple-
mentation of J99-mut restored the wild type phenotype. We
note that live/dead staining did not show a significant dif-
ference between the percentage of live vs. dead bacteria be-
tween the wild type and the mutant strains collected from
22–24 h plates. There was a slight reduction in viability in
the BCM-300-mut strain, but no differences were found in
the other strains (Figure 4B). As in the liquid cultures, an
increased number of rounded bacteria were noticed for J99-
mut (Figure 4C).
m5C methylation contributes to the high mutation frequency
in H. pylori
H. pylori lacks most of the genes involved in mismatch re-
pair (MMR) in other bacteria which is thought to be at
least partially responsible for the high mutation rate of this
bacterium (42,60). Deamination of m5C to thymine (T) is
responsible for the most common single nucleotide muta-
tion (61). H. pylori is known to have a very high mutation
rate, and m5C MTases might contribute to that by increasing
the number of nucleotides susceptible to deamination. To
test whether m5C methylation within GCGC motifs played
a role in H. pylori evolution by favouring deamination,
we aligned whole genomes of two H. pylori strains (26695
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Figure 4. MTase JHP1050 inactivation causes phenotypic effects that vary between strains: growth, viability and morphology. (A) Growth curves for four
wild type strains and mutants and for the complemented strains J99-compl, 26695-compl and BCM-300-compl were measured for 72 h. The doubling
time for H. pylori was calculated to be 3.87 h (46). Statistics: two-way ANOVA, *P < 0.05, **P < 0.01, ****P < 0.0001, bars: SD. (B) Viability of the
strains was studied using epifluorescence microscopy after live/dead staining. Statistics: two-way ANOVA, *P < 0.05, bars: SD. (C) Bacterial morphology
was quantitated from epifluorescence microscopy pictures using ImageJ. A value of 0 represents completely elongated bacteria, while a value of 1 means a
complete circle (coccoid bacteria). Statistics: one-way ANOVA, **P < 0.01, bars: 95% confidence interval (CI).
and PeCan18), used as reference, against 11 other complete
genome sequences (see Material and Methods for details).
The results strongly support a role of m5C methylation in
H. pylori mutagenesis, since the percentage of C→T mu-
tations within GCGC motifs was significantly higher than
the overall percentage of C→T or C→ another base tran-
sition in the genomes of all the tested strains. In addition,
we performed the deamination analysis on (i) other m5C
methylated cytosines within different motifs, (ii) on non-
methylated cytosines within motifs containing m5Cs and (iii)
non-methylated motifs containing cytosines. We observed a
higher frequency of C → T mutations for the m5C within
the motifs.
Therefore, the m5C methylation of the common GCGC
motif in all H. pylori strains may contribute to the high mu-
tation rate of H. pylori and its overall low GC content by
favouring deamination (Supplementary Figure S4B).
Regulation of Outer Membrane Proteins (OMPs) and adher-
ence by m5C methylation in GCGC motifs is strain-specific
OMP genes represent ∼4% of the H. pylori genome (62).
Fourteen OMPs were found to be upregulated in J99-mut
(Supplementary Table S5). Confirmation of the upregula-
tion of OMP genes was obtained using qPCR in J99-mut
(Supplementary Figure S5C, D). We detected either no reg-
ulation or weak upregulation in the other mutated strains
(Supplementary Figure S5C, D), which was in agreement
with the transcriptome data obtained for BCM-300. Only
three of these OMPs were also slightly upregulated in BCM-
300-mut, but the FC was lower than the stringent cut-off of
2 used in the transcriptome analyses. A bacterial adherence
assay based on coincubation of fixed AGS cells with all four
wild type strains and corresponding isogenic GCGC MTase
mutants was performed to test for an adherence phenotype.
Only J99-mut had a significantly higher adherence to the
cells compared to the respective wild type strain, while no
significant differences in adherence were determined for the
rest of the strains (Figure 5C). Taken together, the increased
expression of a number of OMP genes in the absence of
methylation in J99 might contribute to a stronger adherence
of the bacteria to the cells, while this was not observed for
the other tested strains.
GCGC methylation regulates natural competence in H. py-
lori
Natural competence is a hallmark of H. pylori. Compe-
tence is conferred by the ComB system, an unusual type
IV secretion system related to the VirB system of Agrobac-
terium tumefaciens (63). RNA-Seq results identified three
com genes (comB8, comB9 and comEC) that were less tran-
scribed in J99-mut compared to the wild type strain, while
the genes were not found to be differentially regulated in
BCM-300. ComB9 and ComB8 are part of the outer- and
inner-membrane channels of the DNA uptake system, while
ComEC allows the translocation of the DNA through the
inner membrane to the cytoplasm. qPCR demonstrated the
downregulation of these genes in the two additional strains
tested, 26695-mut and H1-mut, in comparison with their re-
spective wild type strains (Supplementary Figures S5A and
S5B).
The DNA uptake capacity of the four MTase-mutated
strains in comparison to the wild types was quantitated by
counting recombinant colonies carrying an antibiotic re-
sistance cassette after standardized transformation exper-
iments (see Materials and Methods). A significant reduc-
tion in the efficiency of transformation to chloramphenicol
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Figure 5. MTase JHP1050 inactivation causes phenotypic effects that vary between strains: natural competence, resistance to copper, and adherence to
host cells. (A) Transformation experiments were performed with 1 g/ml of gDNA. Statistics: Welch‘s unpaired t test, **P < 0.01, ****P < 0.0001, bars:
SD. (B) The growth of J99 wild type, J99-mut, BCM-300 wild type and BCM-300-mut strains was measured 24 h post-inoculation after addition of different
concentrations of copper sulfate to the cultures. Data was normalized to a control culture without copper. Statistics: One-Way ANOVA, **P < 0.01, ***P
< 0.001, ****P < 0.0001, bars: SD. (C) Adherence of H. pylori wild type and mutant strains to fixed AGS cells. Statistics: unpaired t-test, *P < 0.05, bars:
SD.
resistance was observed in the J99, 26695 and H1 mutants
compared to their respective wild type strains, but no dif-
ference was apparent for BCM-300 (Figure 5A). The down-
regulation of these three components of the ComB system
might be sufficient to reduce the competence in three of the
strains.
Loss of m5C methylation of GCGC motifs increases suscepti-
bility to copper
Copper is an essential metal used by H. pylori as a cofactor
in multiple processes and it has been shown, for example,
to be important for colonization (64). However, an excess
of heavy metals can be toxic for the bacterial cells, lead-
ing to the existence of several mechanisms to control cop-
per homeostasis. One of the mechanisms involves the two-
component system CrdR/S. In the presence of copper, the
sensor kinase CrdS phosphorylates the response regulator
CrdR triggering the activation of a copper resistance pro-
tein and a copper efflux complex (65).
The transcriptional regulator gene crdR was less ex-
pressed in both J99 and BCM-300 MTase mutants (Table
2). In both strains, one GCGC motif is located within the
upTSS of the transcriptional regulator, suggesting a direct
regulation via m5C methylation. To test whether the mu-
tated strains were less resistant to copper due to the lower
expression of the crdR gene, we compared the influence of
added copper sulfate on growth in liquid culture between
MTase mutants and wild type strains. The presence of cop-
per caused a clear growth defect of the mutants when com-
pared with the wild type strains, and with a control culture
without added copper (Figure 5B). The results indicate that
m5C methylation within the upTSS is required to ensure suf-
ficient transcription of the transcriptional regulator to pro-
tect against an excess of copper.
DISCUSSION
Most previous studies of R–M systems in Helicobacter py-
lori have focussed on the striking diversity of methylation
patterns and its implications. In contrast to the dozens of
MTases only present in subsets of strains, H. pylori also
possesses few enzymes that are highly conserved between
strains. Here, we have explored the function of one m5C
MTase (JHP1050) that is very highly conserved and that
we predicted to be active in all of a globally representa-
tive collection of 459 H. pylori strains analyzed. The col-
lection included isolates from the most ancestral H. pylori
population, hpAfrica2, and the presence of the MTase in
all H. pylori phylogeographic populations and subpopula-
tions indicates that the gene has been part of the H. pylori
core genome since before the Out of Africa migrations, and
before the cag pathogenicity island was acquired (24). The
cognate REase gene was detected in few strains only, al-
most all of which belong to African H. pylori populations.
This indicates that the REase was lost from the genome very
early in the history of this gastric pathogen. These data in-
dicate a strong selective pressure to maintain the presence
and activity of the MTase, while the REase gene either lost
its function or was completely deleted. The apparent strong
selection of the maintenance of this MTase in the H. py-
lori genome was in striking contrast to the cognate REase
and to the vast majority of R–M systems so far identified in
H. pylori, indicating that the MTase alone is likely to serve
an important function for the bacterium. Since methyla-
tion has been shown to influence gene expression in several
bacterial species, we considered a regulatory function most
likely, and performed global transcriptome analysis using
RNA-Seq.
The results obtained by RNA-Seq analysis of two H. py-
lori wild type strains, J99 and BCM-300, and their respec-
tive MTase mutants confirmed our hypothesis that GCGC
methylation affects the transcription of multiple H. pylori
genes, but we were surprised by the substantial differences
between the two strains. While there were 225 DEGs in
J99, whose transcription was significantly changed in the
MTase mutant, only 29 genes showed an altered expression
in BCM-300, and only 10 DEGs were shared between both
strains.
To better understand the relationship between GCGC
methylation and transcriptional gene regulation, we stud-
ied the correlation between the presence of GCGC mo-
tifs within coding sequences and upstream regulatory se-
quences and the effect of a loss of methylation on transcrip-
tion. When we screened the 500 bp of sequence upstream of
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the start codons of all DEGs for GCGC motifs and com-
pared the results with those obtained for the upstream se-
quences of non-DEGs, we observed that DEGs frequently
contained more than three GCGC motifs while the major-
ity of the non-DEGs had 0 or 1 motifs (Figure 2). Among
the DEGs, the presence of GCGC motifs within the upTSS
was significantly associated with higher fold change (FC)
values (Supplementary Figure S6B). Moreover, there were
more DEGs with higher number of motifs within the cod-
ing sequence than expected when compared with the non-
DEGs (Supplementary Figure S6A). These results are sim-
ilar to reports from Vibrio cholerae, where a significant cor-
relation between differential regulation and the number of
motifs within the coding sequence was reported for a m5C
MTase (21).
Six of the 10 DEGs shared between J99 and BCM-300
contained GCGC motifs within the upTSS. We therefore in-
vestigated the relationship between the presence of a methy-
latable GCGC sequence and gene transcription using site
directed mutagenesis. When the GCGC motif overlapping
the putative promoter of the DEG jhp0832 was changed
to a non-methylated GAGC motif, this caused a down-
regulation of the transcription that was similar to the ef-
fect of MTase inactivation, providing strong evidence that
methylation of the GCGC motif within a promoter se-
quence affects gene transcription. Similar findings were pre-
viously reported for Gm6ACC motifs methylated by the H.
pylori ModH5 MTase, which are involved in the control
of the activity of the flaA promoter in strain P12 (40). We
note that the introduced point mutation itself (in addition
to the absence of methylation) might have an influence on
the promoter activity. We thus introduced the mut2 allele
into a methylase-deficient strain as a control. However, this
strain grew so poorly that reliable qPCR assays could not be
performed, so that this possibility cannot formally be ruled
out. The exact mechanism(s) how methylated sequence mo-
tifs within promoters and most likely also within coding se-
quences influence gene expression in H. pylori is still un-
known. One emerging paradigm is exemplified by the es-
sential cell cycle regulator GcrA from Caulobacter crescen-
tus, a 70 cofactor that binds to almost all 70 promot-
ers, but only induces transcription of genes that harbour
Gm6ANTC methylated sites in their promoters (66).
The 10 DEGs shared by both strains were less expressed
in the absence of methylation. Thus, in contrast to eukary-
otes, where CpG methylation in promoter regions leads
to the silencing of genes, methylation of GCGC sites in
H. pylori promoters enhances transcription. Many of the
shared DEG belong to conserved cellular pathways (i.e. bi-
otin synthesis, Fe(II) uptake, molybdopterin biosynthesis,
bicarbonate and proton production, tRNA modification)
and also include a transcriptional regulator involved in cop-
per resistance. Based on these observations, we propose that
the conserved GCGC-specific MTase directly controls the
expression of those genes involved in various, partially fun-
damental, cellular pathways.
The inactivation of the MTase caused a substantial
growth defect and accelerated conversion to coccoid cells
in H. pylori J99 that were restored to wild type growth in a
complemented strain. The three other wild type strains in-
vestigated did not show a similar growth defect when the
MTase was inactivated. Other phenotypic effects induced
by the MTase inactivation were observed in all or mul-
tiple strains. They included functions important for viru-
lence, such as morphology, competence and adherence to
gastric epithelial cells. The genome diversity of H. pylori,
the distribution of motifs among the genomes and the vari-
able methylomes due to the activity of other MTases must
influence global gene expression. It was demonstrated re-
cently that deletions of two strain-specific MTases, the m5C
MTase M.HpyAVIB (67) and the m4C MTase M2.HpyAII
(22) both also had regulatory effects on the H. pylori tran-
scriptome. While the effects differed widely from those ob-
served for the M.Hpy99III MTase studied here, some genes
were differentially regulated by more than one MTase, sug-
gesting that the effects of different MTases may be inter-
linked. Thus, the strain-specific phenotypes observed in the
absence of m5C methylation in GCGC motifs are likely to
reflect the complex and intrinsic diversity of H. pylori at the
genome, methylome, and transcriptome levels. It is interest-
ing to note that the overrepresentation of GCGC motifs is
far more pronounced in coding sequences, and that H. py-
lori has a strong bias for codons overlapping the GCGC
motif, such as CGC as the by far most common codon for
arginine, and GCG as the second most common codon for
alanine (68). The preference of H. pylori for these codons
may be one reason why a methyltransferase with specificity
for GCGC has evolved to serve such a special function.
While we clearly showed that methylation of a GCGC
motif overlapping the promoter within the upTSS directly
affected transcription, we currently do not understand how
the presence or absence of GCGC methylation can af-
fect so many genes in strain J99, and which mechanisms
contribute to strain-variable effects. It seems likely that at
least some of the massive changes observed in strain J99
are indirect effects, e.g. resulting from the downregulation
of genes affecting growth. The effect of MTase inactiva-
tion in any given strain is likely to be the net outcome of
interlinked direct and indirect regulatory effects that will
need to be further elucidated in the future. Methylation
may affect DNA topology, which has a strong influence on
genome-wide gene regulation, causing secondary effects on
the global transcriptome by a plethora of mechanisms. For
example, modifications of DNA topology affect the bind-
ing of DnaA to the OriC2 of H. pylori (69). The flaA pro-
moter, whose expression is governed mainly by the tran-
scription factor 28, was shown by extensive mutagenesis
to be strongly modulated in a topology-dependent manner
during the growth phase (70). This also fits to the previ-
ously described methylation-dependent indirect regulation
of the flaA promoter (40). Finally, several direct and in-
direct means of methylation-mediated regulatory mecha-
nisms might not exclude each other, generating an intri-
cate network fine-tuning gene expression, which depends on
genome-wide methylation.
CONCLUSION
Global changes in m5C DNA methylation patterns in H. py-
lori affect the expression of several genes directly or indi-
rectly, which results in both strain-independent (conserved)
and strain-dependent effects. Motifs situated within pro-
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moter sequences have a direct effect on transcription, while
surrounding motifs might modulate the expression indi-
rectly by, for example, altering the topology of the DNA.
Furthermore, methylation of GCGC target sequences en-
sures adequate levels of transcription for numerous genes
involved in metabolic pathways, competence and adherence
to gastric epithelial cells.
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Supplementary Figure 1. Localization of the jhp1050 MTase gene and flanking genes in the genomes of four H. pylori strains. The
repeat sequences flanking the REase gene and homologous sequences downstream of orphan MTase genes are shown. Strain ID
(bold and underlined), populations (in parentheses) and the predicted promoters (arrows) are also depicted.
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Supplementary Figure 2. Restriction analysis of GCGC methylation state using HhaI restriction enzyme. Wild type strains, two
MTase‐deficient mutant clones (‐mut1/‐mut2) and the complemented strains (26695‐compl) were tested. Complete restriction
of the gDNA can be observed for the mutated strains when the restriction enzyme was added. Methylation of GCGC motifs in
the wild type and complemented strains protects the DNA from digestion. L: ladder (1 kb), ‐: HhaI not added, +: HhaI added.
* Two different versions of the complemented strains were tested (called in this figure –compl0 and ‐compl). The 26695‐compl
strain is the complemented strain in 26695‐mut expressing the MTase gene under the urease promoter and was used
thoughout the manuscript. The construct labelled –compl0 was not further used in the manuscript.
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Supplementary Figure 3. qPCRs of transcript amounts of the jhp1050 MTase gene. A) in the
four wild type strains used in the study. B) in the J99 and 26695 wild type strains and respective
complementation strains J99‐compl and 26695‐compl. The transcript amounts are given in pg
per µl cDNA and were normalized against the 16S rRNA transcripts in the respective strains, **
(p < 0.01).
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Supplementary Figure 4. Distribution of GCGC motifs in 4 H. pylori genomes and frequencies of single base changes for
cytosines located within and outside of different methylatable motifs and at methylatable and non‐methylatable positions
within one motif. A) Distribution of motifs within every 50 kb of genomic sequence. The two regions with a lower density of
motifs represent the cagPAI and the plasticity zone (PZ). B) Deamination of C to T and changes of C to other bases within
several motifs targeted by m5C MTases and non‐m5C methylated motifs. Conversion of methylated and non‐methylated Cs to
another base that are analysed in each case, are colored in green. Unpaired t‐test with Welsh correction, **** (p < 0.0001) **
(p < 0.01).
A) B)
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Supplementary Figure 5. qPCRs performed to verify RNA‐Seq results Transcript amounts are given in pg per µl cDNA and were
normalized against 16S rRNA transcript for each strain. Statistics: 2‐way ANOVA, * (p < 0.05), ** (p < 0.01), *** (p < 0.001), ****
(p < 0.0001)
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Supplementary Figure 6. Percentage of genes with more or less GCGC motifs than expected and the influence of the
presence of GCGC motifs within the 50 bp sequence upstream of the TSS (upTSS) on transcription (FC). A) Ratio of
observed motifs vs expected motifs within DEGs and non‐DEGs. A value >1 means more motifs observed than expected,
while a value <1 means fewer observed motifs than expected. B) Transcriptional regulation (fold change calculated from
RNA‐Seq data) for DEGs with GCGC motifs present within the upTSS (+) or without GCGC motifs within the upTSS (‐). Test:
Mann‐Whitney, bars: 95% CI, * (p < 0.05).
A) B)
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Supplementary Figure 7. Gram staining of H. pylori strains. A) Gram staining after 9 hours of liquid culture.
Note that J99‐mut entered an early coccoid state when compared with J99‐wt and the complemented strain. B)
Staining after growth for 24 hours. Note that only J99‐mut underwent a morphological change from helical
shape to coccoid, while the rest of the strains maintained the helical shape.
A) B)
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Supplementary Table 1. List of the strains analyzed in the study. 
The MTase gene (jhp1050 ) and the flanking genes were always found in the genome sequences with the exception of the REase gene (jhp1049 ), 
which was present only in 61 strains.
NCBI Accession numbers, Strains ID, Strain Population, presence (yes) or absence (no) of the genes; and the origin of the sequences
(draft, WGS = whole genome sequence) are displayed on the table.
# Accession No. Strain ID Population jhp1046 jhp1047 jhp1048 jhp1049 jhp1050 jhp1051 jhp1052 Sequence
1 CBOR01 SA253C hpAfrica2 yes yes yes yes yes yes yes draft
2 CBOJ01 SA253A hpAfrica2 yes yes yes yes yes yes yes draft
3 AVNI01 SouthAfrica50 hpAfrica2 yes yes yes yes yes yes yes draft
4 CBMV01 SA29A hpAfrica2 yes yes yes yes yes yes yes draft
5 CBQN01 SA160A hpAfrica2 yes yes yes yes yes yes yes draft
6 CBQF01 SA160C hpAfrica2 yes yes yes yes yes yes yes draft
7 CBPG01 SA172C hpAfrica2 yes yes yes yes yes yes yes draft
8 CBPB01 SA47C hpAfrica2 yes yes yes yes yes yes yes draft
9 CBOT01 SA47A hpAfrica2 yes yes yes yes yes yes yes draft
10 CBNN01 SA40A hpAfrica2 yes yes yes yes yes yes yes draft
11 CBQH01 SA169A hpAfrica2 yes yes yes yes yes yes yes draft
12 CBPI01 SA34A hpAfrica2 yes yes yes yes yes yes yes draft
13 CBOK01 SA169C hpAfrica2 yes yes yes yes yes yes yes draft
14 CBQI01 SA36C hpAfrica2 yes yes yes yes yes yes yes draft
15 CBPS01 SA174A hpAfrica2 yes yes yes yes yes yes yes draft
16 CBPO01 SA175A hpAfrica2 yes yes yes yes yes yes yes draft
17 CBOI01 SA175C hpAfrica2 yes yes yes yes yes yes yes draft
18 CBQC01 SA251A hpAfrica2 yes yes yes yes yes yes yes draft
19 CBPA01 SA166A hpAfrica2 yes yes yes yes yes yes yes draft
20 CBOZ01 SA251C hpAfrica2 yes yes yes yes yes yes yes draft
21 CBOX01 SA144C hpAfrica2 yes yes yes yes yes yes yes draft
22 CBNJ01 SA144A hpAfrica2 yes yes yes yes yes yes yes draft
23 CBMW01 SA303C hpAfrica2 yes yes yes yes yes yes yes draft
24 CBOH01 SA155C hpAfrica2 yes yes yes yes yes yes yes draft
25 CBNZ01 SA155A hpAfrica2 yes yes yes yes yes yes yes draft
26 CBPD01 SA233C hpAfrica2 yes yes yes yes yes yes yes draft
27 CBMX01 SA233A hpAfrica2 yes yes yes yes yes yes yes draft
28 CBPW01 SA194A hpAfrica2 yes yes yes yes yes yes yes draft
29 CBNK01 SA194C hpAfrica2 yes yes yes yes yes yes yes draft
30 CBPN01 SA40C hpAfrica2 yes yes yes no yes yes yes draft
31 CBNY01 SA34C hpAfrica2 yes yes yes yes yes yes yes draft
32 NC_022130.1 SouthAfrica20 hpAfrica2 yes yes yes yes yes yes yes WGS
33 NC_017361.1 SouthAfrica7 hpAfrica2 yes yes yes yes yes yes yes WGS
34 AONK01 UM018 hpAsia2 yes yes yes no yes yes yes draft
35 AJFA02 NAB47 hpAsia2 yes yes yes no yes yes yes draft
36 AONL01 UM054 hpAsia2 yes yes yes no yes yes yes draft
37 AONJ01 NAK7 hpAsia2 yes yes yes no yes yes yes draft
38 AUSN01 UM067 hpAsia2 yes yes yes no yes yes yes draft
39 CBQE01 SA222A hpAsia2 yes yes yes no yes yes yes draft
40 CBON01 SA222C hpAsia2 yes yes yes no yes yes yes draft
41 NC_017376.1 SNT49 hpAsia2 yes yes yes no yes yes yes WGS
42 NZ_CP006820.1 oki102 hpAsia2 yes yes yes no yes yes yes WGS
43 NZ_CP006827.1 oki898 hpAsia2 yes yes yes no yes yes yes WGS
44 NZ_CP006824.1 oki422 hpAsia2 yes yes yes no yes yes yes WGS
45 NZ_CP006821.1 oki112 hpAsia2 yes yes yes no yes yes yes WGS
46 NC_017372.1 India7 hpAsia2 yes yes yes no yes yes yes WGS
47 NZ_CP007605.1 BM012B hpAsia2 yes yes yes no yes yes yes WGS
48 NC_022911.1 BM012S hpAsia2 yes yes yes no yes yes yes WGS
49 NC_022886.1 BM012A hpAsia2 yes yes yes no yes yes yes WGS
50 AMOR01 R030b hpEurope yes yes yes no yes yes yes draft
51 AKPC01 Hp H-11 hpEurope yes yes yes no yes yes yes draft
52 AOTW01 Hp A-11 hpEurope yes yes yes no yes yes yes draft
53 AKPU01 Hp P-30 hpEurope yes yes yes no yes yes yes draft
54 AFAO01 B45 hpEurope yes yes yes no yes yes yes draft
55 AKOW01 Hp A-27 hpEurope yes yes yes yes yes yes yes draft
56 AKOV01 Hp A-26 hpEurope yes yes yes no yes yes yes draft
57 AKPQ01 Hp P-16 hpEurope yes yes yes no yes yes yes draft
58 AKQJ01 Hp P-15b hpEurope yes yes yes no yes yes yes draft
59 AKPX01 Hp P-74 hpEurope yes yes yes no yes yes yes draft
60 AKPR01 Hp P-23 hpEurope yes yes yes no yes yes yes draft
61 AKPP01 Hp P-15 hpEurope yes yes yes no yes yes yes draft
62 AKOH01 Hp H-27 hpEurope yes yes yes no yes yes yes draft
63 AKNW01 NQ4044 hpEurope yes yes yes no yes yes yes draft
64 AKNS01 NQ4200 hpEurope yes yes yes no yes yes yes draft
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65 ABSY01 B128 hpEurope yes yes yes no yes yes yes draft
66 CBQM01 SA164C hpEurope yes yes yes no yes yes yes draft
67 CBQK01 SA164A hpEurope yes yes yes no yes yes yes draft
68 CBQJ01 SA165C hpEurope yes yes yes no yes yes yes draft
69 CBQD01 SA165A hpEurope yes yes yes no yes yes yes draft
70 CBPC01 SA171C hpEurope yes yes yes no yes yes yes draft
71 CBOY01 SA172A hpEurope yes yes yes no yes yes yes draft
72 CBOA01 SA171A hpEurope yes yes yes no yes yes yes draft
73 AKNV01 NQ4053 hpEurope yes yes yes no yes yes yes draft
74 AKNR01 NQ4216 hpEurope yes yes yes no yes yes yes draft
75 CBOF01 SA302A hpEurope yes yes yes no yes yes yes draft
76 CBNA01 SA302C hpEurope yes yes yes no yes yes yes draft
77 CADN01 NQ4191 hpEurope yes yes yes no yes yes yes draft
78 CADM01 NQ1671 hpEurope yes yes yes no yes yes yes draft
79 CADL01 NQ367 hpEurope yes yes yes no yes yes yes draft
80 CADF01 NQ1712 hpEurope yes yes yes no yes yes yes draft
81 CADE01 NQ315 hpEurope yes yes yes no yes yes yes draft
82 ASYT01 PZ5026 hpEurope yes yes yes no yes yes yes draft
83 AKNZ01 NQ4110 hpEurope yes yes yes no yes yes yes draft
84 CADK01 NQ4060 hpEurope yes yes yes no yes yes yes draft
85 CADJ01 NQ1707 hpEurope yes yes yes no yes yes yes draft
86 CADI01 NQ392 hpEurope yes yes yes no yes yes yes draft
87 AMOX01 R055a hpEurope yes yes yes no yes yes yes draft
88 AKNT01 NQ4228 hpEurope yes yes yes no yes yes yes draft
89 AKNX01 NQ4076 hpEurope yes yes yes no yes yes yes draft
90 AWNG01 X47-2AL hpEurope yes yes yes no yes yes yes draft
91 AOTV01 UMB_G1 hpEurope yes yes yes no yes yes yes draft
92 AKOQ01 Hp H-45 hpEurope yes yes yes no yes yes yes draft
93 AMOV01 R038b hpEurope yes yes yes no yes yes yes draft
94 AMYU01 A45 hpEurope yes yes yes no yes yes yes draft
95 CBKZ01 HPARG8G hpEurope yes yes yes no yes yes yes draft
96 AONO01 UM045 hpEurope yes yes yes no yes yes yes draft
97 AMOT01 R036d hpEurope yes yes yes no yes yes yes draft
98 AKOT01 Hp A-14 hpEurope yes yes yes no yes yes yes draft
99 AJGJ02 NAD1 hpEurope yes yes yes no yes yes yes draft
100 CBQA01 SA221A hpEurope yes yes yes no yes yes yes draft
101 CBPT01 SA221C hpEurope yes yes yes no yes yes yes draft
102 AWUL01 CG-IMSS-2012 hpEurope yes yes yes no yes yes yes draft
103 AKNY01 NQ4161 hpEurope yes yes yes no yes yes yes draft
104 AMOS01 R32b hpEurope yes yes yes no yes yes yes draft
105 AMOY01 R056a hpEurope yes yes yes no yes yes yes draft
106 AMOW01 R046Wa hpEurope yes yes yes no yes yes yes draft
107 AMOU01 R037c hpEurope yes yes yes no yes yes yes draft
108 AMOQ01 R018c hpEurope yes yes yes no yes yes yes draft
109 AKOI01 Hp H-28 hpEurope yes yes yes no yes yes yes draft
110 AKOC01 Hp A-9 hpEurope yes yes yes no yes yes yes draft
111 AKNU01 NQ4099 hpEurope yes yes yes no yes yes yes draft
112 CBOO01 SA37A hpEurope yes yes yes no yes yes yes draft
113 AYHQ01 E48 hpEurope yes yes yes no yes yes yes draft
114 AIHW01 P79 hpEurope yes yes yes no yes yes yes draft
115 AKOO01 Hp H-43 hpEurope yes yes yes no yes yes yes draft
116 CAHX01 N6 hpEurope yes yes yes no yes yes yes draft
117 AIHX01 NCTC 11637 hpEurope yes yes yes no yes yes yes draft
118 AKPA01 Hp H-9 hpEurope yes yes yes no yes yes yes draft
119 CBPK01 SA213C hpEurope yes yes yes no yes yes yes draft
120 CBOU01 SA173A hpEurope yes yes yes no yes yes yes draft
121 CBOM01 SA213A hpEurope yes yes yes no yes yes yes draft
122 CBNG01 SA173C hpEurope yes yes yes no yes yes yes draft
123 JSXX01 173/00 hpEurope yes yes yes yes yes yes yes draft
124 CCMT01 H3016 hpEurope yes yes yes no yes yes yes draft
125 CBOP01 SA37C hpEurope yes yes yes no yes yes yes draft
126 CADG01 NQ352 hpEurope yes yes yes yes yes yes yes draft
127 NC_014555.1 PeCan4 hpEurope yes yes yes no yes yes yes WGS
128 NC_012973.1 B38 hpEurope yes yes yes no yes yes yes WGS
129 NC_008086.1 HPAG1 hpEurope yes yes yes no yes yes yes WGS
130 NZ_AP014523.1 NY40 hpEurope yes yes yes no yes yes yes WGS
131 NZ_CP007604.1 BM013A hpEurope yes yes yes no yes yes yes WGS
132 NZ_CP007606.1 BM013B hpEurope yes yes yes no yes yes yes WGS
133 NC_014256.1 B8 hpEurope yes yes yes no yes yes yes WGS
134 NC_017063.1 ELS37 hpEurope yes yes yes no yes yes yes WGS
135 NC_017733.1 HUP-B14 hpEurope yes yes yes no yes yes yes WGS
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136 NC_014560.1 SJM180 hpEurope yes yes yes no yes yes yes WGS
137 NZ_CP007603.1 J166 hpEurope yes yes yes no yes yes yes WGS
138 NC_011333.1 G27 hpEurope yes yes yes no yes yes yes WGS
139 NC_017362.1 Lithuania75 hpEurope yes yes yes no yes yes yes WGS
140 NC_000915.1 26695 hpEurope yes yes yes no yes yes yes WGS
141 NC_021217.3 UM037 hpEurope yes yes yes no yes yes yes WGS
142 NC_011498.1 P12 hpEurope yes yes yes yes yes yes yes WGS
143 not published CAM-105A1 hpNEAfrica yes yes yes no yes yes yes draft
144 not published CAM-117A1 hpNEAfrica yes yes yes no yes yes yes draft
145 not published CAM-21A1 hpNEAfrica yes yes yes no yes yes yes draft
146 not published CAM-20A1 hpNEAfrica yes yes yes no yes yes yes draft
147 not published CAM-9A1 hpNEAfrica yes yes yes no yes yes yes draft
148 not published CAM-60A1 hpNEAfrica yes yes yes no yes yes yes draft
149 not published CAM-58A1 hpNEAfrica yes yes yes no yes yes yes draft
150 not published CAM-40A1 hpNEAfrica yes yes yes no yes yes yes draft
151 not published CAM-34A1 hpNEAfrica yes yes yes no yes yes yes draft
152 not published CAM-104A1 hpNEAfrica yes yes yes no yes yes yes draft
153 not published CAM-77C1 hpNEAfrica yes yes yes no yes yes yes draft
154 not published CAM-5A1 hpNEAfrica yes yes yes no yes yes yes draft
155 not published CAM-120A1 hpNEAfrica yes yes yes no yes yes yes draft
156 not published CAM-109A1 hpNEAfrica yes yes yes no yes yes yes draft
157 not published CAM-94A1 hpNEAfrica yes yes yes no yes yes yes draft
158 not published CAM-188A2 hpNEAfrica yes yes yes no yes yes yes draft
159 not published CAM-48A1 hpNEAfrica yes yes yes no yes yes yes draft
160 not published CAM-110A1 hpNEAfrica yes yes yes no yes yes yes draft
161 not published CAM-118A1 hpNEAfrica yes yes yes no yes yes yes draft
162 not published CAM-189C1 hpNEAfrica yes yes yes no yes yes yes draft
163 not published CAM-189A1 hpNEAfrica yes yes yes no yes yes yes draft
164 not published CAM-153A1 hpNEAfrica yes yes yes no yes yes yes draft
165 not published CAM-14A1 hpNEAfrica yes yes yes no yes yes yes draft
166 not published CAM-133A1 hpNEAfrica yes yes yes no yes yes yes draft
167 not published CAM-30A1 hpNEAfrica yes yes yes no yes yes yes draft
168 not published CAM-132A1 hpNEAfrica yes yes yes no yes yes yes draft
169 not published CAM-107A1 hpNEAfrica yes yes yes no yes yes yes draft
170 not published CAM-25A1 hpNEAfrica yes yes yes no yes yes yes draft
171 not published CAM-125A1 hpNEAfrica yes yes yes no yes yes yes draft
172 not published CAM-106A1 hpNEAfrica yes yes yes no yes yes yes draft
173 not published CAM-96C1 hpNEAfrica yes yes yes no yes yes yes draft
174 not published CAM-96A1 hpNEAfrica yes yes yes no yes yes yes draft
175 not published CAM-37A1 hpNEAfrica yes yes yes no yes yes yes draft
176 not published CAM-147A1 hpNEAfrica yes yes yes no yes yes yes draft
177 not published CAM-121A1 hpNEAfrica yes yes yes no yes yes yes draft
178 not published CAM-144A1 hpNEAfrica yes yes yes no yes yes yes draft
179 not published CAM-141A1 hpNEAfrica yes yes yes no yes yes yes draft
180 not published CAM-8A1 hpNEAfrica yes yes yes no yes yes yes draft
181 not published CAM-67C1 hpNEAfrica yes yes yes no yes yes yes draft
182 not published CAM-67A1 hpNEAfrica yes yes yes no yes yes yes draft
183 not published CAM-50A1 hpNEAfrica yes yes yes no yes yes yes draft
184 not published CAM-39A1 hpNEAfrica yes yes yes no yes yes yes draft
185 not published CAM-35A1 hpNEAfrica yes yes yes no yes yes yes draft
186 not published CAM-33A1 hpNEAfrica yes yes yes no yes yes yes draft
187 not published CAM-55A1 hpNEAfrica yes yes yes no yes yes yes draft
188 not published CAM-7A1 hpNEAfrica yes yes yes no yes yes yes draft
189 not published CAM-77A1 hpNEAfrica yes yes yes no yes yes yes draft
190 not published CAM-69C1 hpNEAfrica yes yes yes no yes yes yes draft
191 not published CAM-69A1 hpNEAfrica yes yes yes no yes yes yes draft
192 not published CAM-31A1 hpNEAfrica yes yes yes no yes yes yes draft
193 not published CAM-165C1 hpNEAfrica yes yes yes no yes yes yes draft
194 not published CAM-165A1 hpNEAfrica yes yes yes no yes yes yes draft
195 not published CAM-146A1 hpNEAfrica yes yes yes no yes yes yes draft
196 not published CAM-140A1 hpNEAfrica yes yes yes no yes yes yes draft
197 not published CAM-135A1 hpNEAfrica yes yes yes no yes yes yes draft
198 not published CAM-124A1 hpNEAfrica yes yes yes no yes yes yes draft
199 not published CAM-116A1 hpNEAfrica yes yes yes no yes yes yes draft
200 not published CAM-108A1 hpNEAfrica yes yes yes no yes yes yes draft
201 not published CAM-94C1 hpNEAfrica yes yes yes no yes yes yes draft
202 not published CAM-38A1 hpNEAfrica yes yes yes no yes yes yes draft
203 not published CAM-119A1 hpNEAfrica yes yes yes no yes yes yes draft
204 not published CAM-22A1 hpNEAfrica yes yes yes no yes yes yes draft
205 not published CAM-24A1 hpNEAfrica yes yes yes no yes yes yes draft
206 not published CAM-23A1 hpNEAfrica yes yes yes no yes yes yes draft
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207 not published CAM-190C1 hpNEAfrica yes yes yes no yes yes yes draft
208 not published CAM-190A1 hpNEAfrica yes yes yes no yes yes yes draft
209 not published CAM-193C1 hpNEAfrica yes yes yes no yes yes yes draft
210 not published CAM-193A1 hpNEAfrica yes yes yes no yes yes yes draft
211 not published CAM-149A1 hpNEAfrica yes yes yes no yes yes yes draft
212 not published CAM-126A1 hpNEAfrica yes yes yes no yes yes yes draft
213 not published CAM-41A1 hpNEAfrica yes yes yes no yes yes yes draft
214 ALWV01 Sahul64 hpSahul yes yes yes no yes yes yes draft
215 not published PNGhigh12A hpSahul yes yes yes no yes yes yes draft
216 not published HUI1769 hspAmerind yes yes yes no yes yes yes draft
217 NC_019560.1 Aklavik117 hspAmerind yes yes yes yes yes yes yes WGS
218 NC_017359.1 Sat464 hspAmerind yes yes yes no yes yes yes WGS
219 NC_010698.2 Shi470 hspAmerind yes yes yes no yes yes yes WGS
220 NC_019563.1 Aklavik86 hspAmerind yes yes yes no yes yes yes WGS
221 NC_017740.1 Shi169 hspAmerind yes yes yes no yes yes yes WGS
222 NC_017739.1 Shi417 hspAmerind yes yes yes no yes yes yes WGS
223 NC_017741.1 Shi112 hspAmerind yes yes yes no yes yes yes WGS
224 NC_017358.1 Cuz20 hspAmerind yes yes yes no yes yes yes WGS
225 NC_017378.1 Puno120 hspAmerind yes yes yes no yes yes yes WGS
226 NC_017355.1 v225d hspAmerind yes yes yes no yes yes yes WGS
227 AUSK01 UM023 hspEAsia yes yes yes no yes yes yes draft
228 AKHV02 GC26 hspEAsia yes yes yes no yes yes yes draft
229 JAAA01 HLJ039 hspEAsia yes yes yes no yes yes yes draft
230 AONM01 UM007 hspEAsia yes yes yes no yes yes yes draft
231 ANIO01 D33 hspEAsia yes yes yes no yes yes yes draft
232 AKNJ01 CPY1124 hspEAsia yes yes yes no yes yes yes draft
233 AUSL01 UM038 hspEAsia yes yes yes no yes yes yes draft
234 AOTT01 CPY1662 hspEAsia yes yes yes no yes yes yes draft
235 AKNM01 CPY3281 hspEAsia yes yes yes no yes yes yes draft
236 AKNK01 CPY1313 hspEAsia yes yes yes no yes yes yes draft
237 ALKB01 HLJHP271 hspEAsia yes yes yes no yes yes yes draft
238 CADD01 8A3 hspEAsia yes yes yes no yes yes yes draft
239 AUSM01 UM065 hspEAsia yes yes yes no yes yes yes draft
240 AKNL01 CPY1962 hspEAsia yes yes yes no yes yes yes draft
241 AKHQ02 FD568 hspEAsia yes yes yes no yes yes yes draft
242 CADC01 BCS100 H1 hspEAsia yes yes yes no yes yes yes draft
243 AKNN01 CPY6081 hspEAsia yes yes yes no yes yes yes draft
244 JDVU01 wls-5-5 hspEAsia yes yes yes no yes yes yes draft
245 AKNQ01 CPY6311 hspEAsia yes yes yes no yes yes yes draft
246 AKNP01 CPY6271 hspEAsia yes yes yes no yes yes yes draft
247 ALKC01 HLJHP253 hspEAsia yes yes yes no yes yes yes draft
248 AKHO02 FD506 hspEAsia yes yes yes no yes yes yes draft
249 AONN01 UM034 hspEAsia yes yes yes no yes yes yes draft
250 AUSR01 UM111 hspEAsia yes yes yes no yes yes yes draft
251 AUSP01 UM085 hspEAsia yes yes yes no yes yes yes draft
252 AKNO01 CPY6261 hspEAsia yes yes yes no yes yes yes draft
253 ALKA01 HLJHP256 hspEAsia yes yes yes no yes yes yes draft
254 AKHR02 FD577 hspEAsia yes yes yes no yes yes yes draft
255 AUSQ01 UM077 hspEAsia yes yes yes no yes yes yes draft
256 ABSX01 98-10 hspEAsia yes yes yes no yes yes yes draft
257 ALJI01 HLJHP193 hspEAsia yes yes yes no yes yes yes draft
258 NC_020508.1 OK113 hspEAsia yes yes yes no yes yes yes WGS
259 NC_017367.1 F57 hspEAsia yes yes yes no yes yes yes WGS
260 NC_017368.1 F16 hspEAsia yes yes yes no yes yes yes WGS
261 NZ_CP010013.1 Hp238 hspEAsia yes yes yes no yes yes yes WGS
262 NC_017360.1 35A hspEAsia yes yes yes no yes yes yes WGS
263 NC_017926.1 XZ274 hspEAsia yes yes yes no yes yes yes WGS
264 AP014711.1 ML2 hspEAsia yes yes yes no yes yes yes WGS
265 NC_017375.1 83 hspEAsia yes yes yes no yes yes yes WGS
266 AP014712.1 ML3 hspEAsia yes yes yes no yes yes yes WGS
267 NC_021882.2 UM298 hspEAsia yes yes yes no yes yes yes WGS
268 NC_021216.3 UM299 hspEAsia yes yes yes no yes yes yes WGS
269 NC_021215.3 UM032 hspEAsia yes yes yes no yes yes yes WGS
270 NC_017366.1 F32 hspEAsia yes yes yes no yes yes yes WGS
271 AP014710.1 ML1 hspEAsia yes yes yes no yes yes yes WGS
272 NC_017382.1 51 hspEAsia yes yes yes no yes yes yes WGS
273 NC_017379.1 Puno135 hspEAsia yes yes yes no yes yes yes WGS
274 NZ_CP006822.1 oki128 hspEAsia yes yes yes no yes yes yes WGS
275 NC_017354.1 52 hspEAsia yes yes yes no yes yes yes WGS
276 NC_020509.1 OK310 hspEAsia yes yes yes no yes yes yes WGS
277 NC_021218.3 UM066 hspEAsia yes yes yes no yes yes yes WGS
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278 NZ_CP006826.1 oki828 hspEAsia yes yes yes no yes yes yes WGS
279 NZ_CP006825.1 oki673 hspEAsia yes yes yes no yes yes yes WGS
280 NZ_CP006823.1 oki154 hspEAsia yes yes yes no yes yes yes WGS
281 NC_017365.1 F30 hspEAsia yes yes yes no yes yes yes WGS
282 not published inma52 hspMaori yes yes yes yes yes yes yes draft
283 CBOD01 SA46C hspSAfrica yes yes yes yes yes yes yes draft
284 CBNV01 SA46A hspSAfrica yes yes yes yes yes yes yes draft
285 CBQG01 SA300A hspSAfrica yes yes yes yes yes yes yes draft
286 CBPY01 SA158C hspSAfrica yes yes yes yes yes yes yes draft
287 CBPR01 SA45C hspSAfrica yes yes yes yes yes yes yes draft
288 CBPM01 SA31C hspSAfrica yes yes yes yes yes yes yes draft
289 CBPL01 SA300C hspSAfrica yes yes yes yes yes yes yes draft
290 CBOW01 SA163C hspSAfrica yes yes yes yes yes yes yes draft
291 CBOQ01 SA210C hspSAfrica yes yes yes yes yes yes yes draft
292 CBOL01 SA158A hspSAfrica yes yes yes yes yes yes yes draft
293 CBOG01 SA163A hspSAfrica yes yes yes yes yes yes yes draft
294 CBNW01 SA210A hspSAfrica yes yes yes yes yes yes yes draft
295 CBNU01 SA35C hspSAfrica yes yes yes yes yes yes yes draft
296 CBNE01 SA35A hspSAfrica yes yes yes yes yes yes yes draft
297 CBNB01 SA45A hspSAfrica yes yes yes yes yes yes yes draft
298 CBQB01 SA30C hspSAfrica yes yes yes no yes yes yes draft
299 CBPQ01 SA30A hspSAfrica yes yes yes no yes yes yes draft
300 CBPJ01 SA157C hspSAfrica yes yes yes no yes yes yes draft
301 CBNF01 SA157A hspSAfrica yes yes yes no yes yes yes draft
302 CBNH01 SA226A hspSAfrica yes yes yes no yes yes yes draft
303 CBPV01 SA156C hspSAfrica yes yes yes yes yes yes yes draft
304 CBNR01 SA156A hspSAfrica yes yes yes yes yes yes yes draft
305 CBQL01 SA170C hspSAfrica yes yes yes no yes yes yes draft
306 CBMZ01 SA170A hspSAfrica yes yes yes no yes yes yes draft
307 CBPZ01 SA146A hspSAfrica yes yes yes no yes yes yes draft
308 CBPF01 SA146C hspSAfrica yes yes yes no yes yes yes draft
309 AKQN01 Hp M1 hspWAfrica yes yes yes no yes yes yes draft
310 AKOG01 Hp H-24 hspWAfrica yes yes yes no yes yes yes draft
311 APDL01 GAM245Ai hspWAfrica yes yes yes yes yes yes yes draft
312 AKPO01 Hp P-13 hspWAfrica yes yes yes no yes yes yes draft
313 AKPN01 Hp P-11 hspWAfrica yes yes yes no yes yes yes draft
314 APDA01 GAM114Ai hspWAfrica yes yes yes yes yes yes yes draft
315 AKOJ01 Hp H-29 hspWAfrica yes yes yes no yes yes yes draft
316 AKPI01 Hp P-1 hspWAfrica yes yes yes no yes yes yes draft
317 APED01 GAM80Ai hspWAfrica yes yes yes yes yes yes yes draft
318 APDM01 GAM246Ai hspWAfrica yes yes yes no yes yes yes draft
319 APDF01 GAM120Ai hspWAfrica yes yes yes no yes yes yes draft
320 AKQF01 Hp H-5b hspWAfrica yes yes yes no yes yes yes draft
321 AKPV01 Hp P-41 hspWAfrica yes yes yes no yes yes yes draft
322 AKOP01 Hp H-44 hspWAfrica yes yes yes no yes yes yes draft
323 APDD01 GAM118Bi hspWAfrica yes yes yes no yes yes yes draft
324 APDZ01 GAM268Bii hspWAfrica yes yes yes no yes yes yes draft
325 APDT01 GAM260ASi hspWAfrica yes yes yes no yes yes yes draft
326 APDS01 GAM254Ai hspWAfrica yes yes yes no yes yes yes draft
327 AKPF01 Hp H-21 hspWAfrica yes yes yes no yes yes yes draft
328 APDX01 GAM264Ai hspWAfrica yes yes yes no yes yes yes draft
329 AKOL01 Hp H-36 hspWAfrica yes yes yes no yes yes yes draft
330 AKOZ01 Hp H-6 hspWAfrica yes yes yes yes yes yes yes draft
331 AKOE01 Hp A-20 hspWAfrica yes yes yes no yes yes yes draft
332 APDW01 GAM263BFi hspWAfrica yes yes yes no yes yes yes draft
333 AKON01 Hp H-42 hspWAfrica yes yes yes no yes yes yes draft
334 CADH01 NQ1701 hspWAfrica yes yes yes yes yes yes yes draft
335 AOTU01 CCHI 33 hspWAfrica yes yes yes no yes yes yes draft
336 AKPW01 Hp P-62 hspWAfrica yes yes yes no yes yes yes draft
337 AKPK01 Hp P-3 hspWAfrica yes yes yes no yes yes yes draft
338 AKOM01 Hp H-41 hspWAfrica yes yes yes no yes yes yes draft
339 APER01 HP250ASi hspWAfrica yes yes yes no yes yes yes draft
340 APEP01 HP250AFiii hspWAfrica yes yes yes no yes yes yes draft
341 APEM01 GAMchJs136i hspWAfrica yes yes yes no yes yes yes draft
342 APDQ01 GAM252Bi hspWAfrica yes yes yes no yes yes yes draft
343 APDP01 GAM250T hspWAfrica yes yes yes no yes yes yes draft
344 AKOF01 Hp H-16 hspWAfrica yes yes yes no yes yes yes draft
345 AKOA01 Hp A-4 hspWAfrica yes yes yes no yes yes yes draft
346 ANFP01 GAM100Ai hspWAfrica yes yes yes no yes yes yes draft
347 CBPX01 SA220C hspWAfrica yes yes yes no yes yes yes draft
348 CBND01 SA220A hspWAfrica yes yes yes no yes yes yes draft
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349 APDE01 GAM119Bi hspWAfrica yes yes yes no yes yes yes draft
350 AKPS01 Hp P-25 hspWAfrica yes yes yes no yes yes yes draft
351 AKPM01 Hp P-8 hspWAfrica yes yes yes no yes yes yes draft
352 AKPJ01 Hp P-2 hspWAfrica yes yes yes no yes yes yes draft
353 AKOD01 Hp A-17 hspWAfrica yes yes yes no yes yes yes draft
354 AKOB01 Hp A-5 hspWAfrica yes yes yes no yes yes yes draft
355 CBPH01 SA301A hspWAfrica yes yes yes no yes yes yes draft
356 CBOS01 SA162A hspWAfrica yes yes yes no yes yes yes draft
357 CBNX01 SA227A hspWAfrica yes yes yes no yes yes yes draft
358 CBNT01 SA301C hspWAfrica yes yes yes no yes yes yes draft
359 CBNQ01 SA162C hspWAfrica yes yes yes no yes yes yes draft
360 CBNL01 SA227C hspWAfrica yes yes yes no yes yes yes draft
361 APFC01 HP260Bi hspWAfrica yes yes yes no yes yes yes draft
362 APEG01 GAM93Bi hspWAfrica yes yes yes no yes yes yes draft
363 APDU01 GAM260Bi hspWAfrica yes yes yes no yes yes yes draft
364 AKPD01 Hp H-18 hspWAfrica yes yes yes no yes yes yes draft
365 AKOS01 Hp A-8 hspWAfrica yes yes yes no yes yes yes draft
366 APDH01 GAM210Bi hspWAfrica yes yes yes no yes yes yes draft
367 APDG01 GAM121Aii hspWAfrica yes yes yes no yes yes yes draft
368 AOTX01 Hp H-1 hspWAfrica yes yes yes no yes yes yes draft
369 AKPT01 Hp P-26 hspWAfrica yes yes yes no yes yes yes draft
370 AKOY01 Hp H-4 hspWAfrica yes yes yes no yes yes yes draft
371 CBPE01 SA161A hspWAfrica yes yes yes no yes yes yes draft
372 CBOE01 SA214A hspWAfrica yes yes yes no yes yes yes draft
373 CBNS01 SA214C hspWAfrica yes yes yes no yes yes yes draft
374 CBNO01 SA215C hspWAfrica yes yes yes no yes yes yes draft
375 CBNM01 SA161C hspWAfrica yes yes yes no yes yes yes draft
376 CBNC01 SA216C hspWAfrica yes yes yes no yes yes yes draft
377 AKOK01 Hp H-30 hspWAfrica yes yes yes no yes yes yes draft
378 AWER01 GAM117Ai hspWAfrica yes yes yes no yes yes yes draft
379 APEA01 GAM270ASi hspWAfrica yes yes yes no yes yes yes draft
380 AKPL01 Hp P-4 hspWAfrica yes yes yes no yes yes yes draft
381 AKPH01 Hp H-34 hspWAfrica yes yes yes no yes yes yes draft
382 AKPE01 Hp H-19 hspWAfrica yes yes yes no yes yes yes draft
383 APCY01 GAM105Ai hspWAfrica yes yes yes no yes yes yes draft
384 AKOU01 Hp A-16 hspWAfrica yes yes yes no yes yes yes draft
385 APDY01 GAM265BSii hspWAfrica yes yes yes no yes yes yes draft
386 AKPB01 Hp H-10 hspWAfrica yes yes yes no yes yes yes draft
387 APDB01 GAM115Ai hspWAfrica yes yes yes no yes yes yes draft
388 APCX01 GAM103Bi hspWAfrica yes yes yes no yes yes yes draft
389 AKQM01 Hp P-28b hspWAfrica yes yes yes no yes yes yes draft
390 AKOX01 Hp H-3 hspWAfrica yes yes yes no yes yes yes draft
391 APEF01 GAM83T hspWAfrica yes yes yes no yes yes yes draft
392 APDN01 GAM249T hspWAfrica yes yes yes no yes yes yes draft
393 APEC01 GAM71Ai hspWAfrica yes yes yes no yes yes yes draft
394 AKPG01 Hp H-23 hspWAfrica yes yes yes no yes yes yes draft
395 APEI01 GAMchJs106B hspWAfrica yes yes yes no yes yes yes draft
396 APEB01 GAM42Ai hspWAfrica yes yes yes no yes yes yes draft
397 APCZ01 GAM112Ai hspWAfrica yes yes yes no yes yes yes draft
398 APDK01 GAM244Ai hspWAfrica yes yes yes no yes yes yes draft
399 APDJ01 GAM239Bi hspWAfrica yes yes yes no yes yes yes draft
400 AKOR01 Hp A-6 hspWAfrica yes yes yes no yes yes yes draft
401 APEH01 GAM96Ai hspWAfrica yes yes yes no yes yes yes draft
402 APEK01 GAMchJs117Ai hspWAfrica yes yes yes no yes yes yes draft
403 APEJ01 GAMchJs114i hspWAfrica yes yes yes no yes yes yes draft
404 APDC01 GAM201Ai hspWAfrica yes yes yes no yes yes yes draft
405 APDI01 GAM231Ai hspWAfrica yes yes yes no yes yes yes draft
406 APFB01 HP260BFii hspWAfrica yes yes yes no yes yes yes draft
407 APDV01 GAM260BSi hspWAfrica yes yes yes no yes yes yes draft
408 APEL01 GAMchJs124i hspWAfrica yes yes yes no yes yes yes draft
409 APCW01 GAM101Biv hspWAfrica yes yes yes no yes yes yes draft
410 CBPU01 SA168A hspWAfrica yes yes yes no yes yes yes draft
411 CBPP01 SA224C hspWAfrica yes yes yes no yes yes yes draft
412 CBOV01 SA252C hspWAfrica yes yes yes no yes yes yes draft
413 CBOC01 SA168C hspWAfrica yes yes yes no yes yes yes draft
414 CBOB01 SA224A hspWAfrica yes yes yes no yes yes yes draft
415 CBNI01 SA29C hspWAfrica yes yes yes no yes yes yes draft
416 CBNP01 SA252A hspWAfrica yes yes yes no yes yes yes draft
417 not published CAM-3A1 hspWAfrica yes yes yes no yes yes yes draft
418 not published CAM-129A1 hspWAfrica yes yes yes no yes yes yes draft
419 not published CAM-122A1 hspWAfrica yes yes yes no yes yes yes draft
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420 not published CAM-152A1 hspWAfrica yes yes yes no yes yes yes draft
421 not published CAM-148A1 hspWAfrica yes yes yes no yes yes yes draft
422 not published CAM-16A1 hspWAfrica yes yes yes no yes yes yes draft
423 not published CAM-11A1 hspWAfrica yes yes yes no yes yes yes draft
424 not published CAM-44A1 hspWAfrica yes yes yes no yes yes yes draft
425 not published CAM-32A1 hspWAfrica yes yes yes no yes yes yes draft
426 not published CAM-201C1 hspWAfrica yes yes yes no yes yes yes draft
427 not published CAM-195C1 hspWAfrica yes yes yes no yes yes yes draft
428 not published CAM-195A1 hspWAfrica yes yes yes no yes yes yes draft
429 not published CAM-75C24 hspWAfrica yes yes yes no yes yes yes draft
430 not published CAM-75A1 hspWAfrica yes yes yes no yes yes yes draft
431 not published CAM-123A1 hspWAfrica yes yes yes no yes yes yes draft
432 not published CAM-130A1 hspWAfrica yes yes yes no yes yes yes draft
433 not published CAM-6A1 hspWAfrica yes yes yes no yes yes yes draft
434 not published CAM-46A1 hspWAfrica yes yes yes no yes yes yes draft
435 not published CAM-57C1 hspWAfrica yes yes yes no yes yes yes draft
436 not published CAM-47A1 hspWAfrica yes yes yes no yes yes yes draft
437 not published CAM-173C1 hspWAfrica yes yes yes no yes yes yes draft
438 not published CAM-173A1 hspWAfrica yes yes yes no yes yes yes draft
439 not published CAM-10A1 hspWAfrica yes yes yes no yes yes yes draft
440 not published CAM-143A1 hspWAfrica yes yes yes no yes yes yes draft
441 not published CAM-131A1 hspWAfrica yes yes yes no yes yes yes draft
442 not published CAM-127A1 hspWAfrica yes yes yes no yes yes yes draft
443 not published CAM-4A1 hspWAfrica yes yes yes no yes yes yes draft
444 not published CAM-19A1 hspWAfrica yes yes yes no yes yes yes draft
445 not published CAM-43A1 hspWAfrica yes yes yes no yes yes yes draft
446 not published CAM-45A1 hspWAfrica yes yes yes no yes yes yes draft
447 not published CAM-205C1 hspWAfrica yes yes yes no yes yes yes draft
448 not published CAM-201A1 hspWAfrica yes yes yes no yes yes yes draft
449 not published CAM-128A1 hspWAfrica yes yes yes no yes yes yes draft
450 not published CAM-36A1 hspWAfrica yes yes yes no yes yes yes draft
451 not published CAM-204C1 hspWAfrica yes yes yes no yes yes yes draft
452 not published CAM-204A1 hspWAfrica yes yes yes no yes yes yes draft
453 NZ_LT837687.1 BCM-300 hspWAfrica yes yes yes no yes yes yes WGS
454 NC_000921.1 J99 hspWAfrica yes yes yes yes yes yes yes WGS
455 NC_017381.1 2018 hspWAfrica yes yes yes no yes yes yes WGS
456 NC_017374.1 2017 hspWAfrica yes yes yes no yes yes yes WGS
457 NC_017357.1 908 hspWAfrica yes yes yes no yes yes yes WGS
458 NC_017371.1 Gambia94/24 hspWAfrica yes yes yes no yes yes yes WGS
459 NC_017742.1 PeCan18 hspWAfrica yes yes yes no yes yes yes WGS
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Supplementary Table 2. REase gene sequences analysed to predict their activity.
Predicted full length REase was determined as sequences without any stop codon within the CDS. 
J99 REase sequence used as reference sequence.
Accession numbers, Strains ID, Strain Population, predicted full length protein (+: yes, -: no) 
and the aminoacid length of the protein are on the table.
# Accession No. Population Strain ID
Predicted full 
length protein Aminoacids
1 NC_000921.1  hspWAfrica J99 + 250
2 APDL01  hspWAfrica GAM245Ai + 250
3 APED01 hspWAfrica GAM80Ai + 250
4 APDA01  hspWAfrica GAM114Ai - 179
5 CADH01  hspWAfrica NQ1701 - 124
6 AKOZ01  hspWAfrica Hp H-6 + 250
7 NC_022130.1 hpAfrica2 SouthAfrica20 + 250
8 CBPS01 hpAfrica2 SA174A + 250
9 CBOK01 hpAfrica2 SA169C + 250
10 CBMV01 hpAfrica2 SA29A + 250
11 CBPO01 hpAfrica2 SA175A - 18
12 CBOI01 hpAfrica2 SA175C - 18
13 CBOR01 hpAfrica2 SA253C + 250
14 CBOJ01 hpAfrica2 SA253A + 250
15 AVNI01 hpAfrica2 SouthAfrica50 + 250
16 CBOH01 hpAfrica2 SA155C - 8
17 CBNZ01 hpAfrica2 SA155A - 8
18 CBPI01 hpAfrica2 SA34A - 10
19 CBNK01 hpAfrica2 SA194C - 10
20 CBPB01 hpAfrica2 SA47C - 10
21 CBOT01 hpAfrica2 SA47A - 10
22 CBNN01 hpAfrica2 SA40A - 10
23 CBPW01 hpAfrica2 SA194A - 10
24 CBQI01 hpAfrica2 SA36C - 10
25 CBQC01 hpAfrica2 SA251A - 10
26 CBPD01 hpAfrica2 SA233C - 10
27 CBOX01 hpAfrica2 SA144C - 10
28 CBNJ01 hpAfrica2 SA144A - 10
29 CBMX01 hpAfrica2 SA233A - 10
30 CBPG01 hpAfrica2 SA172C - 10
31 CBQN01 hpAfrica2 SA160A - 10
32 CBQF01 hpAfrica2 SA160C - 10
33 NC_017361.1 hpAfrica2 SouthAfrica7 - 8
34 NC_011498.1 hpEurope P12 + 250
35 CADG01 hpEurope NQ352 + 250
36 AKOW01 hpEurope Hp A-27 - 80
37 JSXX01 hpEurope 173/00 + 250
38 NC_019560.1 hspAmerind Aklavik117 - 125
39 not published hspMaori inma52 - 219
40 CBOD01 hspSAfrica SA46C - 229
41 CBNV01 hspSAfrica SA46A - 229
42 CBNU01 hspSAfrica SA35C - 229
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43 CBNE01 hspSAfrica SA35A - 229
44 CBPV01 hspSAfrica SA156C - 208
45 CBNR01 hspSAfrica SA156A - 208
46 CBPR01 hspSAfrica SA45C - 229
47 CBNB01 hspSAfrica SA45A - 229
48 CBQG01 hspSAfrica SA300A - 229
49 CBPY01 hspSAfrica SA158C - 229
50 CBPM01 hspSAfrica SA31C - 229
51 CBPL01 hspSAfrica SA300C - 229
52 CBOW01 hspSAfrica SA163C - 229
53 CBOQ01 hspSAfrica SA210C - 229
54 CBOL01 hspSAfrica SA158A - 229
55 CBOG01 hspSAfrica SA163A - 229
56 CBNW01 hspSAfrica SA210A - 229
57 -
-
Helicobacter cetorum MIT 
99-5656 + 250
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Supplementary Table 3. Sequences flanking the REase gene and downstream of the MTase gene.
Repeat sequences flanking the REase gene in the REase-carrying strains (superior table) 
and downstream of the MTase gene in the non-carrying strains (table below)
Accession numbers, Strains ID, Strain Population, and flanking sequences are on the table
# Accession No. Population Strain ID Flanking sequence 1 Flanking sequence 2
1 NC_017361.1 hpAfrica2 SouthAfrica7 CAAAATGG CTAAAAATGG
2 NC_022130.1 hpAfrica2 SouthAfrica20 CTAAAAATGG CTAAAAATGG
3 NC_000921.1  hspWAfrica J99 CTAAAAATGG CTAAAAATGG
4 APDL01  hspWAfrica GAM245Ai CTAAAAATGG CTAAAAACGG
5 CBNE01 hspSAfrica SA35A CTAAAAATGG CTAAAAATGG
6 CBNV01 hspSAfrica SA46A CTAAAAATGG CTAAAAATGG
7 NC_011498.1 hpEurope P12 CTAAAAATGG CTAAAATGG
8 CADG01 hpEurope NQ352 CTAAAAATGG CTAAAAACGG
9 NC_019560.1 hspAmerind Akklavik117 CAAAAACTGG CTAAAAATGG
10 - - H. cetorum MIT 99-5656 CTAAAAATGG CTAAAATGG
11 - - H. cetorum MIT 99-5665 CTAAAAATGG CTAAAATGG
# Accession No. Population Strain ID Downstream sequence
1 NC_000915.1 hpEurope 26695 TAAAAAAATGG
2 NC_017362.1 hpEurope Lithuania75 CTAAAAATGG
3 NC_017381.1  hspWAfrica 2018 ATAAAACGG
4 NC_017357.1  hspWAfrica 908 ATAAAACGG
5 CBQB01 hspSAfrica SA30C ATAAAACGG
6 CBPJ01 hspSAfrica SA157C CTAAAAACGG
7 - hpNEAfrica CAM-105A1 CTAAAAATGG
8 - hpNEAfrica CAM-117A1 CTAAAAATGG
9 NC_017376.1 hpAsia2 SNT49 CTAAAAATGG
10 NZ_CP006820.1 hpAsia2 oki102 CTAAAAATGG
11 ALWV01 hpSahul Sahul64 ATAAAATGG
12 - hpSahul PNGhigh12A ATAAAATGG
13 NC_020508.1 hspEAsia OK113 CTAAAAATGG
14 NC_017367.1 hspEAsia F57 ATAAAATGG
15 NC_017359.1 hspAmerind Sat464 ATAAAATGG
16 - - H. acinonychis str. Sheeba ATAAAATGG
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Supplementary Table 4. Shared methylated motifs between the four strains tested in the study. 
Specificity, type of methylation and presence (+) or absence (-) of methylation.
# Specificity 26695 J99 H1 BCM-300 Type of methylation
1 GCGC + + + + m5C
2 GATC + + + + m6A
3 CATG + + + + m6A
4 CCTC / GAGG + - / + ? /+ ? /+ m5C / m6A
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Supplementary Table 5. RNA-Seq results.
List of DEGs (FC > 2, p-adj < 0.01) in J99 (left) and in BCM-300 (right). 
The result is based on the upregulation or downregulation of the genes in the mutated strains compared to the wild type.
DEGs shared between both strains are highlited in blue.
# locus_tag FC
Regulation 
mutant Gene Name # locus_tag FC
Regulation 
mutant Gene Name
1 jhp_0842 8.296 up - 1 BCM_00032 3.183 down icdA
2 jhp_1208 6.552 up - 2 BCM_00033 3.027 down -
3 jhp_0623 5.101 up - 3 BCM_00034 2.998 down bioD
4 jhp_0538 4.833 up oorB 4 BCM_00035 2.942 down bioD
5 jhp_0424 4.512 up horE 5 BCM_00073 2.724 down -
6 jhp_0548 4.427 up flaA 6 BCM_00172 2.006 down -
7 jhp_0585 4.402 up putative 3-hydroxyacid dehydrogenase 7 BCM_00173 2.188 down prtC
8 jhp_0206 4.375 up putative aminotransferase 8 BCM_00513 4.766 down mraY
9 jhp_0043 4.356 up type II DNA MTase, M.Hpy99V 9 BCM_00514 3.105 down murD
10 jhp_0207 4.096 up - 10 BCM_00589 2.123 down -
11 jhp_0537 3.941 up oorA 11 BCM_00590 2.383 down gtp1
12 jhp_0051 3.853 up - 12 BCM_00591 2.536 down pepA
13 jhp_0539 3.764 up oorC 13 BCM_00707 4.325 down feoB
14 jhp_0656 3.502 up - 14 BCM_00850 2.835 down lex2B
15 jhp_0536 3.454 up oorD 15 BCM_00859 3.195 down -
16 jhp_0632 3.367 up Predicted N-methylhydantoinase 16 BCM_00860 3.603 down moeB
17 jhp_1321 3.329 up Histidine and glutamine-rich metal-binding protein 17 BCM_00938 5.520 down -
18 jhp_0022 3.306 up gltA 18 BCM_01111 2.312 down gluP, fucP
19 jhp_0008 3.249 up groEL 19 BCM_01112 2.281 down -
20 jhp_0101 3.222 up dnaK 20 BCM_01124 3.356 down cah
21 jhp_0212 3.204 up hopM 21 BCM_01188 2.681 down holA
22 jhp_0633 3.195 up hyuA 22 BCM_01189 2.174 down vacB
23 jhp_0576 3.134 up hyaC 23 BCM_01191 2.867 down -
24 jhp_0843 3.132 up hook assembly protein 24 BCM_01192 2.724 down oppB
25 jhp_1261 3.120 up hopN 25 BCM_01275 2.938 down -
26 jhp_0763 3.025 up trxA 26 BCM_01276 5.701 down trmU
27 jhp_0263 2.974 up gppA 27 BCM_01305 2.022 down -
28 jhp_0622 2.966 up - 28 BCM_01306 3.412 down -
29 jhp_0334 2.963 up kgtP 29 BCM_01307 3.279 down crdR
30 jhp_1432 2.934 up horL
31 jhp_0586 2.900 up frxA
32 jhp_0849 2.885 up hopB 
33 jhp_0786 2.876 up hsdM 2 (Type I R-M system)
34 jhp_0804 2.863 up flgE 
35 jhp_0495 2.841 up cagA 
36 jhp_0660 2.835 up dcuA 
37 jhp_0554 2.823 up hefC
38 jhp_0541 2.816 up -
39 jhp_0968 2.803 up cfa 
40 jhp_0612 2.790 up -
41 jhp_0262 2.789 up Ferredoxin 
42 jhp_1209 2.731 up -
43 jhp_0661 2.719 up ansB 
44 jhp_1093 2.717 up pgi 
45 jhp_0584 2.688 up -
46 jhp_0214 2.651 up hopA 
47 jhp_0850 2.636 up hopG
48 jhp_0715 2.636 up -
49 jhp_0009 2.633 up groES 
50 jhp_1183 2.630 up nuoC 
51 jhp_0764 2.623 up trxB 1 
52 jhp_0610 2.619 up hemN 1 
53 jhp_0768 2.586 up guaB 
54 jhp_0228 2.573 up napA 
55 jhp_0717 2.548 up -
56 jhp_0575 2.541 up hyaB 
57 jhp_0098 2.495 up metB 
58 jhp_0631 2.480 up -
59 jhp_1182 2.479 up nuoB 
60 jhp_0469 2.468 up cag1
61 jhp_1320 2.461 up hpn, histidine-rich metal binding polypeptide
62 jhp_0848 2.460 up hopC 
63 jhp_0689 2.431 up fliD 
64 jhp_0727 2.407 up hmcT, cadA
65 jhp_0079 2.397 up -
66 jhp_0296 2.393 up -
67 jhp_1038 2.393 up porB 
68 jhp_1352 2.391 up -
69 jhp_0716 2.389 up acnB 
70 jhp_1106 2.379 up nupC
71 jhp_0615 2.372 up aspB 
72 jhp_0833 2.348 up babA 
73 jhp_1164 2.334 up babB 
BCM-300J99
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74 jhp_0387 2.333 up pepQ 
75 jhp_0073 2.328 up horA
76 jhp_0382 2.291 up -
77 jhp_0574 2.282 up hyaA 
78 jhp_1022 2.257 up putative OMP
79 jhp_0573 2.246 up -
80 jhp_1094 2.245 up hofH
81 jhp_0710 2.243 up -
82 jhp_0126 2.242 up -
83 jhp_0376 2.232 up -
84 jhp_0997 2.227 up -
85 jhp_0102 2.202 up grpE 
86 jhp_0570 2.173 up dapD 
87 jhp_0077 2.167 up rplM 
88 jhp_0888 2.165 up rdxA
89 jhp_0839 2.161 up -
90 jhp_1158 2.154 up carA 
91 jhp_1348 2.149 up -
92 jhp_0348 2.139 up nixA 
93 jhp_1260 2.138 up tonB 2 
94 jhp_0775 2.134 up -
95 jhp_0553 2.133 up hefB
96 jhp_0264 2.133 up waaC 
97 jhp_0125 2.126 up -
98 jhp_1103 2.119 up hopQ
99 jhp_0074 2.110 up -
100 jhp_0031 2.109 up -
101 jhp_1105 2.100 up deoB 
102 jhp_0249 2.098 up clpB 
103 jhp_1349 2.086 up lpp20 
104 jhp_0690 2.067 up fliS 
105 jhp_0099 2.061 up cysK 
106 jhp_0193 2.059 up mpr
107 jhp_1181 2.058 up nuoA 
108 jhp_1194 2.055 up nuoN 
109 jhp_0684 2.050 up -
110 jhp_0171 2.037 up glyA 
111 jhp_0844 2.030 up flgE_2
112 jhp_0589 2.028 up -
113 jhp_1159 2.024 up amiF
114 jhp_1047 2.014 up flgK 
115 jhp_0388 2.009 up folK 
116 jhp_1368 2.001 down kdtB 
117 jhp_1278 2.004 down ubiA 
118 jhp_0455 2.007 down -
119 jhp_1270 2.013 down -
120 jhp_1420 2.014 down glmS 
121 jhp_1436 2.025 down -
122 jhp_1410 2.026 down res 2 
123 jhp_0665 2.027 down -
124 jhp_0186 2.030 down rpmF 
125 jhp_0365 2.053 down -
126 jhp_0766 2.061 down -
127 jhp_0751 2.062 down motA 
128 jhp_0812 2.067 down -
129 jhp_0092 2.072 down -
130 jhp_1112 2.072 down cah
131 jhp_0244 2.079 down Type II MTase, M.Hpy99VII
132 jhp_0482 2.087 down cagS 
133 jhp_1414 2.104 down -
134 jhp_1355 2.106 down secreted protein
135 jhp_0191 2.113 down -
136 jhp_0853 2.121 down carB 
137 jhp_0647 2.122 down -
138 jhp_0330 2.125 down -
139 jhp_1165 2.134 down rpsR 
140 jhp_0547 2.169 down spaB
141 jhp_0885 2.170 down -
142 jhp_0027 2.172 down -
143 jhp_1415 2.173 down exoA 
144 jhp_1408 2.185 down -
145 jhp_0025 2.199 down bioD 
146 jhp_1322 2.216 down ksgA 
147 jhp_1140 2.227 down purD 
148 jhp_1412 2.231 down recG 
149 jhp_0929 2.235 down -
150 jhp_1493 2.251 down -
151 jhp_1013 2.254 down -
152 jhp_1048 2.254 down -
153 jhp_0468 2.256 down -
154 jhp_1462 2.257 down -
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155 jhp_0966 2.257 down -
156 jhp_0412 2.263 down pyrD 
157 jhp_0045 2.283 down Type II Mtase, M.Hpy99II
158 jhp_0203 2.284 down -
159 jhp_0299 2.304 down -
160 jhp_1419 2.351 down -
161 jhp_1077 2.351 down -
162 jhp_1422 2.354 down Type I R-M system S subunit, S.Hpy99XV
163 jhp_1021 2.361 down -
164 jhp_1279 2.380 down comEC 
165 jhp_0035 2.387 down comB2 
166 jhp_1056 2.389 down -
167 jhp_1303 2.394 down -
168 jhp_0241 2.396 down -
169 jhp_0744 2.398 down acpS 
170 jhp_0935 2.414 down -
171 jhp_1076 2.415 down -
172 jhp_0164 2.417 down Type IV REase, Hpy99McrBP
173 jhp_0444 2.436 down putative paralog of HpaA 
174 jhp_0311 2.451 down lpxK 
175 jhp_0995 2.459 down -
176 jhp_0115 2.465 down rpmI 
177 jhp_1309 2.469 down -
178 jhp_1478 2.475 down -
179 jhp_1102 2.487 down -
180 jhp_1069 2.541 down fmt 
181 jhp_0064 2.549 down ureF 
182 jhp_0046 2.556 down Type II REase, Hpy99II
183 jhp_1310 2.566 down miaA 
184 jhp_0818 2.568 down cysS 
185 jhp_0331 2.570 down -
186 jhp_0116 2.583 down rplT 
187 jhp_0385 2.588 down -
188 jhp_1318 2.602 down -
189 jhp_0160 2.647 down -
190 jhp_0930 2.650 down -
191 jhp_1134 2.694 down -
192 jhp_1465 2.710 down fliE 
193 jhp_1012 2.733 down Type II MTase, M.Hpy99XVIII
194 jhp_0796 2.769 down -
195 jhp_0880 2.772 down -
196 jhp_0496 2.776 down murI 
197 jhp_0243 2.783 down xseA 
198 jhp_0693 2.797 down -
199 jhp_0013 2.850 down -
200 jhp_1283 2.885 down crdR
201 jhp_1443 2.914 down crdR
202 jhp_1179 2.919 down -
203 jhp_0034 3.046 down comB1 
204 jhp_0971 3.085 down paralog of HpaA
205 jhp_0940 3.103 down -
206 jhp_0933 3.134 down -
207 jhp_0970 3.219 down -
208 jhp_0441 3.226 down -
209 jhp_0941 3.283 down xerCD 
210 jhp_0310 3.373 down flaG 
211 jhp_1253 3.467 down -
212 jhp_1281 3.469 down -
213 jhp_1477 3.518 down -
214 jhp_0014 3.628 down -
215 jhp_0831 3.641 down toxin of a Type II Toxin-Antitoxin (TA) system
216 jhp_0852 3.765 down -
217 jhp_0934 3.805 down -
218 jhp_0749 3.825 down -
219 jhp_0627 3.880 down feoB 
220 jhp_0165 4.036 down -
221 jhp_0750 4.086 down moeB 
222 jhp_1254 4.529 down trmU 
223 jhp_0785 5.345 down Type I R-M system S subunit, S.Hpy99XVI
224 jhp_0832 5.949 down antitoxin of a Type II Toxin-Antitoxin (TA) system 
225 jhp_0951 6.885 down xerCD 
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Supplementary Table 6. Plasmids and mutants used and created in the present study.
Ab = antibiotic, amp = ampicillin, aphA3 = kanamycin, CAT = cholamphenicol
# Plasmid code Description Ab cassette
1 pSUS3401 pUC19_BCM300_GCGC-M_aphA3 amp , aphA3
2 pSUS3402 pUC19_26695_GCGC-M_aphA3 amp , aphA3
3 pSUS3403 pUC19_J99_GCGC-M_aphA3 amp , aphA3
4 pSUS3404 pUC19_H1_GCGC-M_aphA3 amp , aphA3
5 pSUS3406 pUC19_J99_GCGC_RM_aphA3 amp , aphA3
6 pSUS3411 pADC_ 26695_GCGCcomp_P+ amp , aphA3 , CAT
7 pSUS3413 pADC_ 26695_GCGCcomp_P- amp , aphA3 , CAT
8 pSUS3426 pUC19_jhp0832 amp
9 pSUS3427 pUC19_jhp0832_mut1 amp
10 pSUS3428 pUC19_jhp0832_mut2 amp
11 pSUS3429 pUC19_jhp0832_mut3 amp
12 pUC19 - amp
13 pADC/CAT pUC19 derivative amp , CAT
# Description Plasmid / PCR product for transformation Ab cassette
1 H. pylori 26695 hp1121::aphA3 pSUS3402 aphA3
2 H. pylori BCM-300 GCGC_MTase::aphA3 pSUS3401 aphA3
3 H. pylori BCS100-H1 GCGC_MTase::aphA3 pSUS3404 aphA3
4 H. pylori J99 jhp1050-49::aphA3 pSUS3406 aphA3
5 H. pylori 26695 hp1121::aphA3 complemented (P+) pSUS3411 CAT, aphA3
6 H. pylori 26695 hp1121::aphA3 complemented (P-) pSUS3413 CAT, aphA3
7 H. pylori J99 hp1121::aphA3 complemented (P+) pSUS3411 CAT, aphA3
8 H. pylori J99 hp1121::aphA3 complemented (P-) pSUS3413 CAT, aphA3
9 H. pylori jhp0832 mut 1 rdxA::CAT pSUS3427 + rdxA::CAT (PCR product) CAT
10 H. pylori jhp0832 mut 2 rdxA::CAT pSUS3428 + rdxA::CAT (PCR product) CAT
11 H. pylori jhp0832 mut 3 rdxA::CAT pSUS3429 + rdxA::CAT (PCR product) CAT
12 H. pylori jhp0832 mut 4 rdxA::CAT pSUS3427 + pSUS3428 + rdxA::CAT (PCR product) CAT
13 H. pylori jhp0832 mut 6 rdxA::CAT pSUS3428 + pSUS3429 + rdxA::CAT (PCR product) CAT
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Supplementary Table 7. Oligonucleotide sequences used in the present study. 
Lower case letters in the nucleotide sequence indicate the restriction site or the overlapping sequences for overlap PCR. 
In the restriction site column, minus means that a restriction site was not added to the primers
# Primer name Nucleotide sequence (5' - 3') Restriction site Direction Purpose
1 GCGC_M_PstI_for atactgcagATTTTAACTTTTATGGATTTTTG PstI for MTase / R-M system inactivation
2 GCGC_M_OL1_rev_A cggatcggacagtgcTTAACATTTTCAAGCAAGAAAC - rev MTase / R-M system inactivation
3 GCGC_M_OL1_rev_B cggatcggacagtgcTTAACGTTTTCAAGCAAGAAAC - rev MTase / R-M system inactivation
4 GCGC_M_OL2_for_A gctcggtagccttgcACTTTTAATATTATTATCAAAGCC - for MTase / R-M system inactivation
5 GCGC_M_OL2_for_B gctcggtagccttgcACTTTTAAAACCATTATCAAAGCC - for MTase / R-M system inactivation
6 GCGC_M_BamHI_rev ataggatccCAATCACATTCACGCTCA BamHI rev MTase / R-M system inactivation
7 GCGC_R_EcoRI_for atagaattcATAATCATACAAGTTCTTTTGG EcoRI for MTase / R-M system inactivation
8 GCGC_R_OL1_rev cggatcggacagtgcTATATCTTGTCTTGTCGGCT - rev MTase / R-M system inactivation
9 GCGC_R_OL2_for gctcggtagccttgcTGCTTGCATATGAATTTACC - for MTase / R-M system inactivation
10 GCGC_R_XhoI_rev atactcgagTCCTGTAGGGTCAATTTTAA XhoI rev MTase / R-M system inactivation
11 jhp0832_PstI_for atactgcagACTCCCTTTTTTAACCCTC PstI for Site-directed mutagenesis
12 jhp0832_BamHI_rev ataggatccACTACGGCAAGCTAAACTA BamHI rev Site-directed mutagenesis
13 jhp0832_mut_For1_NEW ATCTCTTAAAAAAGAGCTTCTTTAGGGGG - for Site-directed mutagenesis
14 jhp0832_mut_Rev1_NEW TACCGCTTGAATTAACGCCAAGTTTCC - rev Site-directed mutagenesis
15 jhp0832_mut_For2_NEW TCTATCGCTTGAGCTATAATGAATCG - for Site-directed mutagenesis
16 jhp0832_mut_Rev2_NEW GCGGTATTAAAAAGGCTAGAAAATT - rev Site-directed mutagenesis
17 jhp0832_mut_For3_NEW TCCAATTTAAAGAGCTCCATTTAACC - for Site-directed mutagenesis
18 jhp0832_mut_Rev3_NEW GTGCTTTTTTAATCCTTTGCTTTTGA - rev Site-directed mutagenesis
19 jhp0832_check1 ATCCAAACTCAAAAGCAAAG - for qPCR
20 jhp0832_check2 TCTTAGTGTCCTTAGCCCT - rev qPCR
21 RTqPCR_comB8_1 AACCGAACACCATTTCGTG - for semiqRT-PCR and qPCR
22 RTqPCR_comB8_2 ATGAGCGAACGAGCCAAC - rev semiqRT-PCR and qPCR
23 RTqPCR_comB9_1 ATGCAGGATTTAAACGCCAT - for semiqRT-PCR and qPCR
24 RTqPCR_comB9_2 ATCGCTAATGGGTTTTGAAA - rev semiqRT-PCR and qPCR
25 RTqPCR_comEC_1 ATGATATAGGGGTTTTGGTG - for semiqRT-PCR and qPCR
26 RTqPCR_comEC_2 AGCAATTTAGGGAGTAACGC - rev semiqRT-PCR and qPCR
27 RTqPCR_horA_1 AGGTATGGCATTAGCCTT - for semiqRT-PCR and qPCR
28 RTqPCR_horA_2 ATCGGGGTGTTATTGTTAG - rev semiqRT-PCR and qPCR
29 RTqPCR_horE_1 AGGCTTTGCCAATAAATGGT - for semiqRT-PCR and qPCR
30 RTqPCR_horE_2 ACCTAGAGCGAATTTATCC - rev semiqRT-PCR and qPCR
31 RTqPCR_horL_1 ATGGATGGTAATGGCGT - for semiqRT-PCR and qPCR
32 RTqPCR_horL_2 ATTGGCATGAGCGTAGTCA - rev semiqRT-PCR and qPCR
33 RTqPCR_hofH_1 ACTCACCTATAAACCTCATC - for semiqRT-PCR and qPCR
34 RTqPCR_hofH_2 ATCAGAGCGAAAGCCTGT - rev semiqRT-PCR and qPCR
35 RTqPCR_hopA_1 ATCAAGTCTCAAGCGTTAT - for semiqRT-PCR and qPCR
36 RTqPCR_hopA_2 AGAATATTGGGTTTCGTTGA - rev semiqRT-PCR and qPCR
37 RTqPCR_hopB_1 TGAGCGCTAAGGAATTCACT - for semiqRT-PCR and qPCR
38 RTqPCR_hopB_2 AGTGTTTGTGGTGTTGTTTA - rev semiqRT-PCR and qPCR
39 RTqPCR_hopC_1 ACAACAACACCGGAGGCA - for semiqRT-PCR and qPCR
40 RTqPCR_hopC_2 AAAGAGCGTTCGCAGACAC - rev semiqRT-PCR and qPCR
41 RTqPCR_hopG_1 TGGAGTTCTTTTGGGAGAG - for semiqRT-PCR and qPCR
42 RTqPCR_hopG_2 ATGCCAGCCATAATTGATGA - rev semiqRT-PCR and qPCR
43 RTqPCR_hopQ_1 TGCTCCTTTAAATAGCAAAG - for semiqRT-PCR and qPCR
44 RTqPCR_hopQ_2 ATCAACATGGGGCAATAATC - rev semiqRT-PCR and qPCR
45 RTqPCR_hopN/M_1 ACCCTAATTCCCCAGAAGGT - for semiqRT-PCR and qPCR
46 RTqPCR_hopN/M_2 ATACCTTAACCCCCAATTCCT - rev semiqRT-PCR and qPCR
47 16S_RT1 TTACTAGCGATTCCAGCTTC - for semiqRT-PCR and qPCR
48 16S_RT2 TGAGATGTTGGGTTAAGTCC - rev semiqRT-PCR and qPCR
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MIQE Checklist for qPCR Assays: 
 
1. Sample 
 
H. pylori strains were grown in liquid media containing: 
 Brain Heart Infusion (BHI) (32 g/L)+ yeast extract (2.5 g/L) ‐ 90% 
 Horse Serum (heat‐inactivated, autoclaved) ‐ 10% 
 Amphotericin B (4 mg/ml) ‐ Dilution of 1:1000 
 antibiotic cocktail (Vancomycin 10 mg/L, Polymyxin 3,2 mg/L, Trimethoprim 5 g/L) 
Bacteria  were  grown  under  microarobic  conditions  generated  in  airtight  jars  90  (Oxoid,  Wesel, 
Germany)  with  Anaerocult  C  gas  producing  bags  (Merck,  Darmstadt,  Germany),  incubated  with 
shaking (37°C, 140 rpm, microaerobic conditions) and grown to an OD600 ~ 0.6. 
For RNA extraction, 5 ml of  the  cultures were pelleted  (4°C, 6000  x  g, 3 min). Pellets were  snap‐
frozen in liquid nitrogen and stored at ‐80 °C. 
2. Nucleic Acids 
 
Bacterial pellets were disrupted with a FastPrep® FP120 Cell Disrupter (Thermo Savant) using Lysing 
Matrix B 2 ml tubes containing 0.1 mm silica beads (MP Biomedicals, Eschwege, Germany).  
RNA was  isolated using  the RNeasy kit  (Qiagen, Hilden, Germany) and on‐column DNase digestion 
with  DNase  I.  A  second  DNase  treatment  was  carried  out  according  to  the  manufacturer’s 
instructions using the Ambion TURBO DNA‐free™ Kit (Ambion, Kaufungen, Germany).  
Isolated RNA was checked for the absence of DNA contamination by PCR reaction using primers for 
the housekeeping gene efp (listed below). 
Concentrations  of  the  RNA  samples were measured with  the NanoDrop  2000  spectrophotometer 
(Peqlab Biotechnologies).  
RNA quality was given as RINe number, measured with an Agilent 4200 Tape Station system using 
RNA  Screen  Tapes  (Agilent, Waldbronn,  Germany).  A  RIN  number  >  8  was  taken  as  acceptable 
quality.  
3. Reverse transcription 
 
One µg of total RNA (consistent total amount over all samples) was transcribed into cDNA in a total 
volume  of  40  µl  using  the  SuperScript™  III  Reverse  Transcriptase  (Thermo  Fisher  Scientific, 
Darmstadt, Germany).  
The protocol was as follows: 
Step 1: RNA‐Primer Mix                
Component  Volume   
Total RNA           1 µg 
Random Primers (Invitrogen) 3 µg/µl           2 µl (1:60) 
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A. dest (RNase‐free, QIAGEN)  Ad 27 µl 
Incubation: 5 min at 65°C, 1 min on ice 
Step 2        
Setting up the cDNA Synthesis‐Mix: 
Component 
Vol. 1x 
[µl] 
5x First‐Strand Buffer (MgCl2), Invitrogen  8 
DTT (0,1 M)  2 
dNTP (10 mM)  1 
RNaseOUT (40 U/µl)  1 
SuperScript III RT (200 U/µl)  1 
 
Addition of  the 13 µl mix to the RNA‐Primer 
Mix (27 µl) 
Incubation: 5 min at room temperature (25°C), 
90 min at 50°C 
Inactivation: 15 min at 70°C 
   
Step 3 
cDNA synthesis was checked via PCR using primers for housekeeping genes. 
cDNA was stored at ‐20 °C. 
 
4. Target 
 
Genomes of the four strains used in this study are available at the NCBI database and they have been 
published previously in: 
 Krebes, J., Morgan, R.D., Bunk, B., Sproer, C., Luong, K., Parusel, R., Anton, B.P., Konig, C., 
Josenhans, C., Overmann, J. et al. (2014) The complex methylome of the human gastric pathogen 
Helicobacter pylori. Nucleic Acids Res., 42, 2415‐2432. 
 Nell, S., Estibariz, I., Krebes, J., Bunk, B., Graham, D.Y., Overmann, J., Song, Y., Spröer, C., Yang, I., 
Wex, T. et al. (2018) Genome and methylome variation in Helicobacter pylori with a cag 
Pathogenicity Island during early stages of human infection. Gastroenterology, 154, 612‐623. 
 Tomb, J.F., White, O., Kerlavage, A.R., Clayton, R.A., Sutton, G.G., Fleischmann, R.D., Ketchum, 
K.A., Klenk, H.P., Gill, S., Dougherty, B.A. et al. (1997) The complete genome sequence of the 
gastric pathogen Helicobacter pylori. Nature, 388, 539‐547. 
 Alm, R.A., Ling, L.S., Moir, D.T., King, B.L., Brown, E.D., Doig, P.C., Smith, D.R., Noonan, B., Guild, 
B.C., deJonge, B.L. et al. (1999) Genomic‐sequence comparison of two unrelated isolates of the 
human gastric pathogen Helicobacter pylori. Nature, 397, 176‐180. 
 Kennemann, L., Didelot, X., Aebischer, T., Kuhn, S., Drescher, B., Droege, M., Reinhardt, R., 
Correa, P., Meyer, T.F., Josenhans, C. et al. (2011) Helicobacter pylori genome evolution during 
human infection. PNAS, 108, 5033‐5038. 
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Gene accession numbers of genes used for qPCR in the two reference strains J99 and 26695 can be 
easily found in the http://genolist.pasteur.fr/PyloriGene/: 
 
Gene   Locus tag (J99)  Locus tag (26695) 
comB8  jhp_0034  hp_0038 
comB9  jhp_0035  hp_0039 
hopA  jhp_0214  hp_0229 
hopC  jhp_0848  hp_0912 
crdR  jhp_1283, 
jhp_1443 
hp_1365 
bioD  jhp_0025  hp_0029 
trmU  jhp_1254  hp_1335 
feoB  jhp_0627  hp_0687 
cah  jhp_1112  hp_1186 
moeB  jhp_0692  hp_0755 
‐  jhp_0749  hp_0813 
‐  jhp_1102  hp_1102 
‐  jhp_1281  hp_1363 
 
All the RNA-Seq data was placed in the ArrayExpress database with accession number E-MTAB-7162 
5. Primers 
 
Primers were designed manually and produced by Metabion International AG (Germany). All the 
annealing temperatures were between 50°C and 55°C. 
Primers are listed here: 
Primer name  Nucleotide sequence (5' ‐ 3')  Amplicon Length (bp) 
Target 
gene 
Annealing 
temperature
jhp0832_check1  ATCCAAACTCAAAAGCAAAG 
112  jhp_0832  50°C 
jhp0832_check2  TCTTAGTGTCCTTAGCCCT 
qPCR_crdR_for  AGGATAACGCTACCTTAAAAA 
109  crdR  51°C 
qPCR_crdR_rev  TCATTGAAAAACCTTTTAATGC 
qPCR_bioD_for  ACATGCGCTAGGCTATTAGC 
148  bioD 
 
54°C 
qPCR_bioD_rev  AGCGATCTAAAAGGCGGTTA 
qPCR_moeB_for  AGGGTGTATCCAAGCGAGC 
127  moeB  54°C 
qPCR_moeB_rev  AGGGTTTTTGGGTGCTTGAA 
qPCR_jhp1102_for  AGAAGTTGGGTCATGCGAAG 
128  jhp_1102  55°C 
qPCR_jhp1102_rev  ACAAGCGTAGCCTTATGGGT 
qPCR_trmU_for  TTTAGCCTTGAATGCGATGC 
132  trmU  53°C 
qPCR_trmU_rev  ACCACGCCCTCTTTTTCCA 
qPCR_jhp1281_for  ATCGCAAGGGATTTTTCTCA 
117  jhp_1281  52°C 
qPCR_jhp1281_rev  TAAAGCCACGCTCCCTAAA 
116
qPCR_jhp1253_for  ATTTGAGCGGCGTTAAGAATT 
133  jhp_1253  53°C 
qPCR_jhp1253_rev  AAAGCGCTCATCAAATCCAAT 
qPCR_jhp0749_for  AAGGCGATTTTAATCACGCA 
116  jhp_0749  52°C 
qPCR_jhp0749_rev  TCTAGCATGAACACATCGTC 
RTqPCR_comB8_1  AACCGAACACCATTTCGTG 
108  comB8  51°C 
RTqPCR_comB8_2  ATGAGCGAACGAGCCAAC 
RTqPCR_comB9_1  ATGCAGGATTTAAACGCCAT 
159  comB9  50°C 
RTqPCR_comB9_2  ATCGCTAATGGGTTTTGAAA 
16S_RT1   TTACTAGCGATTCCAGCTTC 
272  16S  55°C 
16S_RT2   TGAGATGTTGGGTTAAGTCC 
HPefpF02  GGGCTTGAAAATTGAATTGGGCGG 
501  efp  53°C 
HPefpR01  GTATTGACTTTAATGATCTCACCC 
 
6. PCR Cycling  
 
qPCR was performed with gene specific primers (listed above) and SYBR Green Master Mix (Qiagen, 
Hilden, Germany).  
Standards for all target genes were prepared in ultrapure H2O at different concentrations (2 pg, 0.2 
pg, 0.02 pg, 2 fg, 0.2 fg (concentrations given per µl)). 
Reactions were prepared as follows: 
 
 
 
 
 
The qPCR protocol run for all primers was: 
1: 95.0°C for 15:00 min 
2: 95.0°C for 0:15 min 
3:  X for 0:30 min (X determine the temperature of each primers combination) 
4: 72.0°C for 0:30 min  
Plate Read 
5: GOTO 2, 39 more times (40 cycles in total) 
6: Melt Curve 60.0°C to 95.0°C: Increment 0.5°C 0:05 
 
 
 
SYBR Green Mastermix  10 µl 
Primer for  1 µl 
Primer rev  1 µl 
H20  7.5 µl 
cDNA  0.5 µl 
Final volume  20 µl 
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7. Data analysis 
 
Reactions were  run  in  a  BioRad  CFX96  system.  Threshold,  Cq  and  Sq  values were  automatically 
determined by the  instrument. The efficiency calculated by the  instrument software was  in average 
higher than 94 % (SD = 13.84). 
Standard  curves  and  samples  were  run  as  technical  triplicates.  Cq  values  were  automatically 
determined  by  the  program  CFX  using  the  standards  included  in  every  qPCR  run.  NTCs  were 
predominantly negative (<0.02 pg) and performed with distilled water as negative control (standard 
curve given automatically by the software).  
For quantitative comparisons, samples were normalized  to an  internal 16S rRNA control qPCR. The 
controls were run as technical triplicates. The Sq means of the technical triplicates for all runs were 
normalized to the wild‐type strain values (which were set to 1, for each strain and gene separately), 
in order to create the correction factors. Then, the mean values of the target genes were corrected 
using the corresponding calculated correction factors for each strain.  
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6. DISCUSSION 
 
Rapid genetic diversification is a characteristic feature of H. pylori. The bacteria are normally acquired 
during early childhood and, while all infected individuals develop histological gastritis, most do not 
develop further symptoms. H. pylori infection is commonly only detected later in life when the bacteria 
have established a chronic infection. By the time of writing this thesis, most of the genomic studies 
have been accomplished using isolates obtained at different intervals of time in chronically infected 
patients. These studies allowed the calculation of mutation rates and recombination frequencies, and 
the analysis of the distribution of genetic changes. Nonetheless, very little was known about the 
genome evolution during the early stages of H. pylori infection. H. pylori harbors a large number of 
genes encoding R-M systems and every H. pylori strain carries a unique set of R-M systems leading to 
variable methylomes. Nowadays, the methylome evolution and the functional role of the R-M systems 
in H. pylori are not well understood. In the course of this thesis, I worked on both topics. I studied the 
genome and methylome evolution of H. pylori during early-phase H. pylori infection, and I 
characterized the role of a highly conserved MTase in epigenetic regulation of H. pylori. The thesis 
resulted in two published manuscripts and yet unpublished data. Each manuscript contains detailed 
discussions of the subjects; therefore, this section aims at integrating these novel findings into the 
previous knowledge of H. pylori’s biology. 
6.1. Genome and methylome evolution of H. pylori during acute infection 
6.1.1. The mutation rates during early-stage of infection are in agreement with the 
mutation rates in chronic infections 
In manuscript I, we analyzed whole-genome sequences of isolates from 12 human volunteers who 
were given a prophylactic vaccine candidate or placebo and subsequently challenged with a fully 
virulent H. pylori strain (BCM-300). Afterwards, the volunteers were treated with antibiotics to 
eradicate the infection (Malfertheiner, Selgrad et al. 2018). In vivo genome evolution of H. pylori and 
the calculation of the mutation rates from sequential and paired isolates from chronic infections have 
been studied extensively (Morelli, Didelot et al. 2010, Kennemann, Didelot et al. 2011, Didelot, Nell et 
al. 2013). The estimated mutation rates during long-term infections were found to be higher than for 
most of the bacteria analyzed so far. Our whole-genome comparisons of the re-isolates revealed that 
mutation rates during early-stage (i.e. the first 10-12 weeks) infection were in agreement with those 
calculated for strains from chronically infected individuals. We did not observe any recombination 
event, which is plausible, because the volunteers were H. pylori-negative until they were challenged 
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with the BCM-300 strain. In a previous study from our group, two isolates from volunteers who 
participated in a vaccination trial and were challenged with a cagPAI-negative strain called BCS 100 
(Aebischer, Bumann et al. 2008) were sequenced using 454 sequencing technology (Kennemann, 
Didelot et al. 2011). In an ongoing study (Estibariz, Suerbaum et al., unpublished data) we sequenced 
antrum and corpus isolates that were harvested 10 weeks post-infection from volunteers who 
participated in the same vaccination trial (Aebischer, Bumann et al. 2008). We calculated the average 
mutation rate as 4.50 × 10−6 mutations per site per year, which was also in agreement with previous 
estimates of the mutation rate during chronic infection. In contrast to our results, in the only available 
other study investigating the genetic evolution of H. pylori during acute infection, Linz and colleagues 
(Linz, Windsor et al. 2014) reported a mutation rate 140-fold higher than our estimates, and a high 
recombination rate. Frequent exchange of DNA usually occurs during mixed infections (Falush, Kraft 
et al. 2001). Thus, it is likely that in the study conducted by Linz and colleagues there was an ongoing 
mixed infection. In this particular study, two initially H. pylori positive human volunteers were re-
infected with H. pylori after having received eradication therapy with antibiotics. The success of the 
eradication therapy was monitored only by UBTs. In our samples, although some UBTs were negative 
for H. pylori infection, we were able to culture bacteria from gastric biopsies. Therefore, in the context 
of challenge trials, negative UBTs do not exclude the presence of low levels of H. pylori infection. It is 
possible that in the study conducted by Linz et al. (Linz, Windsor et al. 2014), the infection was not fully 
eradicated by the antibiotic treatment and, therefore, the strains analyzed could be part of the 
preexisting infection. Our results showed no evidence of recombination in the absence of a second 
unrelated H. pylori strain.  
In conclusion, the challenge of H. pylori-negative human volunteers with a reference H. pylori strain in 
the context of a carefully monitored clinical study, and the subsequent analysis of H. pylori isolates 
directly evolved from the challenge strain permits an accurate investigation of mutation rates during 
early-stage infection (Kennemann, Didelot et al. 2011, Nell, Estibariz et al. 2018). The major limitations 
in these studies (manuscript I and unpublished data) are the small number of isolates per individual 
that we obtained. Moreover, this type of infection studies do not allow the investigation of 
recombination events due to the absence of mixed infections.  
6.1.2. Variation of OMP-related genes and virulence factors during acute infection 
Recombination and mutations during chronic infection generate allelic variation in H. pylori, which is 
thought to be important in the adaptation to selective pressures encountered in novel stomach niches 
after transmission to a new host (Suerbaum and Josenhans 2007). In manuscript I, we observed that 
several isolates displayed sequence changes within OMP-encoding genes. The same phenomenon was 
previously reported for chronic infection studies. Several isolates carried mutations within genes of 
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the hop/hof/hor families or switched the activity of the adhesins sabA and sabB due to phase-variation 
and intra-chromosomal recombination events in these two adhesins.  These observations were in 
agreement with the results of genome analyses of H. pylori isolates from chronically infected 
individuals that demonstrated that OMP-related genes show a significantly higher tendency to have 
genetic changes during in vivo colonization (Kennemann, Didelot et al. 2011, Krebes, Didelot et al. 
2014). In an ongoing study (Estibariz, Suerbaum et al., unpublished data); we observed that several 
isolates contained mutations in babA. It was previously shown that there is strong selective pressure 
affecting the major adhesin BabA during the colonization of humans (Colbeck, Hansen et al. 2006, Nell, 
Kennemann et al. 2014), Rhesus monkeys (Solnick, Hansen et al. 2004) and rodents (Styer, Hansen et 
al. 2010).  
Modifications in OMP-related genes seem to occur in many bacteria to establish the infection. For 
example, genetic diversification of adhesins and OMP-related genes was observed in Salmonella 
enterica serovar Typhimurium (Yue, Han et al. 2015) or in Burkholderia dolosa (Lieberman, Flett et al. 
2014). Quick diversification of OMP-associated genes might be important for H. pylori in the adaptation 
to new stomach niches, or to new host individuals. A recent study from our group has provided support 
for this hypothesis: the study analyzed gastric biopsies from three stomach regions of 16 H. pylori-
infected individuals. The results showed that there is an association between gene polymorphisms 
affecting motility, chemotaxis and OMPs, and the adaptation to different stomach parts (antral and 
oxyntic mucosa) (Ailloud, Didelot et al. 2019).  
In manuscript I, we also observed changes in two major virulence factors of H. pylori, the cagPAI and 
VacA. Three of the 12 re-isolates lost cagPAI function due to frameshift mutations in cagY, or the 
insertion of a mobile element in cagE. In addition, two isolates containing non-synonymous SNPs in 
cagA and cagW showed a reduction in IL-8 induction and another isolate carried additional cagA 
copies. Thus, at least in the context of the strain BCM-300, we observed a selection against cagPAI 
function in multiple individuals. It was reported before that the cagPAI could be partially or completely 
lost during chronic infections (Bjorkholm, Lundin et al. 2001, Kraft, Stack et al. 2006, Ailloud, Didelot 
et al. 2019). Modifications in the cagPAI and its ability to induce IL-8 may have an impact on adaptation 
to new hosts by modulating the inflammatory response of the gastric mucosa. 
The ability to produce VacA was abrogated in three isolates from the vaccine group due to stop codons 
in the gene sequence. Although diverse allelic variants of vacA displaying different toxicities and the 
loss of vacA activity have been already identified in vivo (Falush, Kraft et al. 2001, Aviles-Jimenez, Letley 
et al. 2004), VacA inactivation in these three isolates from the vaccination group possibly occurred as 
a response to vaccine-induced selective pressure. Interestingly, VacA has been reported to be an 
important factor in H. pylori colonization of animal models, although it was not completely required 
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for colonization (Wirth, Beins et al. 1998, Salama, Otto et al. 2001, Winter, Letley et al. 2014). Thus, 
inactivation of VacA activity could affect H. pylori colonization, but it might also be a way to evade the 
immune-induced response caused by the vaccine. 
The study reported in manuscript I, is one of the very first studies (Kennemann, Didelot et al. 2011, 
Linz, Windsor et al. 2014) investigating genome adaptation of H. pylori during early-stage infection. 
We showed that genetic changes affecting OMP-related genes and virulence factors occurred early in 
H. pylori infection, potentially contributing to the rapid adaptation of this pathogen to a novel gastric 
niche. Thus, early modulation of adhesion and virulence factor activity might maintain a balance 
between the pathogenicity of the bacteria and the immune response of the host, favoring H. pylori to 
establish a chronic infection. 
6.1.3. Vaccine-induced modulation of virulence factors 
The rapid increase of bacterial resistance to antibiotics is a major concern. There is a need for 
developing novel approaches to stop bacterial infections. Vaccines against H. pylori could end the 
transmission and produce a decrease in antibiotic resistance since fewer antimicrobials would be 
prescribed. For example, a vaccine against Streptococcus pneumoniae was shown to be effective in 
immunocompetent patients and reduced the rate of pneumococcal infections (Shapiro, Berg et al. 
1991, Daniels, Rogers et al. 2016).  
In manuscript I, H. pylori isolates were obtained from human volunteers that were given a prophylactic 
vaccine candidate or placebo. The vaccine was composed of three recombinant H. pylori antigens 
(VacA, CagA, and  NAP, a neutrophil-activating protein) (Malfertheiner, Selgrad et al. 2018). Although 
well tolerated and capable of inducing an immune response in the volunteers, the vaccine was 
ineffective against H. pylori infection. Our whole-genome analysis showed that three of the seven 
isolates from the vaccine group displayed premature stop codons in vacA. In contrast, the analysis of 
whole genomes of isolates from another vaccination and H. pylori challenge study (Aebischer, Bumann 
et al. 2008) did not show modifications within these major virulence factors (Estibariz, Suerbaum et 
al., unpublished data). The vaccine used in this study was a Salmonella Typhi Ty21a strain expressing 
H. pylori urease. Thus, despite the small cohort available to us the use of VacA in the prophylactic 
vaccine (manuscript I) likely led to a selection of isolates with a disrupted vacA gene to avoid the 
immune response. 
In both vaccine studies (manuscript I and Estibariz, Suerbaum et al., unpublished data), we showed 
that OMP-related genes and LPS were prone to modifications, suggesting that these genetic changes 
might help H. pylori escape the immune system. Immune system avoidance due to vaccine-related 
selective pressure has been reported in other microorganisms. For example, despite the effectivity of 
the Hib vaccine preventing Haemophilus influenzae infections, the wide usage of the vaccine caused 
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the emergence of capsular polysaccharide variants, one of the main virulence factors of this bacterium. 
Modifications within this capsular polysaccharide resulted in non-typeable pathogenic H. influenzae 
serotypes (Agrawal and Murphy 2011).  
The development of a successful vaccine is challenging due to the great genetic diversity between H. 
pylori strains, which are able to adapt quickly to novel niches. Although a vaccine would be very 
beneficial to stop the transmission, especially in countries where the infection rate is very high with a 
higher incidence of gastric malignancies, it seems that there are no current efforts by the 
pharmaceutical industry to develop novel vaccines against H. pylori. A recent review by Sutton & Boag 
summarizes the status of the H. pylori vaccine development programs from the past years (Sutton and 
Boag 2018). Most of the studies stopped after preclinical or phase I stages with the exception of one 
vaccine candidate that reached phase III. The recombinant vaccine was given to children and followed-
up to 1 and 3 years. The authors observed a reduced H. pylori infection rate (Zeng, Mao et al. 2015, 
Sutton and Boag 2018). Despite this reduction, the results should be confirmed after longer periods. 
In conclusion, the rapid genetic evolution of H. pylori likely contributes to the ability of the bacteria to 
escape from the action of the vaccines tested so far. However, the exact mechanisms leading to vaccine 
failure have not been elucidated. Thus, to develop a successful vaccine candidate, more efforts are 
needed to understand how H. pylori genetic variability contributes to the avoidance and modulation 
of the immune system.  
6.2. The role of methylation in H. pylori 
6.2.1. Discovery of novel R-M systems and methylomes 
R-M systems are almost ubiquitous in bacteria. Indeed, DNA methylation was found in 93% of bacterial 
and archaeal genomes (Blow, Clark et al. 2016). In manuscript I, we obtained the complete methylomes 
of the challenge strain BCM-300 and all the re-isolates analyzed in the study. We discovered 15 
methylated motifs and of those, 11 were assigned to already known MTase genes. Inactivation of 
candidate genes and subsequent SMRT® sequencing of the mutants allowed the discovery of three 
novel R-M systems. In addition, we studied the methylome of the BCS 100 challenge strain and the re-
isolates (Estibariz, Suerbaum et al., unpublished data). Here, we identified 24 methylated motifs 
corresponding to 22 active Type II and Type III R-M systems, and of those, three were novel R-M 
systems not characterized before. Our findings about the methylomes of BCM-300 and BCS 100 strains 
were in agreement with previous studies in H. pylori, where we observed that H. pylori strains harbor 
a large number of R-M systems. The number of R-M systems found in bacteria usually shows a positive 
correlation with the genome size. Helicobacter and Campylobacter species are an exception to this, 
because they contain a surprisingly large amount of R-M systems despite their small genomes (Vasu 
Discussion 
 
124 
 
and Nagaraja 2013). Thus, while most bacteria harbour two to six R-M systems (Lluch-Senar, Luong et 
al. 2013, Vasu and Nagaraja 2013, Fischer, Römling et al. 2019), H. pylori strains can hold up to 30 R-M 
systems (Vasu and Nagaraja 2013).   
Since the development of SMRT® sequencing technology, we and other researchers have been able to 
characterize the methylomes of many different H. pylori strains (Krebes, Morgan et al. 2014, Lee, Anton 
et al. 2015, Roberts, Vincze et al. 2015, Lamichhane, Chua et al. 2019) demonstrating how complex the 
methylome of H. pylori is. Our comparison of the methylomes of J99, 26695, BCM-300 and BCS 100 
showed that only three motifs (GCGC, GATC and CATG) were shared between the four strains. 
Previously, Vale et al. analyzed 221 H. pylori gDNA samples for their susceptibility to cleavage by 29 
REases (Vale, Megraud et al. 2009). The authors observed very few MTases common to the majority 
of the strains and only one motif (GCGC) present in all. The great diversity of R-M systems and orphan 
MTases in H. pylori suggests they must have another role a part of self-DNA protection.  
6.2.2. Phase-variable MTases are responsible for changes in the methylome of H. pylori 
isolates 
H. pylori methylome studies have uncovered that every strain shows a distinct methylation pattern, 
but as far as we know, there is no information about methylome evolution in vivo in this gastric 
pathogen. In manuscript I, we dissected for the first time methylome modifications during early-stage 
human H. pylori infection and we observed that differences were due to phase-variable MTase genes 
with homopolymeric tracts. Similar results were obtained for the isolates of human volunteers 
challenged with the BCS 100 strain (Estibariz, Suerbaum et al., unpublished data). In both studies, we 
found two different phase-variable R-M systems. In manuscript I, we identified one phase-variable R-
M system gene with two homopolymeric tracts. Alterations in the number of nucleotides within the 
first tract affected the activity (ON/OFF) of the R-M system. Changes in the second repetitive sequence 
led to the methylation of different motifs. The R-M system (Hpy300XI) was homologous to HpyAXVI 
(H. pylori 26695) and Hpy99XIV (H. pylori J99-R3) (Krebes, Morgan et al. 2014). This frameshift-
mediated sequence specificity switch seems to be a particularity of H. pylori.  At least to my knowledge, 
by the time writing this thesis, it has not been discovered in other bacteria.  
Phase-variable R-M systems have been described in many other bacteria. Srikhanta and colleagues 
described what is known as “phasevarion” (Srikhanta, Maguire et al. 2005). Phasevarions are groups 
of genes whose expression is jointly affected by a reversible switch of phase-variable MTase genes. 
The authors studied the role in the phenotype and transcriptome of a phase-variable Type III MTase 
of H. influenzae. Several genes were differentially expressed between the wild type and a mutant strain 
with an inactive MTase gene, which affected many phenotypic traits.  
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Every MTase gene prone to phase-variation could be a potential regulator of the expression of several 
genes. Phasevarions are found in multiple bacterial pathogens and contribute to their virulence and 
adaptation. In M. catarrhalis, different phase-variable MTases have been proposed to modulate the 
expression of genes involved in colonization and defence against host immunity and proposed an 
association with otitis media (Blakeway, Power et al. 2014). The reversible switching of ModA2 in H. 
influenzae resulted in different abilities to fight oxidative stress and resist neutrophil-mediated killing 
(Brockman, Branstool et al. 2017). In pathogenic Neisseria species, phasevarions have been shown to 
affect the expression of genes coding for virulence factors and vaccine antigens (Seib, Jen et al. 2017). 
Likewise, phasevarions have been studied in vitro in H. pylori. The ModH5 MTase activity was found to 
control the expression of the outer membrane gene hopG. Motility was also affected by the regulation 
of the expression of the flaA gene encoding the Flagellin A in the strain P12 (Srikhanta, Gorrell et al. 
2011, Srikhanta, Gorrell et al. 2017).  
Based on these previous studies, it is possible to speculate that phasevarions might influence in vivo 
adaptation of H. pylori to novel niches. So far, we did not investigate the phasevarions associated to 
the phase-variable MTases discovered in manuscript I and in the ongoing project, but this will be part 
of future investigations. 
6.2.3. A very highly conserved MTase found in all H. pylori strains 
When comparing the H. pylori methylomes available, we observed that one methylated motif (GCGC) 
described by Vale and colleagues (Vale, Megraud et al. 2009) was present in all H. pylori methylome 
studies (Krebes, Morgan et al. 2014, Lee, Anton et al. 2015, Nell, Estibariz et al. 2018). Therefore, in 
manuscript II we aimed to characterize the highly conserved MTase (JHP1050) found to be present in 
all H. pylori methylomes analyzed so far.  
We discovered that the MTase gene (jhp1050) was present in the 459 H. pylori genomes analyzed in 
the study and, based on the nucleotide sequence, were predicted to be active in all strains. In contrast, 
the REase gene (jhp1049) was present only in 61 strains and predicted to be functional in 15 of these. 
A 10 bp repeat sequence was identified flanking the REase gene. The same sequence was observed 
downstream of the MTase gene and 48 bp upstream of jhp1048 in REase-negative strains. The 
sequence contained a homopolymeric region with a variable number of adenines. Recombination 
between the repeat sequences flanking the REase gene might have been responsible for the gene 
excision. The fact that the strains carrying the REase had mostly an African ancestry and that the MTase 
was found to be present and active in all the strains, suggested that the R-M system is an ancient 
system acquired early in the history of H. pylori and that the REase was lost likely before the modern 
humans left Africa. The phylogenetic trees of the MTase and REase gene sequences performed in 
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manuscript II clustered the strains into geographical populations according to the MLST genes. MLST 
of seven housekeeping genes has been extensively used to genotype H. pylori into geographical 
populations (Achtman, Azuma et al. 1999, Nell, Eibach et al. 2013, Secka, Moodley et al. 2014). Our 
phylogenetic analysis of the jhp1050 MTase gene demonstrated its very high conservation in H. pylori, 
a rare exception among genes belonging to R-M systems.  
Methylated GCGC motifs are not exclusive to H. pylori. The search of the motif in the REBASE database 
(Roberts, Vincze et al. 2015) exhibited many other species whose methylomes contain this motif or 
similar variants (i.e. RGCGCY, WGCGCD, TGCGCA) including Campylobacters and other Helicobacter 
species. Furthermore, in eukaryotes, methylation usually occurs in CpG dinucleotides and plays a 
pivotal role in cell differentiation and gene silencing (Moore, Le et al. 2013, Jang, Shin et al. 2017). 
In this way, the high conservation of cytosine methylation within GC sequences might reflect its 
importance in the biology of both prokaryotes and higher organisms.  
6.2.4. m5C-Methylation regulates gene expression and the phenotype of H. pylori 
Although R-M systems have been described as “primitive immune systems” in bacteria, the role of 
methylation in modulating gene expression in prokaryotes is extensively recognized. m6A-Methylation 
is the most common type of modification in bacterial genomes, and consequently, its implication in 
epigenetic regulation has been a focus for many years (Messer, Bellekes et al. 1985, Kang, Lee et al. 
1999, Kozdon, Melfi et al. 2013). In manuscript II, we dissected the role of m5C-methylation of GCGC 
motifs in the transcriptome of two different H. pylori strains and their isogenic MTase mutants. So far, 
very few studies attempted to understand the role of cytosine methylation in the biology of H. pylori 
or any other bacterium. The role of m5C-methylation in the transcriptome of H. pylori was investigated 
using microarrays. The deletion of one m5C-MTase gene in two H. pylori strains led to significant 
differences in their transcriptomes (Kumar, Mukhopadhyay et al. 2012). Later, the regulatory role of 
m4C-methylation in transcription in one H. pylori strain was shown using more quantitative techniques 
like RNA-seq (Kumar, Karmakar et al. 2018). Our transcriptome results in manuscript II showed that 
the role of m5C-methylation differed significantly between strains. While the absence of methylation 
modified the expression of 225 genes in strain J99, only 29 genes were differentially regulated when 
GCGC methylation was inactivated in strain BCM-300. Of those, 10 were shared between the two 
strains. We observed that differential expression of OMP-related genes and competence genes had an 
impact on cell adhesion and natural DNA uptake, respectively. Furthermore, the downregulation of 
the response regulator crdR in the absence of methylation had a direct impact on the resistance to 
copper. Interestingly, the strain J99 lacking GCGC methylation entered a coccoid state leading to a 
growth defect in liquid cultures. Thus, changes in the transcriptomes resulted in strain-specific and 
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conserved phenotypes.  The genetic diversity between H. pylori strains and the distribution of Gm5CGC 
motifs among the genomes could contribute to the differences observed between the strains. Besides, 
the activity of other strain-specific MTases could also have an impact on gene expression. 
We observed that differential gene expression was associated with the presence of three or more 
motifs within coding sequences or with motifs within regulatory regions. It was described before in V. 
cholerae, that the number of motifs within coding sequences was correlated with changes in gene 
expression (Chao, Zhu et al. 2015). Therefore, to my knowledge, our study is one of the first exploring 
the link between the amount of motifs within coding sequences and regulatory regions with changes 
in gene expression.  
We showed experimentally that one methylated motif overlapping the promoter sequence had a 
direct impact on gene expression. Using site-directed mutagenesis targeted methylatable GCGC motifs 
were modified to non-methylatable GAGC motifs. We observed a direct impact on gene expression of 
the selected gene when the GCGC motif overlapping the putative promoter was modified, as it 
happened with the J99 mutant strain lacking the MTase gene. In contrast, the modification of a single 
motif upstream of the putative promoter or within the coding sequence did not affect the transcription 
of the target gene. Thus, we were able to confirm that the methylation of target motifs within 
regulatory regions can have a direct impact on gene expression. Similarly, the expression of FlaA was 
modulated by direct methylation of target sites within the flaA promoter (Srikhanta, Gorrell et al. 
2017). DNA methylation of promoter sequences has been shown to regulate the progression of the 
cell cycle in C. crescentus (Gonzalez, Kozdon et al. 2014, Lina, Alzahrani et al. 2014) and DNA replication 
in E. coli (Messer, Bellekes et al. 1985, Kang, Lee et al. 1999) by competition with DNA binding proteins. 
In manuscript II we did not investigate whether the exact same mechanism is behind this direct 
regulation of gene expression. Furthermore, the great amount of DEGs and the fact that very few genes 
contain motifs within regulatory regions, points to an indirect regulation of the transcriptome by 
methylation. Indirect regulation might be caused by changes in DNA topology when the global 
methylation pattern is modified. Thus, a global effect in the transcriptomes might be caused by both, 
direct and indirect methylation-dependent regulation.  
The highly conserved m5C-MTase methylating GCGC motifs in H. pylori may act as a safeguard to 
maintain suitable transcript levels of many genes, in order to ensure adequate activity of several 
biological functions. Indeed, we showed that the inactivation of GCGC methylation caused multiple 
strain-specific phenotypes, including deleterious phenotypes such as a general loss of natural 
competence, reduced resistance to copper, growth defects, changes in morphology and reduced 
adhesion to cells.  
Discussion 
 
128 
 
6.3. Lessons learned and future directions 
In the current PhD thesis, I investigated the molecular mechanisms driving genomic and epigenomic 
evolution of H. pylori. To do so, we compared whole genomes and methylomes from isolates collected 
from early-stage human infections, and characterized the role of a highly conserved m5C-MTase in the 
transcriptome of this gastric pathogen. Despite recent advances made by us and many other scientists, 
many question are still unresolved.  
In manuscript I, we showed that modifications in the methylation patterns were due to changes in the 
activity of phase-variable MTases. However, we did not investigate the effect that the switch in the 
activity of the MTases could cause in the transcriptome. As mentioned above, intensive research has 
shown that methylation plays a key role in gene regulation (Kahramanoglou, Prieto et al. 2012, 
Gonzalez, Kozdon et al. 2014, Chao, Zhu et al. 2015, Kumar, Karmakar et al. 2018). Thus, it would be 
interesting to investigate the role of the phase-variable MTases during the early-stage of the infection, 
to understand how phasevarions could have an impact on adaptation. In Figure 1, a schematic 
representation of how phase-variable MTases could act in early-stage infection is shown. Host specific 
selective pressures would select for H. pylori isolates with ON or OFF alleles. Changes in the 
methylation pattern would change the expression of several genes, as we showed in manuscript II. 
These alterations of gene expression would trigger changes in protein translation and could enhance 
H. pylori‘s adaptation to new stomachs. Our transcriptome analysis showed that the absence of 
methylation in GCGC motifs located in regulatory regions led to a lower gene expression, whether this 
is the case for other motifs is not known. However, in the figure, this case is represented.  
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Figure 1. Schematic representation of phase-variable MTases and their influence on gene expression during 
acute infection. When the MTase gene (dark blue arrow) is in frame (homopolymeric tract is shown in light 
blue), the MTase enzyme (blue circle) methylates the motif (light green line) overlapping the promoter 
sequence (black arrow). Methylation of motifs overlapping the promoter would lead to a higher expression of 
the target gene (green arrow). SAM refers to the donor S-adenyl methionine.  
 
The WHO introduced H. pylori in the priority pathogen list for research and development of new 
antibiotics. The rapid increase in bacterial resistance requires new solutions to eradicate and prevent 
infections. The genetic variability of H. pylori and the high mutation rate we observed during early-
stage infection could partially explain why the vaccine candidates tested so far were not successful in 
preventing the infection. Genomic modifications, such as the ones affecting OMP-related genes, might 
favour immune evasion. Thus, further research in H. pylori‘s immune avoidance would be needed in 
order to develop successful vaccines or alternatives to prevent H. pylori infection. 
The majority of the SNPs observed during early-stage infection occurred in genes with an OMP-related 
role, indicating that active modification of the bacterial surface is important for the adaptation to novel 
niches. However, there were also several other uncharacterized genes carrying non-synonymous SNPs. 
Some of these genes could be implicated in cell adhesion or related with the bacterial surface. The 
central roles of some adhesins such as BabA or SabA have been deeply studied (Mahdavi, Sonden et 
al. 2002, Aspholm-Hurtig, Dailide et al. 2004, Yamaoka 2008, Nell, Kennemann et al. 2014, Hage, 
Howard et al. 2015) but the main receptors of the majority of putative adhesins remains unidentified. 
Recently, it was described that one major adhesin, HopQ, binds human CEACAMS and that the 
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interaction is important for CagA translocation into human epithelial cells (Javaheri, Kruse et al. 2016, 
Königer, Holsten et al. 2016). Understanding the function of OMP-related genes that are still not 
characterized would introduce new knowledge into H. pylori’s biology and the interaction with the 
human gastric epithelial cells. Furthermore, some genes with unknown function might have other 
roles. They could be involved in metabolism, motility or even methylation. Therefore, the great amount 
of uncharacterized genes reflects that more research is needed to understand how H. pylori adapts to 
new stomachs.   
Along the current thesis, the methylomes of bacterial isolates during acute infection have been 
described. In addition, we discovered that the deletion of a conserved m5C-MTase methylating GCGC 
motifs triggered several transcriptome modifications. The results suggested that this enzyme might 
contribute to maintain adequate transcript levels of many biological functions. Nevertheless, the exact 
mechanism of how methylation modulates gene expression is not fully understood. Although we linked 
direct regulation of gene expression to motifs within regulatory regions, we still do not fully 
comprehend the reason behind it. Besides, global regulation by methylation must also occur due to 
indirect effects caused by changes in the methylome. It was discovered that methylation modifies the 
curvature of the DNA (Diekmann 1987, Severin, Zou et al. 2011), and this phenomenon could have an 
impact on DNA-binding proteins. To my knowledge, the effect of methylation on the topology of the 
whole genome has not been researched. Protein-DNA interaction assays, such as chromatin 
immunoprecipitation assays with deep sequencing (ChIP-seq) (Schmidt, Wilson et al. 2009, Myers, Park 
et al. 2015), could answer the question whether the affinity of already known DNA-binding proteins is 
modified in the absence of methylation.  
Hitherto, we have studied a highly conserved MTase in H. pylori. It is well established that R-M systems 
can act as selfish mobile-genetic elements (Kobayashi 2001), which explains partially why this 
pathogen harbors such a high number of genes coding for R-M systems. In contrast, the effect on the 
transcriptome of a newly acquired MTase has not been elucidated. Thus, the in vitro introduction of 
an enzyme into an H. pylori strain could give us a first notion of how the acquisition of a novel R-M 
system modifies the fitness of the bacterium. 
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